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ABSTRACT 
A number of chemical agents have been identified to cause genotoxic 
effects in cells producing clastogenic, teratogenic, mutagenic and 
carcinogenic effects at different dosage of administration. Steroids are 
highly potent chemicals used as contraceptives, antiallergics, anti-
inflammatory and antidepressant agents used therapeutically. Steroids 
causing chromosome breakage, enhanced sister chromatid exchange and 
delayed cell-cycle kinetics have been reported in vitro and in vivo. While 
substitution for these drugs have yet to be found out, mitigation of toxicity 
needs to be attempted in order to help the patients, preferably, through 
dietary anti-mutagens. 
A number of counter toxicity principles have been identified and their 
mode of action studied. Most of these are known antioxidants and chemical 
extracts from plant sources for known biological action with wider medical 
application. Although some studies are available on antigenotoxic potential 
of plant products, few studies are available on anti-genotoxic principles in 
steroid-induced genotoxic effects in human cells in vitro and in vivo. Present 
study, therefore, is directed towards investigation of the antigenotoxic action 
of some natural products in steroid-induced genotoxic damage in human 
lymphocytes in vitro, and, in mice in vivo. 
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The aim of the present work is to study the genotoxic effects of 
steroids on human chromosomes in vitro, to score the observations with the 
administration of anti-mutagens in vitro and in vivo both synergistically as 
well as in isolation, and, to develop models of anti-mutagen-steroid 
interactions in inducing anti-mutagenicity from dose-time dependent 
relationship and suggest reaction mechanisms involved. Synthetic progestins 
such as cyproterone acetate, chlormadinone acetate, megestrol acetate, 
norgestrel and estrogen ethinylestradiol were used for inducing genotoxic 
damage in human peripheral blood lymphocyte culture for different 
concentrations and duration, and, parameters viz. clastogeny, sister 
chromatid exchange and cell cycle kinetics with and without metabolic 
activation were scored. Positive and negative controls were also taken. 
Nordihydroguaiaretic acid (NDGA), allicin and L-ascorbic acid act as 
antimutagenic principles to reduce the genotoxicity of steroids. 
Synthetic progestins are widely used as oral contraceptives in 
addition to their use in the treatment of various menstrual disorders, 
different types of cancers and in hormonal replacement therapy. For 
contraception, these are either used alone or in combination with estrogens 
such as mestranol and ethinylestradiol. There is sufficient data, which 
indicate that the prolonged use of synthetic progestins can cause cancer 
among animals and humans. The works undertaken on the genotoxicity of 
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an estrogen and some progestins and antigenotoxic effects of natural 
products are presented below: 
(i) Ethinylestradiol, a steroidal estrogen, is widely used with various 
progestogens in oral contraceptive formulations. There are sufficient 
evidences for the carcinogenicity of ethinylestradiol in experimental 
animals. The reports on genotoxic potential of ethinylestradiol are 
contradictory. The genotoxicity of ethinylestradiol was studied in human 
lymphocytes using chromosomal aberrations, mitotic index and sister 
chromatid exchanges as parameters. The study was carried out in the 
absence, as well as in the presence of rat liver microsomal fractions, with 
and without NADP. Ethinylestradiol was studied at three different 
concentrations (1,5 and 10 uM) and was found to be non-genotoxic in the 
absence of metabolic activation (S9 mix), as also in the presence of S9 mix 
without NADP. Ethinylestradiol was found to be genotoxic at 5 and 10 uM 
in the presence of S9 mix with NADP. To study the possible mechanism of 
the genotoxicity of ethinylestradiol, superoxide dismutase and catalase 
were used separately, as well as in combination with 10 uM of 
ethinylestradiol at different doses. Superoxide dismutase treatment increases 
chromosomal aberrations and, sister chromatid exchanges and decreases 
mitotic index as compared to the treatment given with 10 uM of 
ethinylestradiol carried in the presence of S9 mix with NADP at both of the 
tested doses. Catalase treatment decreases the frequencies of chromosomal 
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aberrations and sister chromatid exchanges and increases mitotic index, as 
compared to the treatment with 10 uJVl of ethinylestradiol in the presence of 
S9 mix with NADP. Catalase treatment in combination with superoxide 
dismutase also decreases the frequencies of chromosomal aberrations and 
sister chromatid exchanges and increase mitotic index, suggesting the 
possible role of reactive oxygen species for the genotoxic damage. 
(ii) Cyproterone acetate is a potent steroidal antiandrogen with 
progestational activity. It is used alone or in combination with 
ethinylestradiol or estradiol valerate in the treatment of women suffering 
from disorders associated with androgenization due to age or hirsuitism. The 
genotoxicity of cyproterone acetate was studied in human lymphocytes 
using chromosomal aberrations, mitotic index and sister chromatid 
exchanges as parameters. Cyproterone acetate was found to be genotoxic at 
20 and 30 uM of concentration. To study the possible mechanism of the 
genotoxicity of cyproterone acetate, superoxide dismutase and catalase were 
used separately and in combination along with the 30 uM of cyproterone 
acetate at different doses. Superoxide dismutase treatment increases 
chromosomal aberrations, sister chromatid exchanges and decreases mitotic 
index as compared to the treatment with 30 uM cyproterone acetate alone, at 
both of the tested doses. Catalase treatment decreases the frequency of 
chromosomal aberrations and sister chromatid exchanges and increases 
mitotic index in both the cases, as compared to treatment with 30 JUM 
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cyproterone acetate, separately and in combination with superoxide 
dismutase, suggesting the possible role of reactive oxygen species for the 
genotoxic damage. 
(iii) Norgestrel, a synthetic progestin is widely used as contraceptive. 
Amounts of 5, 10 and 20 uM of norgestrel was tested for their genotoxic 
effect in the absence as well as presence of metabolic activation using sister 
chromatid exchanges, chromosomal aberrations, mitotic index and 
replication index as parameters. Norgestrel was found genotoxic at 10 and 
20 uM in the presence of metabolic activation (S9 mix). 
Nordihydroguaiaretic acid (NDGA) is a phenolic lignan and possesses 
antioxidants and a number of properties potentially useful to man. The effect 
of nordihydroguaiaretic acid was studied against norgestrel induced 
genotoxic damage, using sister chromatid exchanges, chromosomal 
aberrations, mitotic index and replication index as parameters. About 10 uM 
of norgestrel was used with 0.5 and 1.0 uM of nordihydroguaiaretic acid, 
alone, as well as in the presence of metabolic activation. Similar treatment 
was given with 20 uM of norgestrel. Treatments given with 
nordihydroguaiaretic acid result in the reduction of sister chromatid 
exchanges, chromosomal aberrations and increase of mitotic index as well 
as replication index, suggesting its protective action on human lymphocytes 
in vitro against the norgestrel induced genotoxic damage. 
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(iv) Chlormadinone acetate, another synthetic progestin, is used as 
contraceptives. The genotoxicity study of chlormadinone acetate was carried 
out in the mouse bone marrow cells using chromosomal aberrations and 
sister chromatid exchanges as parameter. Chlormadinone acetate was 
studied at three different doses in mouse bone marrow cells i.e. 5.62, 11.25 
and 22.50 mg/kg body weight and was found to be non-genotoxic at 5.62 
mg/kg body weight. On the other hand at 11.25 and 22.50 mg/kg body 
weight, chlormadinone acetate increases sister chromatid exchanges and 
chromosomal aberrations at significant level compared to normal control. 
Effect of chlormadinone acetate was also studied at 10, 20, 30 and 40 uM on 
human lymphocytes in vitro, and was found genotoxic at dosage of 30 and 
40 uM. With a view to study the possible mechanism of genotoxicity of 
chlormadinone acetate, superoxide dismutase and catalase were used 
separately and in combination along with the 40 u,M of chlormadinone at 
different doses. Superoxide dismutase treatment increased chromosomal 
aberrations and sister chromatid exchanges at both the doses. Catalase 
treatment decreases the frequencies of chromosomal aberrations and sister 
chromatid exchanges in both the cases, separately and in combination with 
superoxide dismutase, suggesting the possible role of reactive oxygen 
species in the genotoxic damage. Allicin (diallyl thiosulphinate) and L-
ascorbic acid are well known antioxidants. Allicin, one of the sulphur 
compounds of garlic (Allium sativum), possess antioxidant, antigenotoxic 
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and free radical scavenging property. About 5 and 10 uM of allicin and 40 
and 80 uM of L-ascorbic acid was administered, separately with 40 uM of 
chlormadinone acetate. Treatment with allicin and L-ascorbic acid resulted 
in reduction of chromosomal aberrations and sister chromatid exchanges. 
The results suggest a protective role of allicin and L-ascorbic acid against 
chlormadinone acetate induced genotoxic damage. 
(v) Megestrol acetate, a potent synthetic progestin, was studied in 
mouse bone marrow cells using sister chromatid exchanges and 
chromosomal aberrations as parameters. Megestrol acetate (8.12, 16.25 and 
32.50 mg/kg of body weight) was injected intraperitoneally, and separately, 
in different groups of animals. Both chromosomal aberrations and sister 
chromatid exchanges were statistically increased at 16.25 and 32.50 mg/kg 
of body weight. Ascorbic acid (20, 40 and 60 mg/kg of body weight), 
administered together with megestrol acetate (32.50 mg/kg of body weight), 
decreased chromosomal aberrations and sister chromatid exchanges, 
significantly, suggesting the anti-genotoxic role of ascorbic acid against 
megestrol acetate induced genotoxic damage in mice bone marrow cells. 
The antigenotoxic effect was clearly dose dependent. The highest protective 
effect was observed at 60 mg/kg of body weight of ascorbic acid treatment 
with 32.50 mg/kg body weight of megestrol acetate. 
The results of the study reveal that the genotoxic effects of synthetic 
progestins can be reduced by natural plant products. A study on synthetic 
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progestins also reveals that ethynodiol diacetate, norethynodrel, norgestrel 
and lynestrenol, require metabolic activation in the presence of NADP to 
show genotoxic effects. Megestrol acetate, cyproterone acetate and 
chlormadinone acetate show genotoxic effect, even in the absence of 
metabolic activation. It is concluded that the progestins in which double 
bond between carbon-6 and carbon-7 is present undergo nucleophilic 
reaction and generate free radicals in the system and, therefore, show the 
genotoxic effects, and the progestins in which double bonds between 
carbon-6 and carbon-7 are absent, need metabolic activation (like estrogens 
such as estradiol-17(3 and ethinylestradiol) in order to show the genotoxic 
effects. The double bond between carbon-6 and carbon-7 is absent in 
estrogens. Estrogens undergo aromatic hydroxylation by cytochrome P450s 
and generate various forms of quinones. Quinones, via redox cycling in the 
presence of NADP, generate reactive oxygen species, which attack DNA 
and thus are responsible for the genotoxic damage. 
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1. INTRODUCTION 
Synthetic progestins are widely used as oral contraceptives in 
addition to their use in the treatment of various menstrual disorders, a 
number of cancers and in hormonal replacement therapy. Progestins, like 
estrogens, diffuse easily across the cell membranes and bind with highly 
specific, soluble receptor proteins in the cytoplasm. The steroid receptor 
complex modifies the expression of specific genes by binding with 
control elements in DNA (Yamamoto, 1985; Tanenbaum et al., 1998). 
For contraception, these are either used alone or in combination with 
estrogens such as ethinylestradiol, estradiol-17 P and mestranol (Schwend 
and Lippman, 1996). Conjugatted estrogens are listed in the Fourth 
Annual Report on Carcinogens (ROC), and are known to be human 
carcinogens (ROC, 1985). A number of individual steroidal estrogens, 
including estradiol-17(3, estrone, ethinylestradiol and mestranol, were 
listed in the ROC, and reasonably anticipated to be human carcinogens. 
Steroidal estrogens are placed in Group 1, on the basis of sufficient 
evidence of carcinogenicity in humans (IARC, 1979; 1987). 
Chromosomal abnormalities and sister chromatid exchanges have been 
reported in peripheral blood lymphocytes of women taking oral 
contraceptives (Carr, 1967, 1970; Goh, 1967; Murthy and Prema, 1979). 
There is sufficient data which indicate that the prolonged use of synthetic 
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progestins can cause cancer among animals and humans (Rudali, 1975; 
Weikel and Nelson, 1977; Eltreby and Graf, 1979; Misdorp, 1991; Demi 
et al , 1993; Martelli et al., 1996; Heinemann et al., 1997; IARC, 1999; 
Maier and Herman, 2001). A significant increase in the number of 
lymphocytes with DNA migration in alkaline comet assay and frequency 
of sister chromatid exchanges (SCEs) per metaphase was observed in oral 
contraceptive users as compared with their age matched untreated 
controls (Biri et al., 2002). Synthetic progestins have DNA damaging 
property as evident from chromosomal damage, induction of SCEs 
(Dhillon et al., 1994; Singh et al., 1994), formation of endogenous 
adducts and certain neoplastic changes (Brambilla and Martelli, 2002; 
Martelli et al., 2003). 
The use of synthetic progestins cannot be completely eliminated as 
oral contraceptives, but the genotoxic damage caused by the steroids can 
be reduced by the use of antioxidants (Ahmad et al., 2002; Siddique et al, 
2005a; Siddique and Afzal, 2005a) and various natural plant products 
(Ahmad et al., 2004; Siddique and Afzal, 2004a; Siddique and Afzal, 
2005a; Siddique et al., 2005; Siddique et al., 2006). A brief description of 
the only estrogen studied, the synthetic progestins and the natural plant 
products countering their genotoxic effects is as follows: 
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A. Estrogen 
Ethinylestradiol (CAS No. 57-63-6) 
Ethinylestradiol is used with various progestogens in combined 
oral contraceptive formulations (Schwend and Lippman, 1996). Although 
there is sufficient evidence for the carcinogenicity of ethinylestradiol in 
experimental animals (IARC, 1979), the gene mutation tests for it in 
bacterial and mammalian systems have been uniformly negative (Drevon 
et al., 1981; Lang and Reimann, 1993; Hundal et al., 1997). With few 
negative reports (Stenchever et al., 1969; Banerjee et al., 1994; Reimann 
et al., 1996; Shyama and Rahiman, 1996), ethinylestradiol induce sister 
chromatid exchanges and chromosomal aberrations in both in vitro and in 
vivo test systems (Shimazu et al., 1976; Kochhar, 1988; Lang and 
Reimann, 1993; Hundal et al , 1997). Several other workers have also 
reported unscheduled DNA synthesis (UDS) and adduct formation by 
ethinylestradiol in rat and human hepatocytes in vitro (Blakey and White, 
1985; Martelli et al., 2003), whereas contradictory results were reported 
by a group of other workers (Yager and Fifield, 1982; Feser et al., 1996). 
Ethinylestradiol has also been reported to cause aneuploidy in Chinese 
Hamster cells in vitro (Wheeler et al., 1986), and aneuploidy and 
polyploidy in V79 cells in vitro (Sato et al., 1992). Since the reports on 
the genotoxic potential of ethinylestradiol are contradictory, the effect of 
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ethinylestradiol at different doses on the chromosomal aberrations, 
mitotic index and sister chromatid exchanges was studied in the absence 
as well as in the presence of metabolic activation system, with and 
without NADP. Further, the effect of superoxide dismutase and catalase 
on ethinylestradiol, and its genotoxic dose was also evaluated in the 
presence of a metabolic activation system with NADP. 
B. Synthetic Progestins 
(i) Cyproterone acetate (CAS No.: 427-51-0) 
Cyproterone acetate is a potent steroidal antiandrogen with 
progestational activity. It is used alone or in combination with 
ethinylestradiol or estradiol valerate in the treatment of women suffering 
from disorders associated with androgenization, age or hirsuitism. 
Cyproterone acetate competes with dihydrotestrosterone for the androgen 
receptors and inhibits translocation of the hormone receptor complex into 
the cell nucleus (Sciarra et al., 1990). Cyproterone acetate is a tumor 
initiating agent in the liver of female rats (Demi et al., 1993; Martelli et 
al., 1996). It was found negative in V79 cells in vitro (Lang and Reimann, 
1993; Kasper et al., 1995), in Ames test (Lang and Reimann, 1993), and 
for micronucleus in mouse bone marrow cells in vivo (Reimann et al., 
1996), but it was positive for micronucleus in rat liver in vivo (Martelli et 
al., 1996) for chromosomal aberrations in V79 cells (Kasper et al., 1995) 
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and the human peripheral blood lymphocytes in vitro (Reimann et al., 
1996). It induces mutation in Big Blue rat (Krebs et al., 1998). It was also 
found positive for unscheduled DNA synthesis (UDS) test in rat 
hepatocytes (Neumann et al., 1992; Kasper, 1995; Topinka et al., 1995; 
Martelli et al., 1995), human hepatocytes in vitro (Martelli et al., 1995) 
and in rat liver in vivo (Kasper and Mtiller, 1996). In female rats, DNA 
adducts have been observed at low doses of cyproterone acetate, which 
are in the range of therapeutic doses used in women (Werner et al , 1997). 
The effect of cyproterone acetate at different doses on chromosomal 
aberrations, mitotic index and sister chromatid exchanges was studied in 
human lymphocytes in vitro. Further the effect of superoxide dismutase 
and catalase on cyproterone genotoxic dose was also worked out. 
(ii) Norgestrel (CAS No.: 797-63-7) 
Norgestrel was tested by oral administration in mice and rats. No 
increase in the incidence of tumors was observed in either species (I ARC, 
1979). It was reported to be genotoxic in cultured human peripheral blood 
lymphocyte with and without metabolic activation (Ahmad et al., 2001) 
and was negative for micronucleus in mouse bone marrow cells (Jordan, 
2002). The effect of norgestrel was studied on human lymphocytes both 
in the absence as well as presence of metabolic activation, with NADP, 
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using chromosomal aberrations, sister chromatid exchanges and cell cycle 
kinetics as parameters. 
(iii) Chlormadinone acetate (CAS No.: 302-22-7) 
Chlormadinone acetate produced mammary tumors in dogs in one 
study (IARC, 1979) and increased the incidence of mammary gland 
hyperplasia and mammary nodules in another (El Etreby and Graf, 1979). 
It was found negative in bacterial test system (IARC, 1987), unscheduled 
DNA synthesis (UDS) in rat hepatocytes in vitro (Topinka et al., 1995) 
and chromosomal aberrations in human peripheral blood lymphocytes in 
vitro (Stenchever et al , 1969). It was reported to form DNA adducts in 
rat liver in vitro (Topinka et al , 1995; Feser et a l , 1996;), rat and human 
hepatocytes in vitro (Topinka et al., 1995; Werner et al., 1997) and 
micronucleus in rat liver cells in vivo (Martelli et al., 1996). The effect of 
chlormadinone acetate at different doses on sister chromatid exchanges 
and chromosomal aberration frequencies was studied in mouse bone 
marrow cells and in human lymphocytes in vitro. Further, the effect of 
superoxide dismutase and catalase on chlormadinone genotoxic dose was 
also worked out in human lymphocytes in vitro. 
(iv) Megestrol acetate (CAS No.: 595-33-5) 
The carcinogenicity of megestrol acetate has been tested by oral 
administration in the mice, rats, dogs and monkeys. It produced nodular 
7 
hyperplasia and benign and malignant mammary tumors among dogs 
(Weikel and Nelson, 1977). Megestrol acetate plus ethinylestradiol has 
also been tested for carcinogenicity by oral administration in mice and 
rats. In mice, an increased incidence of malignant mammary tumors, was 
observed in both sexes, but no increase in incidence of tumors was seen 
in rats (IARC, 1979). It has been reported negative in unscheduled DNA 
synthesis test using rat hepatocytes; however, the presence of DNA 
adducts has been shown in rat liver in vivo and cultured human 
hepatocytes (Topinka et al., 1995; Feser et al., 1996; Werner et al., 1997). 
It has also been shown to induce micronucleus in rat liver in vivo, but has 
failed to cause chromosomal aberrations in human peripheral blood 
lymphocytes in vitro (Stenchever et al., 1969; Martelli et al., 1996), but 
was found to induce chromosomal aberrations and sister chromatid 
exchanges in cultured human peripheral blood lymphocytes at lower (25 
(ig/ml) but not at higher dose (Shadab, 2000). Therefore, the effect of 
megestrol acetate was studied in mouse bone marrow cells on the 
frequencies of sister chromatid exchanges and chromosomal aberrations. 
C. Natural Plant Products 
(i) Allicin (CAS No.: 539-86-6) 
Allicin, one of the sulphur compounds of garlic (Allium sativum), 
possesses antioxidant and thiol-disulphide exchange activity (Rabinkov et 
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al., 1998). Odorless cloves of garlic contain alliin, a sulphur containing 
amino acid derivative, which is also known as S-allyl-cysteine 
sulphoxide. Alliin is converted to allicin by the enzyme allinase, which is 
activated when garlic is cut or crushed. Allicin, a volatile compound, 
gives garlic its pungent smell (Block, 1985; Koch, 1996). Allicin has 
been reported to reduce radiation induced mutagenesis in Salmonella 
typhimurium tester strain TA 102 (Knasmuller et al., 1989). The main 
pharmacological effect i.e. fungicidal, virucidal, bactericidal and 
antiparasitic effects are attributed to garlic {Allium sativum) sulphur 
compounds especially thiosulphonates of which allicin is the most 
abundant one (Koch, 1996; Bakri and Douglas, 2005; Hunter et al., 
2005). Allicin has also been shown to possess antioxidant activity (Prasad 
et al., 1995; Rabinkov, 1998; Sieger et al , 1999; Ogita et al , 2005; 
Okada et al., 2005; Hasan et al., 2006;), anticancer activity (Dorai and 
Aggarwal, 2004; Oommen et al., 2004; Arnault et al , 2005; Aggarwal 
and Shishodia, 2006) and has been found capable of reducing sister 
chromatid exchanges (Siddique and Afzal, 2004b; Siddique and Afzal, 
2005b) and chromosomal aberrations induced by methyl 
methanesulphonate in cultured human lymphocytes (Siddique and Afzal, 
2005b). The effect of allicin was studied against the genotoxic damage 
induced by chlormadinone acetate in human lymphocytes in vitro. 
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(ii) Nordihydroguaiaretic acid (CAS No.: 500-38-9) 
Nordihydroguaiaretic acid (NDGA) is a phenolic lignan, present in 
the evergreen shrubs Larrea divariacata and Guaiacum officinale 
(Agarwal et al, 1991). Nordihydroguaiaretic acid possesses a number of 
interesting biological properties, which are of potential use for humans 
such as being an enzyme inhibitor (Capdevilla et al., 1988), having 
antimicrobial properties (Hurtado et al., 1979), a protector against 
neurotoxicity and bladder toxicity (Frasier and Kehrer, 1993; Rothman et 
al., 1993), stimulator of corpus luteum for the secretion of progesterone 
(Carlson et al., 1995), potential vaso and branchiodilator (Nagano et al., 
1996), anticancer agent (Galfi et al., 2005; Youngren et al., 2005), and 
having antioxidant (Lee et al., 2003; Fujimoto et al., 2004; Floriano-
Sanchez et al., 2006), anti-inflammatory (Jeon et al., 2005) and anti-
mutagenic action (Wang et al., 1991). Nordihydroguaiaretic acid has been 
reported to possess both genotoxic (Madrigal-Bujaidar et al., 1998) and 
anti-genotoxic potential (Madrigal-Bujaidar et al., 1998) both in vivo and 
in vitro. The anti-genotoxic effect of nordihydroguaiaretic acid was 
studied in human lymphocytes in vitro against the norgestrel induced 
genotoxic damage. 
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(iii) L-ascorbic acid (CAS No.: 50-81-7) 
Ascorbic acid (Vitamin C) is an important water soluble 
antioxidant in biological fluids and is an essential micronutrient required 
for normal metabolic functioning of the body (Chow, 2001). Human 
beings have no ability to synthesize vitamin C due to mutation in the gene 
coding for L-gulonolactone oxidase, an enzyme required for the 
biosynthesis of vitamin via the glucuronic acid pathway (Woodall and 
Ames, 1997). Thus, it is obtained only through the diet, especially, rich 
and plentiful in the fresh fruits, particularly, citrus fruits and vegetables 
(Bendich, 1997). Ascorbic acid can serve as both a pro-oxidant and an 
antioxidant in vitro depending upon experimental conditions (Buettner 
and Jurkiewiez, 1996). Ascorbic acid readily scavenges the reactive 
oxygen metabolites and reduces oxidative DNA damage as well as 
genetic mutations (Ray and Husain, 2002). The antigenotoxic effect of 
ascorbic acid was studied against the genotoxic effect of chlormadinone 
acetate in human lymphocytes in vitro and against megestrol acetate in 
mouse bone marrow cells in vivo. 
M2L<TE%L<ALS 
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2. MATERIALS AND METHODS 
Chemicals 
Ethinylestradiol (CAS No.: 57-63-6, Sigma); Cyproterone acetate 
(CAS No.: 427-51-0, Sigma); Chlormadinone acetate (CAS No.: 302-22-
7, Sigma); Norgestrel (CAS No.: 797-63-7, Sigma); Megestrol acetate 
(CAS No.: 595-33-5, Sigma); RPMI 1640 (Gibco); Phytohemagglutinin-
M (Gibco); Antibiotic-antimycotic mixture (Gibco); Fetal calf serum 
(Gibco); 5-bromo-2-deoxyuridine (Sigma/SRL, India); Hoechst 33258 
stain (Sigma); Giemsa stain (E. Merck, India); Mitomycin C (Sigma); 
Cyclophosphamide (Sigma); Sodium phenobarbitone (Sigma); Colchicine 
(Microlab); Dimethylsulphoxide (E. Merck, India); Superoxide dismutase 
(Fluka); Catalase (Fluka); Allicin (CAS No.: 539-86-6; Wyeth Lab); 
Nordihydroguaiaretic acid (CAS No.: 500-38-9, Fluka); L-ascorbic acid 
(CAS No.: 50-81-7, Central Drug House, India); NADP (SRL, India) N-
methyl-7Y'-nitro-7V-nitrosoguanidine (Sigma). 
Human lymphocyte culture 
Duplicate peripheral blood cultures were treated according to 
Carballo et al. (1993). Briefly, 0.5 ml of heparinized blood samples were 
obtained from a healthy female donor and were placed in a sterile flask 
containing 7 ml of RPMI 1640, supplemented with 1.5 ml of fetal calf 
serum and 0.1 ml of phytohemagglutinin. These flasks were placed in an 
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incubator at 37°C for 24 hr. Untreated culture and negative and positive 
controls were also run simultaneously. 
Animals 
Swiss albino female mice {Mus musculus L.) 25-30 g, 10-12 weeks 
old were procured from Lucknow (U.P.), India and grouped in different 
polypropylene cages (five animals/group) at a mean temperature of 25°C. 
Permission was granted for experimentation by the departmental ethical 
committee. 
A Estrogen 
(i) Ethinylestradiol 
Chromosomal aberrations and mitotic index analysis 
Ethinylestradiol at 1, 5 and 10 uM concentrations respectively 
were dissolved in dimethylsulphoxide and was added after 24 h. The cells 
were cultured for another 48 h at 37°C in an incubator. For metabolic 
activation experiments, 0.5 ml of S9 mix dose to ethinylestradiol was 
used. S9 mix was prepared from the liver of healthy rats (Wistar strain) as 
per standard procedures of Maron and Ames (1983). The S9 fraction so 
obtained was enhanced by addition of 5 uM of NADP and 10 uM of 
glucose-6-phosphate just before use to make S9 mix. The S9 mix without 
NADP was also given with each of the tested dose of ethinylestradiol. An 
amount of 0.2 ml of colchicine (0.2 ug/ml) was added to the culture flask, 
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1 h prior to harvesting. Cells were centrifuged at 1000 rpm for 10 min. 
The supernatant was removed and 5 ml of prewarmed (37°C) 0.075 M 
KC1 (hypotonic solution) was added. Cells were resuspended and 
incubated at 37°C for 15 min. The supernatant was removed by 
centrifugation, and, subsequently 5 ml of chilled fixative (methanol: 
glacial acetic acid, 3:1) was added. The fixative was removed by 
centrifugation and the procedure was repeated twice. To prepare slides, 3-
5 drops of the fixed cell suspension were dropped on clean slides and air-
dried. The slides were stained in 3% Giemsa solution in phosphate buffer 
(pH 6.8) for 15 min. Three hundred metaphases were examined for the 
occurrence of different types of abnormalities. Criteria to classify 
different types of aberrations were in accordance with the 
recommendation of Environmental Health Committee 46 for 
Environmental Monitoring of Human Populations (IPCS, 1985). The 
mitotic index was scored as the number of metaphases among 1000 
lymphocyte nuclei and expressed as a percentage. 
Sister chromatid exchange analysis 
For sister chromatid exchange analysis, bromo-deoxyuridine 
(BrdU, 10 ug/ml) was added at the beginning of the culture. After 24 h, 
ethinylestradiol at final concentrations of 1, 5 and 10 uM, dissolved in 
dimethylsulphoxide, was added and kept for another 48 h at 37°C in an 
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incubator. For metabolic activation experiments, 0.5 ml of S9 mix with 
and without NADP was given along with each of the tested dose. Mitotic 
arrest was attempted, 1 h prior to harvesting by adding 0.2 ml of 
colchicine (0.2 u,g/ml). Hypotonic treatment and fixation were done in the 
same way as described for chromosomal aberrations analysis. The slides 
were processed according to Perry and Wolff (1974) and Afzal and Azfer 
(1994). The sister chromatid exchange induction was analysed from 50 
plates of second division mitoses per dose. 
Induction of chromosomal aberrations and sister chromatid exchanges in 
the presence of superoxide dismutase and catalase by ethinylestradiol 
An amount of 10 uM of ethinylestradiol was used with 10 and 20 
ug/ml of superoxide dismutase and catalase separately and in 
combination in order to see the effect on the chromosomal aberrations, 
mitotic index and sister chromatid exchanges, which had been induced by 
ethinylestradiol in the presence of metabolic activation (S9 mix) with 
NADP. Duplicate cultures for chromosomal aberrations, mitotic index 
and sister chromatid exchanges were set similarly as described in the text 
earlier. 
15 
B. Synthetic Progestins 
(i) Cyproterone acetate 
Chromosomal aberrations and mitotic index analysis 
After 24 h of the initiation of culture, cyproterone acetate was 
added at concentrations of 5, 10, 20 and 30 uJM (dissolved in 
dimethylsulphoxide). The cells were cultured for another 48 h at 37°C in 
the incubator. One hour prior to harvesting, 0.2 ml of colchicine (0.2 
ug/ml) was added to the culture flask. Cells were centrifuged at 1000 rpm 
for 10 min. The supernatant was removed and 5 ml of 0.075 M KC1 
(hypotonic solution prewarmed at 37°C) was added subsequently. Cells 
were resuspended and incubated at 37°C for 15 min. The supernatant was 
removed by centrifugation and 5 ml of chilled fixative (methanol; glacial 
acetic acid; 3:1) was added thereafter. The fixative was removed by 
centrifugation and the procedure was removed twice. Slides were 
prepared and stained in 3% Giemsa solution in phosphate buffer (pH 6.8) 
for 15 min. Three hundred metaphases were examined for the occurrence 
of different types of abnormality i.e. gaps, fragments and breaks. The 
mitotic index was scored from the number of metaphases among 1000 
lymphocyte nuclei and expressed as a percentage. 
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Sister chromatid exchanges and mitotic index analysis 
For sister chromatid exchange analysis, bromodeoxyuridine (BrdU, 
10 ug/ml) was added at the beginning of the culture. After 24 h, 
cyproterone acetate was added at final concentration of 5, 10, 20 and 30 
uM (dissolved in dimethylsulphoxide) and kept for another 48 h at 37°C 
in the incubator. Mitotic arrest was attempted 1 h prior to harvesting by 
adding 0.2 ml of colchicine (0.2 fig/ml). Hypotonic treatment and fixation 
followed in the same way as described for chromosomal aberration 
analysis. The slides were processed according to Perry and Wolff (1974). 
The sister chromatid exchange induction was analyzed in metaphase from 
second cycle after treatment. The mitotic index (MI) was scored 1000 
lymphocyte nuclei as the number of metaphases among and expressed as 
a percentage. 
Induction of chromosomal aberrations and sister chromatid exchanges in 
the presence of superoxide dismutase and catalase by cyproterone 
acetate 
Experiments were set with cyproterone acetate (30 u.M), along with 
10 and 20 u.g/ml of superoxide dismutase and catalase separately and in 
combination, to see the effect of chromosomal aberrations, mitotic index 
and sister chromatid exchange analysis, as described earlier in the text. 
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(ii) Norgestrel 
Chromosomal aberrations and mitotic index analysis 
After 24 h of initiation of the culture, norgestrel was added at 5, 10 
and 20 uM (dissolved in dimethylsulphoxide). For metabolic activation 
experiments, the tested doses of norgestrel (dissolved in 
dimethylsulphoxide) were given along with 0.5 ml of S9 mix. The cells 
were cultured for another 48 h at 37°C in an incubator. Harvesting, 
hypotonic treatment, fixation and slide preparation were done similarly as 
described earlier in the text. Three hundred metaphases were examined 
for the occurrence of different types of abnormality. The mitotic index 
was scored as the number of metaphases among 1000 lymphocyte nuclei 
and expressed as a percentage. 
Sister chromatid exchange analysis 
For sister chromatid exchange analysis, bromodeoxyuridine (BrdU, 
10 ug/ml) was added at the beginning of the culture. After 24 h of 
initiation of the culture, norgestrel dissolved in dimethylsulphoxide at 5, 
10 and 20 uM was added. For metabolic activation experiments, the 
tested doses were given along with 0.5 ml of rat liver microsomal fraction 
(S9 mix). Dimethylsulphoxide (5 ul/ml) was taken as negative control. 
Mitomycin C (0.3 ug/ml) and Cyclophosphamide (0.16 ug/ml) were 
taken as positive control for without metabolic activation, and metabolic 
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activation (S9 mix) experiments, respectively. Harvesting, hypotonic 
treatment and fixation were done accordingly (as described earlier in the 
text). The slides were processed according to Perry and Wolff (1974) and 
stained for 20 min in a 0.05% (w/v), Hoechst 33258 solution and rinsed 
with tap water and placed under a UV lamp for 90 min, covered with 
Sorensen's buffer (pH 6.8) and stained with 3% Giemsa solution in 
phosphate buffer (pH 6.8) for 15 min. The sister chromatid exchange 
average was taken from an analysis of the metaphases during second 
cycle of divisions. 
Cell cycle kinetics 
Cells undergoing first (Mi), second (M2) and third (M3) metaphase 
divisions were detected with BrdU-Harlequin technique for differential 
staining of metaphase chromosomes (Tice et al., 1976; Crossen and 
Morgan, 1977) both in the presence as well as absence of metabolic 
activation (S9 mix). Treatments were similar as described earlier in the 
text. The replication index (RI), an indirect measure of studying cell cycle 
progression, was calculated by applying the following formula (Ivett and 
Tice, 1982): 
M,+2M2+3M3 
100 
where Mh M2 and M3 denote number of metaphases in the first, second 
and third cycle respectively. 
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(iii) Chlormadinone acetate 
Chromosomal aberration analysis in human lymphocytes 
After 24 h, chlormadinone acetate was added at final 
concentrations of 10, 20, 30 and 40 uM dissolved in dimethylsulphoxide 
and kept at 37°C in the incubator for another 48 h. Harvesting, hypotonic 
treatment, fixation and slide preparation were done similarly as described 
earlier in the text. Three hundred metaphases were examined for the 
occurrence of different types of abnormality i.e. gaps, fragments and 
breaks. 
Sister chromatid exchange analysis in human lymphocytes 
For sister chromatid exchange analysis, bromodeoxyuridine (BrdU, 
10 ug/ml) was added at the beginning of the culture. After 24 h, 
chlormadinone acetate at final concentrations of 10, 20, 30 and 40 uM 
(dissolved in dimethylsulphoxide) was added and kept for another 48 h at 
37°C in the incubator. Harvesting, hypotonic treatment, fixation and 
processing of slides were done as described earlier in the text. 
Induction of chromosomal aberrations and sister chromatid exchanges in 
the presence of superoxide dismutase and catalase by chlormadinone 
acetate in human lymphocytes 
Lymphocyte culture were treated with Chlormadinone acetate (40 
uM) and with 10 and 20 ug/ml of superoxide dismutase and catalase 
separately and in combination, to see their effect on chromosomal 
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aberrations and sister chromatid exchanges. Duplicate cultures for both 
chromosomal aberrations and sister chromatid exchanges analysis were 
set, as described earlier in the text. 
Sister chromatid exchange analysis in mouse bone marrow cells 
The fluorescent plus Giemsa techniques (Perry and Wolff, 1974) 
were followed with slight modification, for scoring sister chromatid 
exchange analysis. The tablets of 5-bromo-2-deoxyuridine (BrdU; 1.6 
g/kg body weight) were implanted subcutaneously in the neck region of 
each mouse under mild anaesthesia and, 30 min later, chlormadinone 
acetate at concentration of 5.62, 11.25 and 22.50 mg/kg of body weight 
was injected intraperitoneally (i.p.) but separately, to different groups of 
animals. On the LD50 scale obtained with the method of Lorke (1983), 
(and found to be 90 mg/kg), the highest tested dose chosen corresponds to 
l/4th of this parameter. About 0.1 ml of dimethylsulphoxide was used as 
negative control and 1.2xl04 ug/kg body weight of N-methyl-Af-nitro-JV-
nitrosoguanidine was taken as positive control, and the same were 
injected intraperitoneally to different groups of mice. After 21 h, the 
animals further received an intraperitoneal injection of colchicine (6.0 
mg/kg body weight) and 3 h after, the bone marrow was obtained from 
the femurs in KC1 0.075 M at 37°C, keeping the cells for 30 min at the 
same temperature. The supernatant was removed by centrifugation adding 
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5 ml of fixative (methanol: glacial acetic acid; 3:1). The fixative was 
removed and the procedure was repeated twice. Slides were stained for 20 
min in a 0.05% (w/v) Hoechst 33258 solution, rinsed with tap water and 
placed under a UV lamp for 90 min, covered with Sorensen's buffer, pH 
6.8 and stained with 3% Giemsa solution in the phosphate buffer (pH 6.8) 
for 15 min. The average of sister chromatid exchange was taken from an 
analysis of the metaphases during the second cycle of division. At least 
60 second division mitoses per mouse were scored to determine the 
frequency of sister chromatid exchanges. 
Chromosomal aberration analysis in mouse bone marrow cells 
For the analysis of chromosomal aberrations, the tested and control 
doses were the same as described for the sister chromatid exchange 
analysis. Chlormadinone acetate at 5.62, 11.25 and 22.50 mg/kg body 
weight, was injected intraperitoneally and separately, to different groups 
of animals. After 21 h, the animals were injected i.p. with colchicine (6.0 
mg/kg body weight) 3 h before sacrifice. Bone marrow preparations for 
the analysis of chromosomal aberrations in metaphase cells were obtained 
by the technique of Yosida and Amano (1965). Slides were stained with 
7% Giemsa stain in phosphate buffer (pH 6.8). Five animals were taken 
for each treatment group and hundred well spread metaphases were 
analysed per animal. 
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(iv) Megestrol acetate 
Sister chromatid exchange analysis in mouse bone marrow cells 
The fluorescent plus Giemsa technique with slight modification 
was followed for sister chromatid exchange analysis (Perry and Wolff, 
1974). Again, 5-Bromo-2-deoxyuridine in tablet form (BrdU; 1.6 g/kg 
body weight) was implanted subcutaneously in the neck region of each 
mouse under mild anaesthesia, and 30 min later, megestrol acetate at 
8.12, 16.25 and 32.5 mg/kg body weight was injected intraperitoneally 
(i.p.). As the LD50 level of megestrol acetate was determined by the 
method of Lorke to be 130 mg/kg body weight, the highest tested dose 
corresponded to 1/4 of the LD50 value. Dimethylsulphoxide (0.1 ml) 
was used as negative control and N-methyl-iV'-nitro-7V-nitrosoguanidine 
(1.2 x 104 jixg/kg body weight) was used as positive control. Both the 
compounds were injected i.p. After 21 h, the animals received an i.p. 
injection of colchicine (6.0 mg/kg body weight), and, 3 h later, the bone 
marrow of both the femurs was collected in KC1 0.075 M at 37°C, in 
which the cells were kept for 30 min. The supernatant was removed by 
centrifugation adding 5 ml of fixative (methanol: glacial acetic acid; 3:1). 
The fixative was removed and the procedure was repeated twice. The 
microscopic slides were prepared by air drying and were stained for 20 
min in a 0.05% (w/v) Hoechst 33258 solution, rinsed with tap water and 
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placed under a UV lamp for 90 min, covered with Sorensen's buffer, pH 
6.8, and stained with 3% Giemsa solution in the phosphate buffer (pH 
6.8) for 15 min. The sister chromatid exchange average was obtained 
from the analysis of metaphases in the second cycle of divisions. At least 
60 second division metaphases per mouse were scored to determine the 
frequency of sister chromatid exchanges. 
Chromosomal aberration analysis in mouse bone marrow cells 
For the analysis of chromosomal aberrations, megestrol acetate at 
8.12, 16.25 and 32.50 mg/kg body weight was injected intraperitoneally 
(i.p.). Twenty one hours after treatment, the animals were injected i.p. 
with colchicine (6.0 mg/kg body weight) given 3 h before sacrifice. Bone 
marrow preparations for the analysis of chromosomal aberrations in 
metaphase cells were obtained by the technique of Yosida and Amano 
(1965). The slides were stained with 7% Giemsa stain in phosphate buffer 
(pH 6.8). Five animals were included in each treatment group, and 100 
well spread metaphases were analysed per animal for chromosomal 
aberrations. 
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C. Natural Plant Products 
(i) Allicin 
Chromosomal aberration analysis in human lymphocytes 
After 24 h of incubation of human lymphocyte culture, 
chlormadinone acetate (40 uM) was administered, with 5 and 10 uM of 
allicin respectively and kept for 48 h at 37°C in the incubator. Prior to 1 h 
of harvesting, 0.2 ml of colchicine (0.2 ug/ml) was added to the culture 
flasks. Hypotonic treatment, fixation and processing of slides were done 
similarly as described earlier in the text. Three hundred metaphases were 
examined for the occurrence of different types of abnormality i.e. gaps, 
breaks and exchanges. Criteria to classify the different types of 
aberrations were in accordance with the recommendation of EHC 46 for 
Environmental Monitoring of Human Population (1985). 
Sister chromatid exchange analysis in human lymphocytes 
For sister chromatid exchange analysis, bromodeoxyuridine (BrdU, 
10 |-ig/ml) was added at the beginning of the culture. After 24 h of the 
initiation of culture, 40 uM of chlormadinone separately and along with 5 
and 10 uM of allicin was treated and kept for 48 h at 37°C in the 
incubator. Mitotic arrest was done one hour prior to harvesting by adding 
0.2 ml of colchicine (0.2 ug/ml). Hypotonic treatment and fixation were 
performed in the same way as described earlier in the text. The slides 
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were processed according to Perry and Wolff (1974). Sister chromatid 
exchange average was taken from an analysis of 50-second division 
metaphases. 
(ii) Nordihydroguaiaretic acid 
Treatment of norgestrel along with nordihydroguaiaretic acid 
Norgestrel (10 uM) was treated with 0.5 and 1.0 uJVl of 
nordihydroguaiaretic acid, to assess the effect on sister chromatid 
exchanges, chromosomal aberrations, mitotic index, and cell cycle 
kinetics induced by norgestrel in the presence of 0.5 ml of S9 mix. 
Similar treatment was given along with 20 uM of norgestrel. Duplicate 
cultures for sister chromatid exchanges, chromosomal aberrations, mitotic 
index and cell cycle kinetic analysis were set, similarly, in the presence of 
0.5 ml, of S9 mix, as described earlier in the text. 
(iii) L-ascorbic acid 
Treatment of chlormadinone acetate alongwith ascorbic acid 
Chlormadinone acetate (40 uM) was added with 40 and 80 uM of 
ascorbic acid to see its effect on chromosomal aberrations and the sister 
chromatid exchanges under human lymphocyte culture. Duplicate 
cultures were set, similarly, as described earlier in the text. 
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Treatment of megestrol acetate alongwith ascorbic acid 
Megestrol acetate (32.50 mg/kg body weight) was given alongwith 
20, 40 and 60 mg/kg body weight of ascorbic acid intraperitoneally. The 
doses of ascorbic acid fall within the dose range used in humans 
(Reynolds, 1982). Ascorbic acid treatments alone were also given to 
different groups of animals. Analysis of chromosomal aberrations and 
sister chromatid exchanges were done similarly as described earlier in the 
text. 
Statistical Analysis 
Student's two tailed Mest was used for the analysis of 
chromosomal aberrations and sister chromatid exchanges, whereas chi-
square test {% ) was used to analyse the cell cycle kinetics. The level of 
significance was tested from standard statistical tables of Fisher and 
Yates (1963). 
%£SUOTS 
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3. RESULTS 
Ethinylestradiol neither induced chromosomal aberrations nor 
sister chromatid exchanges, nor did it affect mitotic index at significant 
level in the absence of metabolic activation (S9 mix) or in S9 mix without 
NADP (Tables 1-4; Figures 1-6). However, in the presence of S9 mix 
with NADP, a significant increase was observed at 5 and 10 uM of 
ethinylestradiol in chromosomal aberrations analysis (Table 5; Figure 7). 
When 10 uM of ethinylestradiol was used with 10 and 20 ug/ml of 
superoxide dismutase, the numbers of abnormal cells increased as 
compared with ethinylestradiol treatment alone (Table 6; Figure 9). A 
significant decrease in abnormal cells was observed when 10 uM of 
ethinylestradiol was used with 10 and 20 ug/ml of catalase separately and 
in combination with superoxide dismutase as compared with 
ethinylestradiol treatment alone (Table 6; Figure 9). 
The mitotic index showed a reduction in the percentage of mitosis 
in all the dose assayed in the presence of S9 mix with NADP (Table 5; 
Figure 8). When 10 uM of ethinylestradiol was used with 10 and 20 
ug/ml of superoxide dismutase only (in the presence of S9 mix with 
NADP), a reduction in the percentage of mitosis was observed. There was 
increase in the percentage of mitosis when 10 uM of ethinylestradiol was 
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administered with 10 and 20 ug/ml of catalase separately and in 
combination with superoxide dismutase, in the presence of S9 mix with 
NADP, as compared to ethinylestradiol treatment alone (Table 6; Figure 
10). 
In sister chromatid exchange analysis, a clear dose dependent 
increase in sister chromatid exchanges per cell was observed when cells 
were treated with ethinylestradiol alone in the presence of S9 mix with 
NADP (Table 7; Figure 11). Sister chromatid exchanges per cell were 
significantly increased at 5 and 10 uM of ethinylestradiol, when 10 uM of 
ethinylestradiol was used with 10 and 20 ug/ml of superoxide dismutase. 
Sister chromatid exchanges per cell were further increased, but sister 
chromatid exchanges per cell decreased significantly, when treated with 
10 and 20 fig/ml of catalase alone and in combination with superoxide 
dismutase, as compared to ethinylestradiol treatment alone in the 
presence of S9 mix with NADP (Table 8; Figure 12). 
In chromosomal aberration analysis, treatment with cyproterone 
acetate alone resulted in a dose-dependent increase of chromosomal 
aberrations. However, a significant increase was observed at 20 and 30 
uM of cyproterone acetate (Table 9; Figure 13). When 30 uM of 
cyproterone acetate was used with 10 and 20 ug/ml of superoxide 
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dismutase, the number of abnormal cells increased, as compared to 
cyproterone acetate treatment given alone (Table 10; Figure 15). A 
significant decrease in abnormal cells were observed when 30 uM of 
cyproterone acetate was used with 10 and 20 ug/ml of catalase separately 
and in combination with superoxide dismutase, in contrast with 
cyproterone acetate treatment alone (Table 10; Figure 15). 
In sister chromatid exchanges analysis, a clear dose dependent 
increase in sister chromatid exchanges per cell was observed when treated 
with cyproterone acetate alone (Table 11; Figure 17). Sister chromatid 
exchanges per cell were significantly increased at 20 and 30 uM of 
cyproterone acetate. When 30 uM of cyproterone acetate was used with 
10 and 20 ug/ml of superoxide dismutase, sister chromatid exchanges per 
cell were further increased, but sister chromatid exchanges per cell were 
decreased significantly when treated with 10 and 20 ug/ml of catalase 
separately and in combination with superoxide dismutase as compared to 
cyproterone acetate treatment alone (Table 12; Figure 19). 
The mitotic index showed a reduction in the percentage of mitosis 
in all the dose assayed (Tables 9 and 11; Figures 14 and 18). When 30 
uM of cyproterone acetate was used with 10 and 20 |ug/ml of superoxide 
dismutase separately, a reduction in the percentage of mitosis was 
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observed as compared to cyproterone acetate treatment alone. There was 
increase in the percentage of mitosis when 30 uM of cyproterone acetate 
was used with 10 and 20 ug/ml of catalase separately and in combination 
with superoxide dismutase, as compared to cyproterone acetate treatment 
alone (Tables 10 and 12; Figures 16 and 20). 
Norgestrel induced neither sister chromatid exchanges nor 
chromosomal aberrations, nor affected mitotic index and replication 
index at significant level in the absence of metabolic activation (Tables 
13-15; Figures 21-24). In sister chromatid exchange analysis, a clear dose 
dependent increase in sister chromatid exchanges per cell was observed 
when cells were treated with norgestrel alone in the presence of metabolic 
activation (Table 16; Figure 25). Sister chromatid exchanges per cell 
were significantly increased at 10 and 20 uM of norgestrel treatment. 
When 10 uM of norgestrel was used with 0.5 and 1 uM of 
nordihydroguaiaretic acid, sister chromatid exchanges per cell got 
decreased significantly as compared to norgestrel treatment alone. Similar 
trend was observed when 20 uM of norgestrel was used with 0.5 and 1 
uM of nordihydroguaiaretic acid (Table 16; Figure 25). 
In chromosomal aberration analysis, treatment with norgestrel 
alone resulted in a dose dependent increase of chromosomal aberrations 
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in the presence of metabolic activation. However, a significant increase 
was observed at 10 and 20 uM of norgestrel (Table 17; Figure 26). When 
10 uM of norgestrel was used with 0.5 and 1.0 uM of 
nordihydroguaiaretic acid, a significant decrease in abnormal cells was 
observed as compared to norgestrel treatment alone. Similar trend was 
observed when 20 uM of norgestrel was used with 0.5 and 1 uM of 
nordihydroguaiaretic acid (Table 17; Figure 26). 
The mitotic index showed a reduction in the percentage of mitosis 
in all of the dose assayed in the presence of metabolic activation (Table 
17; Figure 27). There was increase in the percentage of mitosis when 10 
uM of norgestrel was administered with 0.5 and 1.0 uM of 
nordihydroguaiaretic acid as compared to the norgestrel treatment alone. 
Similar trend was observed when 20 uM of norgestrel treatment was 
given with 0.5 and 1.0 uM of nordihydroguaiaretic acid as compared to 
norgestrel treatment alone (Table 17; Figure 27). 
In cell cycle kinetics, treatment with norgestrel alone resulted in a 
dose dependent decrease in replication indices in the presence of 
metabolic activation. However, a significant decrease was observed at 10 
and 20 uM of norgestrel (Table 18; Figure 28). When 10 uM of 
norgestrel was given with 0.5 and 1.0 uM of nordihydroguaiaretic acid, a 
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significant increase in replication index was observed as compared to 
norgestrel treatment alone. Similar trend was observed when 20 uM of 
norgestrel was used with 0.5 and 1.0 uM of nordihydroguaiaretic acid 
(Table 18; Figure 28). 
A dose of 11.25 and 22.50 mg/kg body weight of chlormadinone 
acetate induced sister chromatid exchanges at significant level as 
compared to normal values. At 5.62 mg/kg body weight, the value of 
sister chromatid exchanges induced per cell was not significant (Table 19; 
Figure 29). The compounds, N-methyl-Af'-nitro-iV-nitrosoguanidine and 
dimethylsulphoxide, were associated with mean values of sister 
chromatid exchanges per cell as 10.76±1.46 and 2.36±0.11. The 
percentage of abnormal metaphases without gaps in animals treated with 
the tested doses, i.e. 11.25 and 22.50 mg/kg body weight were significant 
at p<0.01, when compared to the normal values. At a dose of 5.62 mg/kg 
body weight, abnormal metaphases were not significant and there were 
no Robertsonian translocations at all. At 11.25 and 22.50 mg/kg body 
weight, a dose dependent increase was observed in fragments, 
Robertsonian translocations and polyploidies (Table 20; Figure 30). 
In cultured human lymphocytes, a dose dependent increase was 
observed in the number of abnormal cells when treated with different 
doses of chlormadinone acetate (Table 21; Figure 31). However, a 
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significant increase in the same was observed at 30 and 40 uM of 
chlormadinone acetate. When 40 uM of chlormadinone acetate was used 
with 10 and 20 |ig/ml of superoxide dismutase, the number of abnormal 
cells increased as compared to chlormadinone acetate given alone, 
however, a significant decrease of abnormal cells was observed when 40 
uM of chlormadinone acetated was given with 10 and 20 jag/ml of 
catalase separately and in combination with superoxide dismutase (Table 
22; Figure 33). 
In sister chromatid exchange analysis, a clear dose dependent 
increase in sister chromatid exchange per cell was observed when cells 
were treated with chlormadinone acetate alone (Table 23; Figure 32). 
Sister chromatid exchanges per cell significantly increased at 30 and 40 
uM of chlormadinone acetate treatments. When 40 uM of chlormadinone 
acetate was used with 10 and 20 |ag/ml of superoxide dismutase, the sister 
chromatid exchanges per cell further increased, but sister chromatid 
exchanges, per cell decreased significantly when cells were treated with 
10 and 20 u,g/ml of catalase separately and in combination with 
superoxide dismutase (Table 24; Figure 34). 
A clear dose dependent increase in sister chromatid exchanges per 
cell was observed when megestrol acetate alone was administered (Table 
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25; Figure 35). Sister chromatid exchanges per cell got significantly 
increased at 16.25 and 32.50 mg/kg of body weight, when 32.50 mg/kg 
body weight of megestrol acetate was given along with different doses of 
ascorbic acid, a clear significant dose-dependent decrease in sister 
chromatid exchanges per cell was observed at all of the doses tested 
(Table 26; Figure 37). 
In the chromosomal aberrations analysis, a dose dependent increase 
was observed in the number of abnormal cells. A statistically significant 
increase was observed at 16.25 and 32.50 mg/kg body weight of 
megestrol acetate treatment (Table 27; Figure 36). Treatment with 32.50 
mg/kg body weight of megestrol acetate, along with 20, 40 and 60 mg/kg 
body weight of ascorbic acid, resulted in a significant decrease in the 
number of abnormal cells (Table 28; Figure 38). Robertsonian 
translocations were found to be completely eliminated when 32.50 mg/kg 
body weight of megestrol acetate was given along with 60 mg/kg body 
weight of ascorbic acid. 
In chromosomal aberrations analysis, reduction in the number of 
abnormal cells was observed when 40 uM of chlormadinone acetate was 
used with 5 and 10 uM of allicin. Similarly, 40 and 80 uM of 
chlormadinone acetate result in the significant reduction of abnormal 
cells (Table 29; Figure 39). 
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In sister chromatid exchange analysis, a clear dose dependent 
significant decrease was observed when 40 uM of chlormadinone acetate 
was used with 5 and 10 uM of allicin. Similar trend was observed when 
40 uM of chlormadinone acetate was given with 40 and 80 uM of L-
ascorbic acid (Table 30; Figure 40). 
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Fig. 9: Effect of superoxide dismutase and catalase on abnormal 
metaphases without gaps in cultured human lymphocytes 
induced by ethinylestradiol in the presence of metabolic 
activation with NADP. 
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Fig. 10: Mitotic index after treatment of superoxide dismutase and 
catalase along with ethinylestradiol in cultured human 
lymphocytes in the presence of metabolic activation with NADP. 
E3 = Ethinylestradiol (10 pM); E3+S1 = Ethinylestradiol (10 nM) + SOD (10 ng/ml) 
E3+S2 = Ethinylestradiol (10 nM) + SOD (20 ng/ml); E3+C1 = Ethinylestradiol (10 nM) + CAT(10 ng/ml) 
E3+C2 = Ethinylestradiol (10 \iM) + CAT(20 ng/ml) 
E3+S1+C1 = Ethinylestradiol (10 uM) + SOD (10 pig/ml) + CAT(10 ng/ml) 
E3+S2+C2 = Ethinylestradiol (10 \iM) + SOD (20 ng/ml) + CAT(20 ng/ml); U = Untreated 
S1 = SOD(10 ng/ml); S2 = SOD (20 ng/ml); C1 = CAT (10 ng/ml); C2 = CAT (20 ng/ml) 
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Fig. 11: Sister chromatid exchanges in cultured human lymphocytes 
treated with ethinylestradiol in the presence of metabolic 
activation with NADP. 
Fig. 12: Effect of superoxide dismutase and catalase on sister chromatid 
exchanges induced by ethinylestradiol in the presence of 
metabolic activation with NADP. 
E1 = Ethinylestradiol (1 nM); E2 = Ethinylestradiol (5 nM); E3 = Ethinylestradiol (10 nM) 
U = Untreated; N = Negative Control (DMSO, 5|il/ml); P = Positive Control (Cyclophosphamide, 0.16 ng/ml) 
E3+S1 = Ethinylestradiol (10 nM) + SOD (10 ng/ml) 
E3+S2 = Ethinylestradiol (10 nM) + SOD (20 ng/ml); E3+C1 = Ethinylestradiol (10 \M) + CAT(10 ng/ml) 
E3+C2 = Ethinylestradiol (10 uM) + CAT(20 ng/ml) 
E3+S1+C1 = Ethinylestradiol (10 uM) + SOD (10 ng/ml) + CAT(10 ng/ml) 
E3+S2+C2 = Ethinylestradiol (10 ^ ) + SOD (20 ng/ml) + CAT(20 ng/ml); U = Untreated 
S1 = SOD(10 (ig/ml); S2 = SOD (20 ng/ml); C1 = CAT (10 ng/ml); C2 = CAT (20 ng/ml) 
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Fig. 15: Effect of superoxide dismutase and catalase on the number of 
abnormal metaphases without gaps in cultured human 
lymphocytes treated with cyproterone acetate. 
Mill 
Fig. 16: Mitotic index after treatment of superoxide dismutase and 
catalase with cyproterone acetate in cultured human lymphocytes. 
CPA4 = Cyproterone acetate (30|iM) 
CPA4+S1 = Cyproterone acetate (30 nM) + SOD (10 ng/ml) 
CPA4+S2 = Cyproterone acetate (30 nM) + SOD (20 ng/ml) 
CPA4+C1 = Cyproterone acetate (30 |iM) + CAT (10 ng/ml) 
CPA4+C2 • Cyproterone acetate (30 nM) + CAT (20 ng/ml) 
CPA4+S1+C1 = Cyproterone acetate (30 pM)+ SOD (10 ng/ml)+ CAT (10 ng/ml) 
CPA4+S2+C2 = Cyproterone acetate (30 |iM) + SOD (20 ng/ml) + CAT (20 ng/ml); U = Untreated 
S1 = SOD (10 ng/ml); S2 = SOD (20 ng/ml); C1 = CAT (10 ng/ml); C2 = CAT (20 ng/ml) 
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Fig. 19: Effect of superoxide dismutase and catalase on sister chromatid 
exchanges induced by cyproterone acetate. 
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CPA4 = Cyproterone acetate (30uM) 
CPA4+S1 = Cyproterone acetate (30 nM) + SOD (10 ng/ml) 
CPA4+S2 = Cyproterone acetate (30 \xM) + SOD (20 ng/ml) 
CPA4+C1 = Cyproterone acetate (30 nM) + CAT (10 ng/ml) 
CPA4+C2 = Cyproterone acetate (30 nM) + CAT (20 ng/ml) 
CPA4+S1+C1 = Cyproterone acetate (30 nM)+ SOD (10 ng/ml)+ CAT (10 ng/ml) 
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Fig. 25: Effect of nordihydroguaiaretic acid on sister chromatid exchanges 
induced by norgestrel in the presence of metabolic activation. 
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Fig. 26: Effect of nordihydroguaiaretic acid on abnormal metaphases 
induced by norgestrel in the presence of metabolic activation. 
NOR1 = Norgestrel (5nM); NOR2 = Norgestrel (10 nM); NOR3 = Norgestrel (20 nM) 
NDGA1+NOR2 = NDGA (0.5 nM) + Norgestrel (10 nM) 
NDGA1+NOR3 = NDGA (0.5 nM) + Norgestrel (20 \iM) 
NDGA2+NOR2 = NDGA (1.0 uM) + Norgestrel (10 |iM) 
NDGA2+NOR3 = NDGA (1.0 |iM) + Norgestrel (20 nM) U = Untreated 
NDGA1 = Nordihydroguaiaretic acid (0.5 nM); NDGA2 = Nordihydroguaiaretic acid (1.0 nM) 
N = Negative control (DMSO, 5 nl/ml); P = Positive control (Cyclophosphamide, 0.16 ng/ml) 
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Fig. 27: Effect of nordihydroguaiaretic acid and norgestrel on mitotic 
index in cultured human lymphocytes in the presence of 
metabolic activation. 
Fig. 28: Effect of nordihydroguaiaretic acid and norgestrel on replication 
index in the presence of metabolic activation in cultured human 
lymphocytes. 
NOR1 = Norgestrel (5nM); N0R2 = Norgestrel (10 nM); NOR3 = Norgestrel (20 nM) 
NDGA1+NOR2 = NDGA (0.5 nM) + Norgestrel (10 nM) 
NDGA1+NOR3 = NDGA (0.5 |iM) + Norgestrel (20 nM) 
NDGA2+NOR2 = NDGA (1.0 nM) + Norgestrel (10 ^M) 
NDGA2+NOR3 = NDGA (1.0 nM) + Norgestrel (20 pM); U = Untreated 
N = Negative control (DMSO, 5 nl/ml); P = Positive control (Cyclophosphamide, 0.16 ng/ml) 
NDGA1 = Nordihydroguaiaretic acid (0.5 nM); NDGA2 = Nordihydroguaiaretic acid (1.0 \M) 
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Fig. 33: Effect of superoxide dismutase and catalase on abnormal 
metaphases without gaps in cultured human lymphocytes treated 
with chlormadinone acetate. 
Fig. 34: Effect of superoxide dismutase and catalase on sister chromatid 
exchanges induced by chlormadinone acetate in cultured human 
lymphocytes. 
CMA4 = Chlormadinone acetate (40 |iM); CMA4+S1 = Chlormadinone acetate (40 |iM) + SOD (10 ng/ml) 
CMA+S2 = Chlormadinone acetate (40 pM) + SOD (20 ng/ml) 
CMA+C1 = Chlormadinone acetate (40 jaM) + CAT (10 ng/ml) 
CMA+C2 = Chlormadinone acetate (40 nM) + CAT (20 ng/ml) 
CMA+S1+C1 = Chlormadinone acetate (40 nM) + SOD (10 ng/ml) + CAT (10 ng/ml) 
CMA4+S2+C2 = Chlormadinone acetate (40 \iM) + SOD (20 ng/ml) + CAT (20 ng/ml) 
U = Untreated; S1 = SOD (10 ng/ml); S2 = SOD (20 ng/ml); C1 = CAT (10 ^g/ml); C2 = CAT (20 ng/ml) 
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Fig. 39: Effect of allicin and L-ascorbic acid on abnormal metaphases 
induced by chlormadinone acetate in cultured human 
lymphocytes. 
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Fig. 40: Effect of a///c/n and L-ascorbic acid against sister chromatid 
exchanges induced by chlormadinone acetate in cultured human 
lymphocytes. 
CMA4 = Chlormadinone acetate (40 |iM) 
CMA4+AL1 = Chlormadinone acetate (40 ^M) + Allicin (5 nM) 
CMA4+AL2 = Chlormadinone acetate (40 ^M) + Allicin (10 nM) 
CMA4+AS1 = Chlormadinone acetate (40 nM) + L-ascorbic acid (40 |iM) 
CMA4+AS2 = Chlormadinone acetate (40 |iM) + L-ascorbic acid (80 (iM); 
AL1 = Allicin (5 nM); AL2 = Allicin (10 nM); AS1 = L-ascorbic acid (40 nM); AS2 = L-ascorbic acid (80 nM) 
U = Untreated; N = Negative control (DMSO, 5 nl/ml); P = Positive control (mitomycin C, 0.3 \ig/m\) 
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4. DISCUSSION 
A study on ethinylestradiol reveals that this compound is not potent 
enough to cause genotoxic damage in human lymphocytes in the absence 
of S9 mix as well as in the presence of S9 mix without NADP at the 
doses selected, however, the same was found genotoxic in the presence of 
S9 mix with NADP. The experimental evidence suggests that the 
metabolic activation of ethinylestradiol and its possible conversion to 
reactive species is responsible for its genotoxicity. Similar observations 
on the DNA damaging properties of synthetic steroids are evident from 
chromosomal breakage, and induction of sister chromatid exchanges, 
reported elsewhere (Dhillon et al , 1994; Singh et al., 1994; Shadab, 
2000; Ahmad et al., 2001; Siddique and Afzal, 2003; Siddique and Afzal, 
2004c,d,e), in the micronucleus induction (Martelli et al., 1996; Martelli 
et al., 1998), DNA fragmentation (Mattioli et al , 2004) and formation of 
endogenous DNA adducts and certain neoplastic changes reported earlier 
(Shimomura et al., 1992; Martelli and Brambilla, 2002; Martelli et al., 
2003). Estrone 3,4-quinone produces free radicals in human breast cancer 
cells (MCF) which are responsible for chromosomal damage (Nutter et 
al., 1994). Other catechol estrogens are reported to induce DNA damage 
by generating reactive oxygen species or free radicals (Roy et al , 1991; 
Li et al., 1994; Han and Liehr, 1995; Chen et al , 1998; Thibodeau and 
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Paquette, 1999). Certain synthetic steroids have been reported to be 
mutagenic in the Ames tester strains by generating active oxygen species 
in the system (Islam et al., 1991). With a view to understand the possible 
mechanism and cause of genotoxicity by ethinylestradiol, one of the 
genotoxic doses, i.e. 10 uM of ethinylestradiol, was given along with 10 
and 20 (ig/ml of superoxide dismutase in the presence of S9 mix along 
with NADP. Since the treatment with superoxide dismutase increased the 
frequency of chromosomal aberrations and sister chromatid exchanges, it 
might be inferred that ethinylestradiol generates reactive oxygen species, 
which on treatment with superoxide dismutase, further converts these into 
hydrogen peroxide (H2O2). Hydrogen peroxide has been known to cause 
DNA damage in the form of single strand breaks and double strand 
breaks (Thibodeau and Paquette, 1999), and as chromosomal aberrations 
(Tsuda, 1981; Sofuni andlshidate, 1984). Superoxide dismutases (SODs) 
are a family of metal enzymes that convert 02~ to H2O2 according to the 
following reaction (Culotta, 2000). 
O" + (X > 2H202 
2 2
 S 0 D 2 2 
Further treatment of 10 uM of ethinylestradiol with 10 and 20 
ug/ml of catalase separately and in combination with superoxide 
dismutase (in the presence of S9 mix with NADP), results in the 
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significant decrease in chromosomal aberrations and sister chromatid 
exchanges. This observation suggests the production of H202, in the 
presence of S9 mix with NADP, while catalase brings about the 
decomposition of H2O2 into water and oxygen. Catalase is a heme 
containing protein (Reid et al., 1981). The mechanism of reaction is: 
2H 2 0 2 CAT ) 2H 2 0 + 0 2 
Catalase is found to reduce sister chromatid exchange levels 
resulting from the treatment with H2O2 (MacRae and Stich, 1979). In 
light of the above results, a possible mechanism of generation of reactive 
oxygen species by ethinylestradiol, is suggested (Plate I). Since, 
ethinylestradiol is genotoxic only in the presence of S9 mix with NADP, 
the first step would involve the aromatic hydroxylation catalysed by 
cytochrome P450, as occurs in the case of estrone and the 17p-estradiol 
forming catechol metabolites (Maclusky et al., 1981; Fishman, 1983; 
Bolton et al., 1998). Cytochrome P450 in liver S9 fractions plays an 
important role in activating promutagens to proximate and/or ultimate 
mutagens. Rat and human liver P450 is involved in the activation of some 
chemical carcinogens having different isoforms (Maron and Ames, 1983; 
Guengerich and Shimada, 1991). In the tissues of liver, 2-hydroxylation 
predominates over 4-hydroxylation by approximately 9:1, however, in 
extra hepatic tissues the ratio drops to 1:1 (Zhu and Conney, 1998). Only 
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4-hydroxyestrone, 3,4-dihydroxy l,3,5(10)-oestraien-17one (40HE) was 
found to be carcinogenic in the male Syrian golden hamster kidney 
tumor-model, whereas 2-OHE was found to be without any activity 
(Liehr et al., 1986; Li and Li, 1987). Once formed, the endogenous 
catechol estrogens can be oxidized by virtually any oxidative enzymes in 
the absence or presence of metal ion and can give rise to o-quinones 
(Yager and Liehr, 1996; Bolton et al., 1998). The results of the study on 
ethinylestradiol confirms the presence of reactive oxygen species (ROS) 
and the source of reactive oxygen species has been suggested to be the 
result of redox cycling between the o-quinones and their semi-quinone 
radicals generating superoxide, hydrogen-peroxide and ultimately 
reactive hydroxyl radicals which cause oxidative cleavage of the 
phosphate-sugar backbone as well as oxidation of the purine/pyrimidine 
residues of DNA (Han and Liehr, 1994). The present hypothesis may 
need further experimental validation which would be taken in future. 
The results of the study on cyproterone acetate and chlormadinone 
acetate reveal that the compounds increase chromosomal aberrations and 
frequencies of sister chromatid exchange, significantly in cultured human 
lymphocytes. Chlormadinone acetate increases sister chromatid 
exchanges frequencies and chromosomal aberration significantly at two 
of the three tested doses in the mouse bone marrow cells. With a view to 
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understand the mechanism and cause of the genotoxicity by cyproterone 
acetate and chlormadinone acetate, one of the genotoxic dose of both 
cyproterone acetate (30 uM) and chlormadinone acetate (40 uM) was 
given separately, along with 10 and 20 ug/ml of superoxide dismutase, to 
cultured human lymphocytes. Since the treatment with superoxide 
dismutase increased the frequencies of chromosomal aberrations and 
sister chromatid exchanges generated by both cyproterone acetate and 
chlormadinone acetate, it can be concluded that somehow cyproterone 
acetate and chlormadinone acetate are generating reactive oxygen 
species, which on treatment with superoxide dismutase, get changed into 
hydrogen peroxide and result in the increase of the frequency of 
chromosomal aberrations and sister chromatid exchanges. 
Further, the treatment of 30 uM of cyproterone acetate and 40 uM 
of chlormadinone acetate with 10 and 20 ug/ml of catalase separately, 
and in combination with superoxide dismutase, result in the significant 
decrease in chromosomal aberrations and sister chromatid exchanges. 
This also proves the production of hydrogen peroxide species, because 
catalase brings about the decomposition of hydrogen peroxide into water 
and oxygen molecule (Reid et al., 1981). In the light of the above results, 
a possible mechanism of free radical generation for cyproterone acetate 
and chlormadinone acetate can be suggested (Plate II and III). As is 
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obvious from the Plate II and III, XOOH can also give rise to XOO 
(alkoxyl) and OOH (peroxyl) radicals. The presence of alkoxyl (XOO) 
radical appears to be a very remote possibility in view of the highly polar 
nature of the living system, because X would have to be essentially an 
alkyl group (Islam et al., 1991). Hydroxy radical (OH) is converted into 
hydrogen peroxide by superoxide dismutase (Culotta, 2000), as a result, 
the increase in chromosomal aberrations and sister chromatid exchanges 
was observed when cyproterone acetate and chlormadinone acetate were 
treated by superoxide dismutase. 
The treatment of chlormadinone acetate with allicin and L-ascorbic 
acid results in the reduction of the genotoxic damage induced by 
chlormadinone acetate. Allicin possesses antioxidant (Prasad et al., 1995) 
and thioldisulphide exchange activity (Rabinkov et al., 1998). In the 
present study, allicin (diallylthiosulphinate) might have diffused through 
the cell membrane to perform its biological activity (Miron et al., 2000), 
this probably prevented free radicals from reaching the critical target sites 
(Plate IV) and thus resulted in the reduction of the genotoxic damage 
induced by chlormadinone acetate. 
Again L-ascorbic acid is a powerful antioxidant, which plays an 
important role in the intracellular oxidation-reduction system, and in 
binding of free radicals produced endogenously (Laurence et al , 1997). 
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However, L-ascorbic acid has been shown to be cytotoxic at higher 
concentration (Shamberger, 1984), although, the selected doses in the 
present study lie within the range of human use (Szeto et al., 2002). The 
treatment with L-ascorbic acid results in the reduction of genotoxic 
damage induced by chlormadinone acetate. This also confirms the 
production of reactive oxygen species by chlormadinone acetate. 
Megestrol acetate was observed to increase chromosomal 
aberrations and sister chromatid exchange frequencies at two of the three 
tested dosages in mouse bone marrow cells. Vitamins act as antioxidants 
and free radical scavengers, thereby acting as anticarcinogenic, 
anticlastogenic and antimutagenic agents in the in vivo and in vitro assays 
(Khan and Sinha, 1996; Amare-Mokrane et al , 1996; Vijayalaxmi and 
Venu, 1999;). Of these, ascorbic acid and ot-tocopherol are among the 
best known antioxidants used in the in vivo animal models (Koul et al., 
1989). Ascorbic acid possesses a substantial nucleophilic character and it 
has been suggested that ascorbate might protect against electrophilic 
attack on cellular DNA by intercepting reactive agents (Edgar, 1974) or 
otherwise, the ascorbyl anion radical, with a high extent of unpaired 
electron derealization, is responsible for the scavenging of free radicals 
(Bielski et al., 1981; Bielski, 1982). However, ascorbic acid has been 
shown to be cytotoxic at higher concentrations, but the selected doses lie 
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within the range of humans (Szeto et al., 2002). As the treatment with 
ascorbic acid results in a decrease of the genotoxic damage induced by 
megestrol acetate, it is possible that it generates free radicals or the 
reactive oxygen species, which are responsible for the genotoxic damage. 
In the light of the results obtained, a possible mechanism of free radical 
generation for megestrol acetate (Plate V) with the scavenging role of 
ascorbic acid is suggested (Plate VI). The reactive oxygen species that 
interacts with DNA is considered to be the hydroxyl radical (OH) 
generated from hydrogen peroxide by Fenton reaction (Halliwell and 
Gutteridge, 1986). Ascorbic acid scavenges the hydroxyl radical (OH) 
and prevents genotoxic damage (Plate VI). 
The treatment with norgestrel reveal that norgestrel was not 
genotoxic in the absence of S9 mix, but it increased sister chromatid 
exchanges and frequencies of chromosomal aberrations significantly at 
two of the three tested doses in the presence of S9 mix. This is contrary to 
the observation by Ahmad et al. (2001), in which norgestrel was reported 
to be genotoxic in the absence as well as presence of metabolic activation 
(S9 mix), which might have been due to the high doses (>25 ug/ml) of 
norgestrel used by them. The exact cause for the genotoxicity of 
norgestrel is not yet known. The metabolic activation of norgestrel and 
possible conversion of it to reactive species may be responsible for its 
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genotoxicity. Metabolic activation of estrogens such as estradiol-17(3 and 
ethinylestradiol results in the production of reactive oxygen species via 
redox cycling between quinones and semi-quinone radicals (Bolton, 
2002; Siddique et al., 2005b). Nordihydroguaiaretic acid possesses 
antioxidant (Olivetto, 1972) and free radical scavenging property 
(Nakadate, 1989; Murthy et al., 1990), which may be useful in reducing 
the genotoxic potential of synthetic progestins. Nordihydroguaiaretic acid 
is also a potent inhibitor of cytochrome P450 (Capdevilla et al., 1988). 
Since the nordihydroguaiaretic acid treatment, in the presence of S9 mix, 
reduced the genotoxic damage by norgestrel, the reduction may be due to 
the inhibition of cytochrome P450, which prevents the metabolic 
activation of norgestrel. The doses of nordihydroguaiaretic were selected 
on the basis of study performed by Madrigal-Bujaidar et al. (1998). The 
identification of specific mechanisms are under investigation. The 
modulatory property of nordihydroguaiaretic acid may be responsible for 
the reduction of the genotoxic damage. The study shows that allicin, 
ascorbic acid and nordihydroguaiaretic acid are potent enough to reduce 
the genotoxic damage induced by synthetic progestins due to their 
antioxidant and free radical scavenging properties (Siddique et al., 2005a; 
Siddique and Afzal, 2005a; Siddique et al., 2006). 
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The genotoxic potential of various synthetic progestins has been 
tested in different experimental models using different genotoxic end 
points. The reports are contradictory (Joosten et al., 2004). Very little 
attention has been paid to the structural relationship and the potentiality 
to induce the genotoxic damage by synthetic progestins. Structural 
relationship and ability to induce genotoxic damage has been worked out, 
using DNA repair assay and micronucleus formation in the liver of 
female rats (Brambilla and Martelli, 1997). For DNA repair following 
trend was found, viz. cyproterone acetate > chlormadinone acetate > 
megestrol acetate. It was reported that cyproterone acetate with (a) a 1, 2 
a-methylene group, (b) a keto group at carbon-3, (c) two double bonds, 
C4 = C5 and C(, = C7 and (d) CI at carbon-6, is the most genotoxic 
molecule. The lower genotoxic potencies of chlormadinone acetate and 
megestrol acetate might well be due to the absence of 1, 2oc-methylene 
group, and for megestrol acetate, perhaps due to the presence of methyl 
group (-CH3) at carbon-6 instead of CI (Brambilla and Martelli, 1997). 
However, when the adduct formation in cyproterone acetate, 
medroxyprogesterone acetate, megestrol acetate and chlormadinone 
acetate are considered, the cyproterone acetate, megestrol acetate and 
chlormadinone acetate are found to form adducts in human liver slices in 
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vitro (Feser et al., 1998). Medroxyprogesterone acetate forms these at low 
level. 
Studies performed on megestrol acetate (Siddique et al , 2005a), 
cyproterone acetate (Siddique and Afzal, 2005c), chlormadinone acetate 
(Siddique and Afzal, 2004c,d), ethynodiol diacetate (Siddique and Afzal, 
2004e), norethynodrel (Siddique and Afzal, 2005d), norgestrel (Siddique 
et al., 2006) and lynestrenol (Siddique and Afzal, 2004f; Siddique and 
Afzal, 2005e), show that the progestins, in which double bond between 
carbon-6 and carbon-7 is present, like megestrol acetate, cyproterone 
acetate and chlormadinone acetate, can undergo nucleophilic reaction and 
generate free radicals in the system, and therefore, show the genotoxic 
effects, and the progestins, in which double bond between carbon-6 and 
carbon-7 is absent, may require additional metabolic activation to show 
the genotoxic effects in the test system (Plate VII). Looking at the 
chemical structure of estradiol and ethinylestradiol, the double bond is 
found to be absent between carbon-6 and carbon-7. It is well known that 
estradiol undergoes aromatic hydroxylation in liver by cytochrome P450s 
and results in the formation of catechol metabolites (Maclusky et al., 
1981; Fishman, 1983; Liehr et al., 1986; Li and Li, 1987; Bolton, 2002). 
The redox cycling between O-quinones and their semi-quinone radicals 
results in the generation of superoxide, hydrogen peroxide, and ultimately 
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reactive hydroxyl radicals which cause oxidative cleavage of the 
phosphate-sugar backbone as well as oxidation of the purine/pyrimidine 
residues of DNA (Han and Liehr, 1994). Ethinylestradiol shows the 
generation of reactive oxygen species in the presence of metabolic 
activation with NADP (Siddique et al , 2005b). The study performed on 
norgestrel, ethynodioldiacetate, lynestrenol and norethynodrel shows that 
they exhibit genotoxic effects only in the presence of metabolic activation 
with NADP. The similarity in the structure of the above synthetic 
progestins and the estrogens lies mainly in the absence of double bond 
between carbon-6 and carbon-7. 
Moreover, if the adduct formation on the basis of presence and 
absence of double bond between carbon-6 and carbon-7 is considered, a 
definite correlation is established. A study, carried out by Feser et al. 
(1998) on some selected sex-steroids, shows that chlormadinone acetate 
(C6 = C7), cyproterone acetate (C6 = C7) and megestrol acetate (C6 = C7) 
form DNA adducts, while norgestrel (C6 - C7), estradiol (C6 - C7) and 
ethinylestradiol (C6 - C7) do not form DNA adducts in human liver slices. 
It is thus concluded that the double bond between carbon-6 and carbon-7 
plays an important role in determining the mode of the genotoxicity of 
synthetic progestins. 
3 OH 
Ethinylestradiol 
i C ^ C H 
P450 
2-OHE-o-quinone 4-OHE-o-quinone 
4-OHEN-o-quinone 
NADPH NADP 
P450 
•o," O, 
•O2 + 0 2 ^ L 2H202 + 02 
SOD 
CAT 
2H202 —»• 2H20 + 0 2 
4-OHEN-Semiquinone Radical 
PLATE -1 
Possible metabolism of ethinylestradiol to catechols and quinones 
and generation of reactive oxygen species by redox cycling of 
4-hydroxy equilenin. 
CH3 
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H 2 Q / / H 3 C 
Cyproterone acetate (CPA) 
Homolytic 
fission y CI XO + OH . SOD 
OH + OH - » • 
2H202 CAT 
—w 
XOH = Reactive nucleophile within the cell 
CI = Chlorine attached to the carbon atom (C-6) of cyprotene acetate 
_ ->. = Enhancing the electrophilic nature of O moiety 
OH = Hydroxyl radical unstable 
SOD = Superoxide dismutase 
CAT = Catalase 
PLATE - II 
Possible mechanism of generating reactive oxygen species 
by cyproterone acetate. 
Chlormadinone acetate (CMA) 
j j omo ly t i ^ X x i, 
fissiorP*" />< 
X - O ^ Q - H + 
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OH + " O H ^ H202 
H 2 0 2 ^ 2 H 2 0 + 0 2 
XOH = Reactive nucleophile within the cell. 
CI = Chlorine attached to the carbon atom (C-6) of chlormadinone acetat* 
- ->. = Enhancing the electrophilic nature of O moiety 
OH* = Hydroxyl radical unstable 
SOD = Superoxide dismutase 
CAT = Catalase 
PLATE - III 
Possible mechanism of generating free radicals by chlormadinone acetate. 
Chlormadinone acetate (CMA) 
Nucleophilic reaction results 
in the production of reactive 
oxygen species (ROS) 
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PLATE - IV 
Possible mechanism of scavenging free radicals by allicin generated 
by chlormadinone acetate. 
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Fe2+ 
= Reactive nucleophile within the cell. 
= Methyl group attached to the carbon atom (C-6) of megestrol acetate 
= Enhancing the electrophilic nature of O moiety 
= Hydroxyl radical unstable 
= Superoxide dismutase 
= Ferrous ion present within the cell 
PLATE - V 
Possible mechanism of generating free radicals by megestrol acetate (in mice). 
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PLATE - VI 
Possible mechanism of ascorbic acid in scavenging free radicals 
generated by megestrol acetate and chlormadinone acetate. 
COCH3 
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COCH3 
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PLATE - VII 
Structure of synthetic progestins and estrogens. Presence of double bond 
between carbon-6 and carbon-7 (A to C). Absence of double bond between carbon-6 
and carbon-7 (D to I). 
<BI<BLIOQ%&P!Hy 
48 
BIBLIOGRAPHY 
Afzal, M. and Azfer, M.A. 1994. Standardization of sister chromatid 
exchange (SCE) assay for studying effects of environmental 
mutagen in human test system. Chemical and Environmental 
Research 3(l&2), 67-70. 
Agarwal, R., Wang, Z.Y, Bik, D.P, Mukhtar, H„ 1991. 
Nordihydroguaiaretic acid, an inhibitor of lipoxygenase, also 
inhibits cytochrome P-450 mediated monooxygenase activity in 
rat epidermal and hepatic microsomes. Drug Metabolism and 
Disposition 19, 620-624. 
Aggarwal, B.B., Shishodia, S., 2006. Molecular targets of dietary agents 
for prevention and therapy of cancer. Biochemical Pharmacology 
71, 1397-1421. 
Ahmad, M.S., Sheeba, Afzal, M., 2004. Amelioration of genotoxic 
damage by certain phytoproducts in human lymphocytes cultures. 
Chemico Biological Interactions 150, 107-115. 
Ahmad, S., Hoda, A., Afzal, M., 2002. Additive action of vitamin C and 
E against hydrocortisone induced genotoxicity in human 
lymphocyte chromosome. International Journal for Vitamin and 
Nutrition Research 72, 204-209. 
Ahmad, M.E, Shadab, G.G.H.A, Azfer, M.A., Afzal, M., 2001. 
Evaluation of genotoxic potential of synthetic progestins 
norethindrone and norgestrel in human lymphocytes in vitro 
Mutation Research 494, 13-20. 
Amara Mokrane, Y.A., Lehucher-Michel, M.P., Balarsard, G., Dumenil, 
G., Botta, B., 1996. Protective effects of alpha-hederin, 
chlorophyllin and ascorbic acid towards the induction of 
micronuclei by doxorubicin in cultured human lymphocytes. 
Mutagenesis 11, 161-167. 
Arnault, I., Haffner, T., Siess, M.H., Vollmar, A., Kahane, R., Auger, J., 
2005. Analytical method for appreciation of garlic therapeutic 
potential and for validation of a new formulation. Journal of 
Pharmaceutical and Biomedical Analysis 37, 963-970. 
49 
Bakri, I.M., Douglas, C.W.I., 2005. Inhibitory effect of garlic extraction 
in oral bacteria. Archives of Oral Biology 50, 645-651. 
Banerjee, S.K., Banerjee, S., Li, S.A., Li, J.J. 1994. Induction of 
chromosome aberrations in Syrian Hamster renal cortical cells by 
various estrogens. Mutation Research 311, 191-197. 
Bendich, A., 1997. Vitamin C safety in humans. In: Packer, L., Fuchs, J., 
Vitamin C in Health and Disease, Marcel Dekker, New York, pp. 
341. 
Bielski, B.H.J., Allen, A.O., Schwarz, H.A., 1981. Mechanism of 
, disproportionate of ascorbic acid radicals. Journal of the 
American Chemical Society 103, 3516-3518. 
Bielski, B.H.J., 1982. Chemistry of ascorbic acid radicals. In: Sieb, P.A., 
Tolbert, B.M., eds. Acorbic Acid: Chemistry. Metabolism and 
Uses. Washington DC: American Chemical Society. 
Biri, A., Civelek, E., Karahalil, B., Sardas, S., 2002. Assessment of DNA 
damage in women using oral contraceptives. Mutation Research 
521, 113-119. 
Blakey, D.C., White, I.N.H., 1985. Unscheduled DNA synthesis caused 
by norethindrone and related contraceptive steroids in short term 
male rat hepatocyte cultures. Carcinogenesis 6, 1201-1205. 
BlockJE., 1985. The chemistry of garlic and onions. Scientific American 
252, 114-119. 
Bolton, J.L., 2002. Quinoids, quinoid radicals and phenoxyl radicals 
formed from estrogens and antiestrogens. Toxicology 111, 55-65. 
Bolton, J.L., Pisha, E., Zhang, F., Qiu, S., 1998. Role of quinoids in 
estrogen carcinogenesis. Chemical Research in Toxicology 11, 
1113-1127. 
Brambilla, G., Martelli, A., 1997. Preliminary data for a study on 
relationship between structure and genotoxicity of progestins. 
Mutation Research 379, SI5. 
Brambilla, G., Martelli, M. 2002. Are some progestins genotoxic liver 
carcinogens? Mutation Research 512, 155-163. 
50 
Buettner, G.R., Jurkiewicz, B.A., 1996. Catalytic metals, ascorbate and 
free radicals: combinations to avoid. Radiation Research 145, 
532-541. 
Capdevila, J., Gil, L., Orellana, M., Marnett, L.J., Mason, J.L., Yadagiri, 
P., Falck, J.R., 1988. Inhibitors of cytochrome P-450 dependent 
arachidonic acid metabolism. Archives of Biochemistry and 
Biophysics 261, 257-263. 
Carballo, M.A., Alvarez, S., Boveris, A., 1993. Cellular stress by light 
and Rose Bengal in human lymphocytes. Mutation Research 288, 
215-222, 
Carlson, J.C., Sawada, M., Boone, D.L., Stauffer, J.M., 1995. Stimulation 
of progesterone secretion in dispersed cells of rat corpora lutea by 
antioxidants. Steroids 60, 272-276. 
Carr, D.H., 1967. Chromosomes after oral contraceptives. Lancet 2, 830. 
Carr, D.H., 1970. Chromosome studies in selected spontaneous 
abortions. 1. Conception after oral contraceptives. Canadian 
Medical Association Journal 103, 343-348. 
Chen, Y., Shen, L., Zang, F., Lau, S.S., van Breeman, R.B., Nickolic, D., 
Bolton, J.L., 1998. The equine estrogen metabolite 4-
hydroequilenin causes DNA single-strand breaks and oxidation of 
DNA bases in vitro. Chemical Research in Toxicology, 11, 1105-
1111. 
Chow, C.K., 2001. In: Rucker, R., Suttie, J.W., McCormick, D.B., 
Machlin, L.J., (Eds.). Handbook of Vitamins, Marcel Decker, New 
York, pp. 165-196. 
Crossen, P.E., Morgan, W.F., 1977. Analysis of human lymphocyte cell 
cycle time in culture measured by sister chromatid differential 
staining. Experimental Cell Research 104, 453-457. 
Culotta, V.C., 2000. Superoxide dismutase, oxidative stress, and cell 
metabolism. Current Topics in Cellular Regulation 36, 117-132. 
Demi, E., Schwarz, L.R., Oesterle, D., 1993. Initiation of enzyme altered 
foci by the synthetic steroid cyproterone acetate in rat liver foci 
bioassay. Carcinogenesis 14, 1229-1231. 
51 
Dhillon, V.S., Singh, J.R., Singh, H., Kler, R.S., 1994. In vitro and in 
vivo genotoxicity evaluation of hormonal drugs V, Mestranol. 
Mutation Research 322, 173-183. 
Dorai, T., Aggarwal, B.B., 2004. Role of chemopreventive agents in 
cancer therapy. Cancer Letters 215, 129-140. 
Drevon, C , Piccoli, C , Montesano R., 1981. Mutagenicity assays of 
estrogenic hormones in mammalian cells. Mutation Research 89, 
83-90. 
Edgar, J.A., 1974. Ascorbic acid and biological alkylating agents. Nature 
248, 136-137. 
El Etreby, M.F., Graf, K.J., 1979. Effect of contraceptive steroids on 
mammary gland of beagle dog and its relevance to human 
carcinogenicity. Pharmacology and Therapeutics 5, 369-402. 
Feser, W., Kerdar, R.S., Baumann, A., Korber, J., Blode, H., Kuhnz, W., 
1998. DNA adduct formation of selected sex steroids in human 
liver slices in vitro. Toxicology in vitro 12, 353-364. 
Feser, W., Kerdar, R.S., Bolde, H., Reimann, R., 1996. Formation of 
DNA-adducts by selected sex steroids in rat liver. Human and 
Experimental Toxicology 15, 556-562. 
Fisher, R.A., Yates, Y., 1963. Statistical Table for Biological, 
Agricultural and Medical Research Workers, Sixth ed. Oliver and 
Boyd, Edinburgh, p. 138. 
Fishman, J., 1983. Aromatic hydroxylation of estrogens. Annual Review 
of Physiology 45, 61-72. 
Floriano-Sanchez, E., Villanueva, C, Medinacampos, O.N., Rocha, D., 
Sanchez, D.J.., Cardenas-Rodriguez, N., Pedraza-Chaverri, J., 
2006. Nordihydroguaiaretic acid is a potent in vitro scavenger of 
peroxynitrile, singlet oxygen, hydroxyl radical, superoxide anion 
and hypochlorus acid and prevents in vivo ozone induced tyrosine 
nitration in lungs. Free Radical Research 40, 523-533. 
Frasier, L., Kehrer, J.P., 1993. Effect of indomethacin, aspirin, 
nordihydroguaiaretic acid, and piperonyl butoxide on 
52 
cyclophosphamide induced bladder damage. Drug and Chemical 
Toxicology 16, 117-133. 
Fujimoto, N., Kohta, R., Kitamura, S., Honda, H., 2004. Estrogenic 
activity of an antioxidant, nordihydroguaiaretic acid (NDGA). Life 
Sciences 74, 1417-1425. 
Galfi, P., Neogrady, Z., Amberger, A., Margreiter, R., Csordas, A., 2005. 
Sensitization of colon cancer cell lines to butyrate-mediated 
proliferation inhibition by combined application of indomethacin 
and nordihydroguaiaretic acid. Cancer Detection and Prevention 
29, 276-285. 
Goh, K.O., 1967. Chromosomal breaks in women taking birth control 
pills. USAEC-ORAU, Research Report 106, pp. 97-104. 
Guengerich, F.P., Shimada, T., 1991. Oxidation of toxic and carcinogenic 
chemicals by human cytochrome P-450 enzymes. Chemical 
Research in Toxicology 4, 391-407. 
Halliwell, B., Gutteridge, J.M.C., 1986. Oxygen free radicals and iron in 
relation to biology and medicine: some problems and concepts. 
Archives of Biochemistry and Biophysics 246, 501-514. 
Han, X., Liehr, J.G., 1994. 8-Hydroxylation of guanine bases in kidney 
and liver DNA of Hamsters treated with estradiol: role of free 
radicals in estrogen induced carcinogenesis. Cancer Research 54, 
5515-5517. 
Han, X., Liehr, J.G., 1995. Microsome mediated 8-hydroxylation guanine 
base of DNA by steroid estrogens: correlation of DNA damage by 
free radical with metabolic activation to quinones. Carcinogenesis 
16,2571-2574. 
Hasan, N., Yusuf, N., Toossi, Z., Islam, N., 2006. Suppression of 
Mycobacterium tuberculosis induced reactive oxygen species 
(ROS) and TNF-oc mRNA expression in human monocytes by 
allicin. FEBSLetters 580, 2517-2522. 
Heinemann, L.A.J., DoMinh, T., Guggenmoos-Holzmann, I., Thie, C, 
Garbe, E., Feinstein, A.R., Thomas, D., Brechot, C, Spitzer, 
W.O., vs. Watanabe, Beral, V., Meirik, O., 1997. Oral 
contraceptives and liver cancer. Results of the multicentre 
53 
international liver tumor study (MILTS). Contraception 56, 275-
284. 
Hundal, B.S., Dhillon, V.S., Sidhu, I.S., 1997. Genotoxic potential of 
estrogen. Mutation Research 389, 173-181. 
Hunter, R., Caira, M., Stellenboom, N., 2005. Thiosulfmate allicin from 
garlic: inspiration for a new antimicrobial agent. Annals of the 
New York Academy of Sciences 1056, 234-241. 
Hurtado, L., Hernandez, R., Hernandez, F., Fernandez, F., 1979. 
Fungitoxic compounds in the Larrea resin. In: Campos, E., Mabri, 
J.J., Fernandez, S. (Eds.), Editorial Centro de Investigacion en 
Quimica Aplicada Larrea. Mexico, pp. 328-340. 
IARC. 1979. IARC Monographs on the Evaluation of Carcinogenic Risks 
to Humans. Vol. 21, Sex Hormones (II), International Agency for 
Research on Cancer, Lyon, France pp. 233-439. 
IARC. 1987. IARC Monographs on the Evaluation of Carcinogenic Risks 
to Humans (Suppl. 7) Overall Evaluation of Carcinogenicity: An 
updating of IARC Monographs, Vol. 1-42, International Agency 
for Research on Cancer, Lyon, France, pp. 280. 
IARC. 1999. IARC Monographs on the Oral Contraceptives Combined. 
Vol. 72 (Group 1). International Agency for Research on Cancer, 
Lyon, France, pp. 49. 
IARC. 1999. IARC Monographs on the Hormonal Contraceptives, 
Progestogens only. Vol. 72 (Group 2B). International Agency for 
Research on Cancer, Lyon, France, pp. 399. 
IPCS. 1985. IPCS Monographs on Environmental Health Criteria, Vol. 
46, Guidelines for the study of Genetic Effects in Human 
Populations, IPCS, WHO, Geneva, pp. 25-54. 
Islam, S., Shafiullah, Ahmad, M., 1991. Mutagenic activity of certain 
synthetic steroids: structural requirement for mutagenic activity in 
Salmonella and E. coli. Mutation Research 259, 177-187. 
Ivett, J.L., Tice, R.R., 1982. Average generation time: a new method of 
analysis and quantitation of cellular proliferation kinetics. 
Environmental Mutagenesis 4, 358. 
54 
Jeon, S., Ji, K.A., You, H.J., Kim, J.H., Jou, I, Joe, E.H., 2005. 
Nordihydroguaiaretic acid inhibits IFN-y-induced STAT tyrosine 
phosphorylation in rat brain astrocytes. Biochemical and 
Biophysical Research Communications 328, 595-600. 
Joosten, H.F.P., van Acker, F.A.A., van den Dobbelsteen, D.J., Horbach, 
G.J.M.J., Krantc, E.I., 2004. Genotoxicity of hormonal steroids. 
Toxicology Letters 151, 113-134. 
Jordan, A., 2002. Toxicology of progestogens of implantable 
contraceptives for women. Contraception 65, 3-8. 
Kasper, P., Mueller, L., 1996. Time related induction of DNA repair 
synthesis in rat hepatocytes following in vivo treatment with 
cyproterone acetate. Carcinogenesis 17, 2271-2274. 
Kasper, P., Tegethoff, K., Mueller, L., 1995. In vitro mutagenicity studies 
on cyproterone acetate using female rat hepatocytes for metabolic 
activation and as indicator cells. Carcinogenesis 16, 2309-2314. 
Khan, P.K., Sinha, S.P., 1996. Ameliorating effect of vitamin C on 
murine sperm toxicity induced by three pesticides (endosulfan, 
phosphamidon and mancozeb). Mutagenesis 11, 33-36. 
Knasmuller, S., de Martin R., Domjan, G., Szakmary, A., 1989. Studies 
on the antimutagenic activities of garlic extract. Environmental 
and Molecular Mutagenesis 13,357-365. 
Koch, H.P., 1996. Biopharmaceutics of garlic's effective constituents. In: 
Garlic: The Science and Therapeutic Applications of Allium 
sativum L. and Related Species (Eds. H.P. Koch and D. Lawson). 
William and Wilkins, Baltimore, pp. 213-220. 
Kochhar, T.S., 1988. Steroid hormones enhanced sister chromatid 
exchange in cultured CHO cells. Experientia 44, 62-63. 
Koul, A., Khanduja, K.L., Koul, LB., Gupta, M.P., Mazid, S., Sharma, 
R.R., 1989. Effect of ascorbic acid on antioxidant defense systems 
and lipid peroxidation in guinea pig. Journal of Clinical 
Biochemistry and Nutrition 6, 21-27. 
Krebs, O., Schafer, B., Wolff, T., Oesterle, D., Demi, E., Sund, M, 
Favor, J., 1998. The DNA damaging drug cyproterone acetate 
causes a* gene mutations and induces glutatkipne'-S^toflsferas^'m 
the liver of female Big Blue™ transgenie-~i^44^rats. 
Carcinogenesis 11, 241-245. 
Lang, R , Reimann, R., 1993. Studies for a genotoxic potential of some 
endogenous and exogenous steroids. I. Communication: 
examination for the induction of gene mutations using the Ames 
Salmonella / Microsomes Test and the HGPRT Test in V79 cells. 
Environmental and Molecular Mutagenesis 21, 272-304. 
Laurence, D.R., Bennett, P.N., Brown, M.J., 1997. Clinical 
Pharmacology, 8th edition, Churchill Living Stone, New York pp. 
669. 
Lee, C.H., Jang, Y.S., Her, S.J., Moon, Y.M., Baek, S.J, Eling, T., 2003. 
Nordihydroguaiaretic acid, an antioxidant, inhibits transforming 
growth factor- (3 activity through the inhibition of Smad signaling 
pathway. Experimental Cell Research 289, 335-341. 
Li, J.J, Li, S.A, 1987. Estrogen carcinogenesis in Syrian hamster tissues: 
role of metabolism. Federation Proceedings 46, 1858-1863. 
Li, Y , Trush, M.A, Yager, J.D, 1994. DNA damage cause by reactive 
oxygen species origination from a copper dependent oxidation of 
the 2-hydroxy catechol of estradiol. Carcinogenesis 15, 1421-
1427. 
Liehr, J.G, Fang, W.F, Sirbasku, D.A, Ari-Ulubelen, A , 1986. 
Carcinogenecity of catechol estrogens in Syrian Hamster. Journal 
of Steroid Biochemistry 24, 353-356. 
Lorke, D , 1983. A new approach to practical acute toxicity testing. 
Archives of Toxicology 54, 275-287. 
Maclusky, N.J, Naftolin, F , Krey, L.C, Franks, S , 1981. The catechol 
estrogens. Journal of Steroid Biochemistry 15, 111-124. 
MacRae, W.D, Stich, H.F, 1979. Induction of sister chromatid 
exchanges in Chinese Hamster Ovary Cells by thiol and hydrazine 
compounds. Mutation Research 68, 351-365. 
Madrigal-Bujaidar, E , Diaz Barriga, S, Cassani, M , Marquez, P , 
Revuelta, P , 1998. In vivo and in vitro antigenotoxic effect of 
56 
nordihydroguaiaretic acid against SCEs induced by methyl 
methanesulfonate. Mutation Research 419, 163-168. 
Madrigal-Bujaidar, E., Diaz Barriga, S., Cassani, M., Molina, D., Ponce 
G., 1998. In vivo and in vitro induction of sister chromatid 
exchanges by nordihydroguaiaretic acid. Mutation Research 412, 
139-144. 
Maier, W.E., Herman, J.R., 2001. Pharmacology and toxicology of 
ethinylestradiol and norethindrone acetate in experimental 
animals. Regulatory Toxicology and Pharmacology 34, 53-61. 
Maron, D.M., Ames, B.N., 1983. Revised methods for the salmonella 
mutagenicity test. Mutation Research 113, 173-215. 
Martelli, A., Campart, G.B., Ghia, M., Allavena, A., Mereto, E., 
Brambilla, G., 1996. Induction of micronuclei and initiation of 
enzyme altered foci in the liver of female rats treated with 
cyproterone acetate, chlormadinone acetate or megestrol acetate. 
Carcinogenesis 17, 551-554. 
Martelli, A., Mattioli, F., Angiola, M., Reimann, R., Brambilla, G., 2003. 
Species, sex and inter individual differences in DNA repair 
induced by nine sex steroids in primary cultures of rats and human 
hepatocytes. Mutation Research 536, 69-78. 
Martelli, A., Mattioli, F., Fazio, S., Andrae, U., Brambilla, G., 1995. 
DNA repair synthesis and DNA fragmentation in primary cultures 
of human and rat hepatocytes exposed to cyproterone acetate. 
Carcinogenesis 16, 1265-1269. 
Martelli, A., Mereto, E., Ghia, M., Orsi, P., Allavena, A., De Pascalis, 
C.R., Brambilla, G., 1998. Induction of micronuclei and of 
enzyme-altered foci in the liver of female rats exposed to 
progesterone and three synthetic progestins. Mutation Research 
419,33-41. 
Mattioli, F., Garbero, C , Gosmar, M., Manfredi, V., Carrozzino, R., 
Martelli, A., Brambilla, G., 2004. DNA fragmentation, DNA 
repair and apoptosis induced in primary rat hepatocytes by 
dienogest, dydrogesterone and l,4,6-androstatriene-17 beta-ol-3-
one acetate. Mutation Research 564, 21-29. 
57 
Miron, T., Rabinkov, A., Mirelman, D., Wilchek, R., Weiner, L., 2000. 
The mode of action of allicin: Its ready permeability through 
phospholipid membranes may contribute to its biological activity. 
Biochimica et Biophysica Acta 1463, 20-30. 
Misdorp, W., 1991. Progestogens and mammary tumors in dogs and cats. 
Acta Endocrinologica 125, 27-31. 
Murthy, P.B., Prema, K., 1979. Sister chromatid exchanges in oral 
contraceptives users. Mutation Research 68, 149-152. 
Murthy, S.N., Cooney, C.G., Clearfield, H.R., 1990. Hydrogen peroxide-
induced alterations in prostaglandin secretion in the rat colon in 
vitro. Inflammation 14, 645-661. 
Nagano, N., Imaizumi, Y., Hirano, M., Watanabe, M., 1996. Opening of 
Ca -dependent K channels by nordihydroguaiaretic acid in 
porcine coronary arterial smooth muscle cells. Japanese Journal 
of Pharmacology 70, 281-284. 
Nakadate, T., 1989. The mechanism of skin tumor promotion caused by 
phorbol esters: possible involvement of arachidonic acid 
cascade/lipoxygenase, protein kinase C and calcium/calmodulin 
systems. Japanese Journal of Pharmacology 49, 1-9. 
Neumann, I., Thierau, D., Andrae, U., Greim, H., Schwarz, L.R., 1992. 
Cyproterone acetate induces DNA damage in cultured rat 
hepatocytes and preferentially stimulates DNA synthesis in y-
glutamyltranspeptidase positive cells. Carcinogenesis 13, 373-
378. 
Nutter, L.M., Wu, Y.Y., Ngo, E.O., Sierra, E.E., Gutierrez, Y.J., Abul 
Hajj, Y.J., 1994. An o-quinone form of estrogen produces free 
radicals in human breast cancer cells: correlation with DNA 
damage. Chemical Research in Toxicology, 7, 23-28. 
Ogita, A., Hirooka, K., Yamamota, Y., Tsutsui, N., Fujita, K., Taniguchi, 
M., Tanaka, T., 2005. Synergistic fungicidal activity of Cu2+ and 
allicin, an allyl sulfur compound from garlic and its relation to the 
role of alkyl hydroperoxide reductase 1 as a cell surface defense in 
Saccharomyces cerevisiae. Toxicology 215, 205-213. 
58 
Okada, Y., Tanaka, K., Fujita, I , Sato, E., Okajima, H., 2005. 
Antioxidant activity of thiosulfmates derived from garlic. Redox 
Report: Communication in Free Radical Research 10, 96-102. 
Olivetto, E.P. 1972. Nordihydroguaiaretic acid. A naturally occurring 
antioxidant. Chemical Industry 2, 677-679. 
Oommen, S., Anto, R.J., Srinivas, G., Karunagaran, D., 2004. Allicin 
(from garlic) induces caspase-mediated apoptosis in cancer cells. 
European Journal of Pharmacology 485, 97-103. 
Perry, P., Wolff, S., 1974. New Giemsa method for the differential 
staining of sister chromatids. Nature 251, 156-158. 
Prasad, K., Laxdal, V., Yu, M., Raney, B.L., 1995. Antioxidant activity 
of allicin, an active principle in garlic. Molecular Cellular 
Biochemistry 148, 183-189. 
Rabinkov, A., Miron, T., Konstantinovski, L., Wilchek, M., Mirelman, 
D., Weiner, L., 1998. The mode of action of allicin: Trapping of 
radicals and interaction with thiol containing proteins. Biochimica 
et Biophysica Acta 1379, 233-244. 
Ray, G., Husain, S.A., 2002. Oxidants, antioxidants and carcinogenesis. 
Indian Journal of Experimental Biology 40, 1213-1232. 
Reid, T.J. 3rd, Murthy, M.R., Sicignano, A., Tanaka, N., Musick, W.D., 
Rossmann, M.G., 1981. Structure and haeme environment of beef 
liver catalase at 2.5 A resolution. Proceedings of the National 
Academy of Sciences U.S.A. 78, 4767-4771. 
Reimann, R., Kalweit, S., Lang, R., 1996. Studies for a genotoxic 
potential of some endogenous and exogenous sex steroid. II. 
Communication: examination for the induction of cytogenetic 
damage using the chromosomal aberration assay on human 
lymphocytes in vitro and the mouse bone marrow micronucleus 
test in vivo. Environmental and Molecular Mutagenesis 28, 133-
144. 
ROC, 1986. Further Report on Carcinogens. USDHHS, National 
Toxicology Program. 
59 
Rothman, S.M., Yamada, K.A., Lancaster, N., 1993. 
Nordihydroguaiaretic acid attenuates NMDA neurotoxicity action 
beyond the receptor. Nephropharmacology 32, 1279-1288. 
Roy, D., Floyd, R.A., Liehr, J.G., 1991. Elevated 8-hydroxy 
deoxyguanosine levels in DNA of diethylstilbestrol treated Syrian 
hamster: covalent DNA damage by free radicals generated by 
redox cycling of dimethylstilbestrol. Cancer Research 51, 3883-
3885. 
Rudali, G., 1975. Induction of tumors in mice with synthetic sex 
hormones. Gann Monograph 17, 243-252. 
Sato, Y., Sakakibara, Y., Oda, T , Aizu-Yokota, E. Ichinoseki, K., 1992. 
Effect of estradiol and ethinylestradiol on microtubule disruption 
in Chinese Hamster V79 cells. Chemical and Pharmaceutical 
Bulletin 40, 182-184. 
Schwend, T.H., Lippman, J.S., 1996. Comparative review of recently 
introduced oral contraceptives containing norgestimate, 
desogestrel, and gestodene and older oral contraceptives, In: 
Pavlik, E.J. (Ed.), Estrogens, Progestins and their Antagonists. 
Birkhauser, Boston, pp. 273-296. 
Sciarra, F., Tosano, V., Concolino, G., Di Silverio, F., 1990. Androgens: 
clinical applications. Journal of Steroid Biochemistry and 
Molecular Biology 37, 349-362. 
Shadab, G.G.H.A., 2000. Cytogenetic and Clinical Studies of Certain 
Steroids on Human Chromosomes. Ph.D. Thesis, Department of 
Zoology, A.M.U., Alig9*h. 
Shamberger, R.J., 1984. Genetic toxicology of ascorbic acid. Mutation 
Research 133, 135-159. 
Shimazu, H., Shiraishi, N., Akematsu, T., Ueda, N., Sugiyama, T., 1976. 
Carcinogenicity screening tests on induction of chromosomal 
aberrations in rat bone marrow cells in vivo. Mutation Research 
38,347. 
Shimomura, M., Higashi, S., Mizumoto, R., 1992. 32P-post labelling 
analysis of DNA adducts in rats during estrogen-induced 
60 
hepatocarcinogenesis and effect of tamoxifen on DNA adduct 
level. Japanese Journal of Cancer Research 83, 438-444. 
Shyama, S.K., Rahiman, M.A., 1996. Genotoxicity of lynoral 
(ethinylestradiol, an oestrogen) in mouse bone marrow cells, in 
vivo. Mutation Research 370, 175-180. 
Siddique, Y.H., Afzal, M , 2003. Induction of sister chromatid exchanges 
by androstenedione in human lymphocytes in vitro. Bulletin on 
Environmental Biology 1, 9-12. 
Siddique, Y.H., Afzal, M., 2004a. Antigenotoxic effect of 
nordihydroguaiaretic acid (NDGA) against SCEs induced by 
estradiol-17(3 in human lymphocyte chromosomes in vitro. Indian 
Biologist 36, 25-27'. 
Siddique, Y.H., Afzal, M., 2004b. Antigenotoxic effect of allicin against 
SCEs induced by methyl methanesulphonate in cultured 
mammalian cells. Indian Journal of Experimental Biology 42, 
437-438. 
Siddique, Y.H., Afzal, M., 2004c. Evaluation of genotoxic potential of 
synthetic progestin chlormadinone acetate. Toxicology Letters 
153,221-225. 
Siddique, Y.H., Afzal, M., 2004d. Induction of chromosomal aberrations 
and sister chromatid exchanges by chlormadinone acetate in 
human lymphocytes: A possible role of reactive oxygen species. 
Indian Journal of Experimental Biology 42, 1078-1083. 
Siddique, Y.H., Afzal, M., 2004e. Evaluation of genotoxic potential of 
ethynodiol diacetate in human lymphocyte in vitro. Current 
Science %6, 1161-1165. 
Siddique, Y.H., Afzal, M., 2004f. Evaluation of genotoxic potential of 
synthetic progestin lynestrenol in human lymphocytes in vitro. 
Indian Biologist 36, 11-17. 
Siddique, Y.H., Afzal, M. 2005a. Protective role of allicin and L-ascorbic 
acid against the genotoxic damage induced by chlormadinone 
acetate in cultured human lymphocytes. Indian Journal of 
Experimental Biology 43, 769-772. 
61 
Siddique, Y.H., Afzal, M., 2005b. Antigenotoxic effect of allicin against 
methyl methanesulphonate induced genotoxic damage. Journal of 
Environmental Biology 26, 547-550. 
Siddique, Y.H., Afzal, M., 2005c. Genotoxic potential of cyproterone 
acetate: a possible role of reactive oxygen species. Toxicology in 
vitro 19,63-68. 
Siddique, Y.H., Afzal, M., 2005d. Evaluation of genotoxic potential of 
norethynodrel in human lymphocytes in vitro. Journal of 
Environmental Biology 26, 387-392. 
Siddique, Y.H., Afzal, M , 2005e. In vivo induction of sister chromatid 
exchanges (SCEs) and chromosomal aberrations (CAs) by 
lynestrenol. Indian Journal of Experimental Biology 43, 291-293. 
Siddique, Y.H., Beg, T., Afzal, M , 2005a. Antigenotoxic effects of 
ascorbic acid against megestrol acetate induced genotoxicity in 
mice. Human and Experimental Toxicology 24, 121-127. 
Siddique, Y.H., Beg, T., Afzal, M., 2005b. Genotoxic potential of 
ethinylestradiol in cultured mammalian cells. Chemico Biological 
Interaction 151, 133-141. 
Siddique, Y.H., Ara, G., Beg, T., Afzal, M., 2005. Protective role of 
natural plant products against estradiol-17$ induced genotoxic 
damage. Recent Progress in Medicinal Plants 15, 415-429. 
Siddique, Y.H., Beg, T., Afzal, M., 2006. Protective effect of 
nordihydroguaiaretic acid (NDGA) against norgestrel induced 
genotoxic damage. Toxicology in vitro 20, 227-233. 
Siegers, C.P., Robke, A., Pentz, R., 1999. Effects of garlic preparations 
on superoxide production by phorbol ester activated granulocytes. 
Phytomedicine 6, 13-16. 
Singh, H., Singh, J.R., Dhillon, V.S., Bali, D., Paul, H., 1994. In vitro and 
in vivo genotoxicity evaluation of hormonal drugs.II. 
Dexamethasone. Mutation Research 308, 89-97. 
Sofuni, T., Ishidate, M. Jr., 1984. Induction of chromosomal aberrations 
in cultured Chinese Hamster Cells superoxide generation system. 
Mutation Research 140, 27-31. 
62 
Stenchever, M.A., Jarvis, J.A., Kreger, N.K., 1969. Effect of selected 
estrogens and progestins on human chromosomes in vitro. 
Obstetrics and Gynecology 34, 249-251. 
Szeto, Y.T., Tomlinson, B., Benzie, I.F., 2002. Total antioxidant and 
ascorbic acid content of fresh fruits and vegetables: Implications 
for dietary planning and food preservation. The British Journal of 
Nutrition 87, 55-59. 
Tanenbaum, D.M., Wang, Y., Williams, S.P., Sigler, P.B, 1998. 
Crystallographic comparison of the estrogens and progesterone 
receptors ligand binding domains. Proceeding of the National 
Academy of Sciences U.S.A. 95, 5998-6003. 
Thibodeau, P.A., Paquette, B., 1999. DNA damage induced by catechol 
estrogens in the presence of copper (II): generation of reactive 
oxygen species and enhancement by NADH. Free Radical Biology 
and Medicine 27', 1367-1377. 
Tice, R., Schneider, E.L., Rary, J.M., 1976. The utilization of 
bromodeoxyuridine incorporation into DNA for the analysis of 
cellular kinetics. Experimental Cell Research 102, 232-236. 
Topinka, J. Binkova, B., Zhu, H.K. Andrae, U., Neumann, I., Schwarz, 
L.R., Werner, S., Wolff, T., 1995. DNA damaging activity of 
cyproterone acetate analogues, chlormadinone acetate and 
megestrol acetate in rat liver. Carcinogenesis 16, 1483-1487. 
Tsuda, H., 1981. Chromosomal aberrations induced by hydrogen 
peroxide in cultured mammalian cells. Japanese Journal of 
Genetics 56, 1-8. 
Vijayalaxmi, K.K., Venu, R., 1999. In vivo anticlastogenic effects of L-
ascorbic acid in mice. Mutation Research 438, 47-51. 
Wang, Z.Y., Agarwal, R., Zhou, Z.C., Bickers, D.R., Mukhtar, H , 1991. 
Antimutagenic and antitumorigenic activities of 
nordihydroguaiaretic acid. Mutation Research 261, 153-162. 
Weikel, J.H., Nelson, L.W., 1977. Problems in evaluating chronic toxicity 
of contraceptive steroids in dogs. Journal of Toxicology and 
Environmental Healths, 161-Ml. 
63 
Werner, S., Kuntz, S., Beckurts, T., Heidecke, CD., Wolff, T., Schwarz, 
L.R., 1997. Formation of DNA adducts by cyproterone acetate and 
some structural analogues in primary cultures of human 
hepatocytes. Mutation Research 395, 179-187. 
Wheeler, W.J., Cherry, L.M., Downs, T., Hsu, T.C., 1986. Mitotic 
inhibition and aneuploidy induction by naturally occurring and 
synthetic estrogens in Chinese Hamster Cells in vitro. Mutation 
Research 171,31-41. 
Woodal, A.A., Ames, B.N., 1997. Diet and oxidative damage to DNA: 
the importance of ascorbate as an antioxidant. In: Packer, L., 
Fuchs, J., Vitamin C in Health and Disease, Marcel Dekker, New 
York, pp. 193. 
Yager, J.D., Fifield, D.S., 1982. Lack of hepatogenotoxicity of oral 
contraceptive steroids. Carcinogenesis 3, 625-628. 
Yager, J.D., Liehr, J.G., 1996. Molecular mechanisms of estrogens 
carcinogenesis. Annual Review of Pharmacology and Toxicology 
36, 203-232. 
Yamamoto, K.R., 1985. Steroid receptor regulated transcription of 
specific genes and gene networks. Annual Review of Genetics 19, 
209-225. 
Yosida, T.H., Amano, K., 1965. Autosomal polymorphism in laboratory 
bred and wild Norway rats, Rattus norvegicus found in Misima. 
Chromosoma 16, 658-667. 
Youngren, J.F., Gable, K., Penaranda, C , Maddux, B.A., Zavodovskaya, 
M., Lobo, M., Campbell, M., Kerner, J., Goldfme, I.D., 2005. 
Nordihydroguaiaretic acid (NDGA) inhibits the IGF-1 and c-
erbB2/HER2/new receptors and suppresses growth in breast 
cancer cells. Breast Cancer Research and Treatment 94, 37-46. 
Zhu, B.T., Conney, A.H., 1998. Functional role of estrogen metabolism 
in target cells: review and perspectives. Carcinogenesis 19, 1-27. 
(PWBLICMlOViS 
Available online at www.sciencedirect.com 
S C I E N C E (ff\ D I R E C T * ; N C E @ ' 
ELSEVIER Toxicology Letters 153 (2004) 221-225 
Toxicology 
Letters 
www.elsevier.com/locate/toxlet 
Evaluation of genotoxic potential of synthetic progestin 
chlormadinone acetate 
Yasir Hasan Siddique*, Mohammad Afzal 
Section of Genetics, Department of Zoology, Faculty of Life Sciences, A.M.U., Aligarh, Uttar Pradesh 202002, India 
Received 19 January 2004; received in revised form 24 March 2004; accepted 30 March 2004 
Available online 10 June 2004 
Abstract 
The genotoxicity study of a synthetic progestin chlormadinone acetate, was carried out on mouse bone marrow cells using 
sister chromatid exchanges (SCEs) and chromosomal aberrations (CAs) as parameter, chlormadinone acetate was studied at 
three different doses, i.e. 5.62, i 1.25 and 22.50 mg/kg body weight and was found to be non-genotoxic at 5.62mg/kg body 
weight. But at 11.25 and 22.50 mg/kg of body weight chlormadinone acetate increases SCE (P < 0.001) and CA (P < 0.01) at 
significant level compared to normal control. The results suggests a genotoxic and cytotoxic effect of chlormadinone acetate in 
mouse bone marrow cells. 
© 2004 Elsevier Ireland Ltd. All rights reserved. 
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1. Introduction 
Synthetic progestins are widely used as oral con-
traceptives in addition to their use in the treatment of 
various menstrual disorders, various types of cancers 
and in hormonal replacement therapy. For contracep-
tion, these are either used alone or in combination 
with estrogens. Progestins, like estrogens diffuses eas-
ily across the cell membranes and bind to highly spe-
cific, soluble receptor proteins in the cytoplasm. The 
steroid receptor complex modifies the expression of 
specific genes by binding to control elements in DNA 
* Corresponding author. Fax: +91 571 2708088. 
E-mail address: yasirJiasansiddique@rediffmail.com 
(Y.H. Siddique). 
(Yamamoto, 1985; Tanenbaum et al., 1998). Chlor-
madinone acetate is used either as single entity drug 
or in combination with estrogen, such as ethinyl estra-
diol or mestranol in oral contraceptives. Chlormadi-
none acetate was tested in mice, rats and dogs by 
oral administration. In dogs, it produce mammary tu-
mours in one study (IARC, 1979) and increased the 
incidence of mammary gland hyperplasia and mam-
mary nodules in another (El Etreby and Graf, 1979). 
It did not induce chromosomal aberrations (CAs) in 
cultured human lymphocytes and was not mutagenic 
to bacleria (IARC, 1987). Here in the present study, 
we decided to see the effect of chloromadinone acetate 
at three different doses on sister chromatid exchanges 
(SCEs) and chromosomal aberrations frequencies in 
mouse bone marrow cells. 
0378-4274/S - see front matter © 2004 Elsevier Ireland Ltd. All rights reserved. 
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2. Materials and methods 
2.1. Chemical agents 
Chlormadinone acetate (CAS no: 302-22-7; 17 
- (acety-loxy)-6-chloropregna-4,6-diene-3,20-dione) 
(Sigma); dime-thylsulfoxide (DMSO) (0.1 ml/animal) 
(E. Merck, Mumbai, India); colchicine (6.0mg/kg 
body weight); Hoechst 33258 stain (0.05% w/v) 
(Sigma); 3% and 7% Giemsa solution in phos-
phate buffer (pH 6.8) (E. Merck, Mumbai, India); 
Af-methyl-/V'-nitro-/V-nitrosoguanidine (MNNG) (1.2 
x 104 jig/kg body weight); 5-bromo-2-deoxyuridine 
(BrdU) (1.6g/kg body weight). 
2.2. Animals 
Swiss albino female mice (Mus musculus L.) 
25-30 g, 10-12 weeks old were procured from Luc-
know (UP), India and grouped in different cages (five 
animals/group) and kept in polypropylene cages at a 
mean temperature of 25 °C. 
2.3. Sister chromatid exchanges analysis 
The fluorescent plus Giemsa techniques (Perry and 
Wolff, 1974) were followed with slight modification 
for SCE analysis. 5-Bromo-2-deoxyuridine in tablet 
form (BrdU; 1.6g/kg body weight) was implanted 
subcutaneously in the neck region of each mouse un-
der mild anaesthesia and 30 min later chlormadinone 
acetate at 5.62, 11.25 and 22.50 mg/kg of body weight 
was injected intraperitoneally (i.p.) separately, to dif-
ferent group of animals. According to the LD50 ob-
tained with the method of Lorke (1983), which gave a 
result of 90 mg/kg, the highest tested dose corresponds 
to 1/4 of this parameter. A 0.1 ml of dimethylsulfox-
ide as negative control and 1.2 x 104 pig/kg body 
weight of 7V-methyl-/V'-nitro-A'-nitrosoguanidine as 
positive control were injected intraperitoneal to differ-
ent groups of mice. After 21 h, the animals received 
an intraperitoneal injection of colchicine (6.0 mg/kg 
body weight) and 3 h later, the bone marrow of both 
femurs were obtained in KC1 0.075 M at 37 °C keep-
ing the cells for 30 min at the same temperature. The 
supernatant was removed by centrifugation and 5 ml 
of fixative (methanol: glacial acetic acid; 3:1) was 
added. The fixative was removed and the procedure 
was repeated twice. Slides were stained for 20 min 
in a 0.05% (w/v) Hoechst 33258 solution, rinsed 
with tap water and placed under a near UV lamp, for 
90 min, covered with Sorensen's buffer, pH 6.8 and 
stained with 3% Giemsa solution in phosphate buffer 
(pH 6.8) for 15 min. The SCE average was taken from 
an analysis of the metaphases during the second cycle 
of divisions. At least 60s division mitoses per mouse 
were scored to determine the frequency of SCEs. 
2.4. Chromosomal aberrations analysis 
For the analysis of chromosomal aberrations the 
tested and control doses were same as described for 
the SCE analysis. Chlormadinone acetate at 5.62, 
11.25 and 22.50 mg/kg body weight was injected 
intraperitoneally separately, to different group of ani-
mals. After 21 h, the animals were injected i.p. with 
colchicine (6.0 mg/kg body weight) 2h before sac-
rifice. Bone-marrow preparations for the analysis of 
chromosomal aberrations in mctaphase cells were ob-
tained by the technique of Yosida and Amano (1965). 
Slides were stained with 7% Giemsa stain in phos-
phate buffer (pH 6.8). Five animals were taken for 
each treatment and 100-well spread metaphases were 
analysed per animal. 
2.5. Statistical analysis 
The significance of the difference between experi-
mental and control data was calculated using the r-test. 
The level of significance was tested from standard sta-
tistical table of Fisher and Yates (1963). 
3. Results and discussion 
A 11.25 and 22.50 mg/kg body weight of chlor-
madinone acetate doses induces sister chromatid 
exchanges at significant level as compared to 
normal values. At 5.62 mg/kg body weight the 
value of SCEs/cell was not significant (Table 1). 
ALmethyl-/V'-nitro-/V-nitrosoguanidine and DMSO 
were associated with the mean values of 10.76 ± 
1.46 and 2.36 ±0 .11 SCEs/cell. It is evident from 
Table 2 that the percentage of abnormal metaphases 
without gaps in animals treated with the tested doses, 
i.e. 11.25 and 22.50 mg/kg body weight were signif-
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Table 1 
Frequency of sister chromatid exchanges (SCEs) induced by chlormadinone acetate in mice bone marrow 
Treatment 
Chlormadinone acetate (mg/kg body weight) 
5.62 
11.25 
22.50 
Normal 
Positive control MNNG (1.2 x I04 |xg/kg body weight) 
Negative control (DMSO 0.1 ml/animal) 
BrdU (1.6g/kg body weight) 
MNNG: iV-methyl-rV'-nitro-yV-nitrosoguanidine; DMSO: dimethylsulfoxide; BrdU: 5-bromo-2-deoxyuridine; S.E.: standard error. 
* Significant at P < 0.001 vs. normal. 
Number of 
metaphases analyzed 
300 
300 
300 
300 
300 
300 
300 
Mean SCEs/ 
metaphase ± S.E. 
3.01 ± 0.21 
8.46 ± 0.83* 
9.43 ± 0.96* 
2.02 ±0 .10 
10.76 ± 1.46* 
2.36 ± 0.11 
2.98 ±0 .13 
Rang 
1-7 
2-8 
3-9 
1-6 
3-10 
1-6 
1-6 
icant at P < 0.01 when compared to normal values. 
At 5.62mg/kg body weight abnormal metaphases 
were not significant and there were no robertsonian 
translocations. At 11.25 and 22.50 mg/kg body weight 
a dose dependent increase was observed in fragments, 
robertsonian translocations and polyploidy. 
The results of the present investigation reveal that 
chlormadinone acetate increases sister chromatid ex-
changes and chromosomal aberrations frequencies 
significantly at two doses of the three tested doses. 
Similar observations on the DNA damaging proper-
ties of steroids as evident from chromosomal damage, 
induction of SCEs and formation of endogenous DNA 
adducts and certain neoplastic changes have also been 
reported earlier (Singh et al., 1994; Dhillon et al,, 
1994; Lehmann et al., 1989; Ahmad et al, 2001; 
Martelli et al., 2003). Some drugs were unable to in-
duce significantly higher frequencies of chromosomal 
aberrations and micronuclei formation in bone mar-
row cells of rats (Herrera et al., 1980). Metabolism of 
estrone 3,4-quinone produces free radicals in human 
breast cancer cells (MCF-7) and these are responsible 
for chromosomal DNA damage (Nutter et al., 1994). 
Other catechol estrogen are reported to induce' DNA 
damage by generating reactive oxygen species or free 
radicals (Thibodeau and Paquette, 1999; Chen et al., 
Table 2 
Mean percentage of chromosomal aberrations in mouse bone marrow cells after chlormadinone acetate treatment 
Treatment 
Chlormadinone acetate 
(mg/kg body weight) 
5.62 
11.25 
22.50 
Normal 
Positive control MNNG 
(1.2 x 104txg/kg body 
weight) 
Negative control DMSO 
(0.1 ml/animal) 
Abnormal 
Number 
14 
56 
82 
8 
132 
10 
metaphases without gaps 
Mean% ± S.E. 
2.8 ± 0.73 
11.2 ± 1.41* 
16.4 ± 1.65* 
1.60 ± 0.56 
26.4 ± 1.97* 
2.0 ± 0.62 
Chromosomal aberrations 
Gaps 
Number 
9 
23 
29 
6 
34 
5 
% 
1.8 
4.6 
5.8 
1.2 
6.8 
1 
Fragments 
and or breaks 
Number % 
11 
39 
53 
6 
91 
7 
2.2 
7.8 
10.6 
1.2 
18.2 
1.4 
Robertsonian 
translocations 
Number % 
-
7 
16 
-
25 
-
-
1.4 
3.2 
-
5 
-
Polyploidy 
Number % 
3 0.6 
10 2 
13 2.6 
2 0.4 
16 3.2 
3 0.6 
One hundred cells were analyzed per animal, for a total of 500-ccll per treatment. MNNG: /V-methyl-A"-nitro-/V-nitrosoguanidine; DMSO: 
dimethylsulfoxide; S.E.: standard error. 
* Significant different from the normal (P < 0.01). 
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1998; Han and Liehr, 1995; Li et al., 1994; Roy et al., 
1991). Induction of DNA repair was reported in pri-
mary rat hepatocytes exposed to synthetic progestins 
(Martelli et al., 2003). Synthetic progestins like mege-
strol acetate and chlormadinone acetate also shows 
the formation of DNA adducts in the primary cultures 
of human hepatocytes (Werner et al., 1997). Certain 
synthetic steroids have been reported to be mutagenic 
in the Ames tester strains by generating active oxygen 
species in the system (Islam et al., 1991). A signif-
icant increase in the number of lymphocytes with 
DNA migration in alkaline comet assay and frequency 
of sister chromatid exchanges per metaphase were 
observed in the oral contraceptives; user as compared 
with their age matched untreated controls (Biri et al., 
2002). Most of the chromosomal aberrations observed 
in cells are lethal, but there are many corresponding 
aberrations that are viable and can cause genetic ef-
fects, either somatic or inherited (Swierenga et al., 
1991). SCE is generally a more sensitive indicator of 
genotoxic effects than structural aberrations (Tucker 
and Preston, 1996). There is a correlation between the 
carcinogenicity and SCE inducing ability of a large 
chemicals (Swierenga et al., 1991). Our study shows 
induction of SCEs and CAs at significant level by two 
out of the three tested doses of chlormadinone acetate 
in mouse bone marrow cells. The exact mechanism 
for the cause of the genotoxicity by chlormadinone 
acetate is not known. Hence it is therefore advisable 
to be careful of the potential hazards of these drugs. 
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reactive oxygen species 
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Genotoxicity study of a synthetic progestin chlormadinone acetate (CMA) was carried out in human lymphocytes using 
chromosomal aberrations (CAs) and sister chromatid exchanges (SCEs) as parameter. Effect of CMA was studied at 10, 20, 
30 and 40 U.M. CMA was genotoxic at 30 and 40 \iM. With a view to study the possible mechanism of genotoxicity of 
CMA, superoxide dismutase (SOD) and catalase (CAT) were used separately and in combination along with the CMA (40 
u,M) at different doses. SOD treatment increased CAs and SCEs at both the doses. CAT treatment decreased the frequencies 
of CAs and SCEs in both, separately and in combination with SOD, suggesting a possible role of reactive oxygen species for 
the genotoxic damage. 
Keywords: Chlormadinone acetate, Chromosomal aberrations, Human lymphocytes, Reactive oxygen species, Sister 
chromatid exchanges. 
Synthetic progestins are widely used as oral 
contraceptives in addition to their use in the treatment 
of various menstrual disorders, cancers and in 
hormonal replacement therapy. For contraception, 
these are either used alone or in combination with 
estrogens. Progestins, like estrogen diffuses easily 
across the cell membranes and bind to highly specific, 
soluble receptor proteins in the cytoplasm. The steroid 
receptor complex modifies the expression of specific 
gene by binding to control elements in DNA1'2. 
Chlormadinone acetate (CMA) is used either as single 
entity drug or in combination with estrogen, such as 
ethinyl-estradiol or mestranol in oral contraceptives. 
CMA was tested in mice, rats and dogs by oral 
administration. In dogs, it produces mammary 
tumours in one study3 and increases the incidence of 
mammary gland hyperplasia and mammary nodules in 
another4. CMA is not mutagenic to bacteria5. In the 
present study, effect of CMA at different doses on 
chromosomal aberrations (CAs) and sister chromatid 
exchanges (SCEs) frequencies in human lymphocytes 
was studied and further, effect of superoxide 
•Correspondent author: 
E-mail:y asirjiasansiddique @ rediffmail.com 
Fax: 0571-2708088 
dismutase (SOD) and catalase (CAT) on CMA 
genotoxic dosages was also worked out. 
Materials and Methods 
Chemicals—RPMI 1640 (Gibco), fetal calf serum 
(Gibco), phytohaemagglutinin-M (Gibco), dimethyl-
sulphoxide (5 jj,l/ml; E. Merck, India), colchicine 0.20 
Hg/ml (Microlab), Hoechst 33258 stain (0.05% w/v; 
Sigma), 3% giemsa solution in phosphate buffer (pH 
6.8; E. Merck, India), mitomycin C (Sigma), 
superoxide dismutase and catalase (Fluka), 
chlormadinone acetate (CAS No: 302-22-7; 17-(ace-
tyloxy)-6-chloropreg-4,6-diene-3,20-dione (Wyeth 
lab), 5-bromo-2-deoxyuridine (Sigma), antibiotic-
antimycotic mixture (Gibco) was used in the present 
study. 
Human lympliocyte culture—Duplicate peripheral 
blood cultures were prepared according to Carballo 
et at. Heparinized blood samples (0.5 ml) were 
obtained from two healthy female donors with no 
recent history of exposure to mutagens, and were 
placed in a sterile flask containing 7 ml of RPMI 1640 
supplemented with fetal calf serum (1.5 ml) and of 
phytohaemagglutinin (0.1 ml). They were placed in 
the incubator at 37°C for 24 hr. Dimethylsulphoxide 
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(DMSO; 5 nl/ml) and mitomycin C were taken as 
negative and positive control respectively. 
Chromosomal aberrations (CAs) analysis—After 
24 hr, chlormadinone at final concentrations of 10, 20, 
30 and 40 [iM dissolved in DMSO was added and 
kept for another 48 hr at 37°C in the incubator. After 
47 hr, 0.2 ml of colchicine (0.2 jAg/ml) was added to 
the culture flask. Cells were centrifuged at 1000 rpm 
for 10 min. The supernatant was removed and 5 ml of 
pre-warmed (37°C) KC1 hypotonic solution (0.075 M) 
was added. Cells were resuspended and incubated at 
37°C for 15 min. The supernatant was removed by 
centrifugation at 1000 rpm for 10 min, and 5 ml of 
chilled fixative (methanol : glacial acid; 3:1) was 
added. The fixative was removed by centrifugation 
and the procedure was repeated twice. The slides were 
stained in 3% of Giemsa solution in phosphate buffer 
(pH 6.8) for 15 min. At least 300 metaphases were 
examined for the occurrence of different types of 
abnormality i.e. gaps, fragments and breaks. Criteria 
to classify the different types of aberrations were in 
accordance with the recommendation of EHC 46 for 
Environmental Monitoring of Human Population7. 
Sister chromatid exchanges (SCEs) analysis—For 
SCE analysis, bromodeoxyuridine (BrdU, 10 Jig/ml) 
was added at the beginning of the culture. After 24 hr 
CM A at final concentrations of 10, 20, 30 and 40 \xM 
dissolved in DMSO was added and kept for another 
48 hr at 37°C in the incubator. Mitotic arrest was done 
1 hr prior to harvesting by adding 0.2 ml of colchicine 
(0.2 ug/ml). Hypotonic treatment and fixation were 
performed in the same way as described for CAs 
analysis. The slides were processed according to 
Perry and Wolff8. The SCE average was taken from 
an analysis of the metaphase during second cycle of 
divisions. 
Induction of CAs and SCEs in presence of 
superoxide dismutase (SOD) and catalase (CAT) by 
CMA - CMA (40 \xM) was treated with 10 and 20 
ug/ml of SOD and CAT separately and in 
combination to see the effect on CAs and SCEs 
induced by CMA. Duplicate cultures for both CAs 
and SCEs analysis were set, as described earlier in the 
text. 
Statistical analysis—Student's t test was used for 
the analysis of CAs and SCEs. The level of 
significance was tested from standard statistical tables 
of Fisher and Yates9. 
Results 
In CAs analysis, a dose-dependent increase was 
observed in the number of abnormal cells. However, a 
significant increase was observed at 30 and 40 \iM of 
CMA (Table 1). When 40 jiW of CMA was treated 
with 10 and 20 ug/ml of SOD the number of 
abnormal cells increased as compared to CMA treated 
alone, but a significant decrease of abnormal cells 
were observed when 40 \iM of CMA was treated with 
10 and 20 ug/ml of CAT separately and in 
combination with SOD (Table 2). 
In SCEs analysis a clear dose dependent increase in 
SCEs/cell was observed when treated with CMA 
alone (Table 3). SCEs/cell were significantly 
increased at 30 and 40 \x.M. When 40 \iM of CMA was 
Table 1—Chromosomal aberrations (CAs) in human lymphocytes treated with chlormadinone acetate 
Treatment 
CMA (uAf) 
10 
20 
30 
40 
Untreated 
Negative control 
(DMSO 5 ul/ml) 
Positive control 
(Mitomycin C 0.3 ug/ml) 
Abnormal 
Number 
3 
4 
7 
15 
3 
2 
25 
metaphases without gaps 
Percentagev 
1.00±0.57 
1.3410.66 
2.3410.87" 
5.0011.25b 
1.00+0.57 
0.6710.47 
8.34+1.59b 
Number 
2 
3 
4 
7 
1 
2 
10 
Gaps 
Chromosc 
% 
0.67 
1.00 
1.34 
2.34 
0.34 
0.67 
3.34 
ime aberrations 
Fragments and/< 
Number 
6 
9 
10 
20 
4 
5 
32 
ar breaks 
% 
2 
3 
3.34 
6.67 
1.34 
1.67 
10.67 
"Significant difference from the untreated (f'<0.05). 
bSignificant difference from the untreated (P<0.01). 
CMA: Chlormadinone acetate,DMSO: Dimethylsulphoxide, '•'Values are mean 1 SE. 
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treated with 10 and 20 jig/ml of SOD the SCEs/cell 
were further increased, but SCEs/cell were decreased 
significantly when treated with 10 and 20 )J.g/ml of 
CAT separately and in combination of SOD (Table 4). 
Discussion 
The results of the present investigation revealed 
that CMA increased CAs and SCEs significantly at 
two doses of the four tested doses. Similar 
observations on DNA damaging properties of 
steroids, as evident from chromosomal damage, 
induction of SCEs10"13 and formation of endogenous 
DNA adducts and certain neoplastic changes have 
also been reported earlier14'15. Estrone 3,4-quinone 
produces free radicals in human breast cancer cells 
(MCF-7) and these are responsible for chromosomal 
DNA damage16. Other catechol estrogens are reported 
to induce DNA damage by generating reactive oxygen 
species or free radicals17"21. Induction of DNA repair 
has been reported in primary rat hepatocytes exposed 
, 14,22 to synthetic progestins ' . Synthetic progestins like 
megestrol acetate and CMA also show the formation 
of DNA adducts in primary cultures of human 
„23 hepatocytes . A significant increase in the number of 
Table 3—Sister chromatid exchanges (SCEs) in cultured 
human lymphocytes exposed to chlormadinone acetate 
Cells 
scored SCEs/cell
v
 Range Treatment 
CMA (\lM) 
10 
20 
30 
40 
Untreated 
Negative control 
(DMSO 5 ul/ml) 
Positive Control 
(Mitomycin C 0.3 ug/ml) 
"Significant difference with respect to untreated (P<0.05). 
CMA: Chlormadinone acetate, DMSO: Dimethylsulphoxide, 
^Values are mean 1 SE. 
50 
50 
50 
50 
50 
50 
50 
2.23 ±0.14 
3.0310.17 
5.31 ±0.35a 
6.02 ± 0.40a 
1.3110.07 
1.8910.10 
8.9010.53a 
1-5 
1-6 
2-6 
2-7 
0-5 
0-5 
2-11 
Table 2—Effect of superoxide dismutase (SOD) and catalase (CAT) on chromosomal aberrations in human 
lymphocytes treated with chlormadinone acetate 
Abnormal metaphases without gaps Chromosome aberrations Treatment 
CMA (uM) 
40 
CMA (uM)+ SOD ((ug/ml) 
40+ 10 
40 + 20 
CMA (U.M) + CAT (ug/ml) 
40+10 
40 + 20 
CMA(uM) + SOD (ug/ml)+ 
CAT(ug/ml) 
40+10+10 
40 +20 +20 
Untreated 
SOD (ug/ml) 
10 
20 
CAT (ug/ml) 
10 
20 
Number 
16 
18 
20 
11 
9 
8 
6 
2 
3 
4 
3 
2 
Percentage'1' 
5.3411.29" 
6.0011.37" 
6.6711.44" 
3.6711.08" 
3.0010.98" 
2.6710.93" 
2.0010,80" 
0.6710.47 
1.0010.57 
1.3410.66 
1.0010.57 
0.6710.47 
Gaps 
Number 
8 
9 
11 
6 
5 
4 
3 
1 
2 
1 
2 
1 
% 
2.67 
3.00 
3.67 
2.00 
1.67 
1.34 
1.00 
0.34 
0.67 
0.34 
0.67 
0.34 
Fragments 
Number 
23 
26 
28 
10 
8 
9 
6 
3 
4 
3 
2 
2 
and/or breaks 
% 
7.67 
8.67 
9.34 
3.34 
2.67 
3.00 
2.00 
1.00 
1.34 
1.00 
0.67 
0.67 
"Significant difference from the untreated (P<0.01). 
"Significant difference from the CMA (/><0.01). 
CMA: Chlormadinone acetate, SOD: Superoxide dismutase, CAT: Catalase, ''Values are mean 1 SE. 
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Table 4—Effect of superoxide dismutase (SOD) and 
catalase (CAT) on sister chromatid exchanges (SCEs) 
induced by chlormadinone acetate 
Treatment 
CMA (nA/) 
40 
CMA (uJW) + SOD 
(Hg/ml) 
40+10 
40 + 20 
CMA (\xM) + CAT 
(Hg/ml) 
40+10 
40 + 20 
CMA (\lM) + SOD 
(Hg/ml)+ CAT (|ig/ml) 
40+10+10 
40 + 20 + 20 
Untreated 
SOD (ng/ml) 
10 
20 
CAT (ng/ml) 
10 
20 
Cells 
scored 
50 
50 
50 
,50 
50 
50 
50 
50 
50 
50 
50 
50 
SCEs/cell* 
6.63 ± 0.43a 
. 7.14 ±0.47" 
7.89 ± 0.49a 
3.60±0.2:!b 
3.21±0.18b 
2.78±0.15b 
2.02 + 0.13" 
1.6710.09 
1.9310.10 
1.98 + 0.11 
1.4310.03 
1.4110.03 
Rang 
2-7 
2-7 
2-8 
1-6 
1-6 
1-5 
1-5 
0-5 
0-5 
1-5 
0-5 
0-5 
"Significant difference with respect to untreateci (P<0.05). 
"Significant difference with respect to CMA (P<0.05). 
CMA: Chlormadinone acetate, SOD: Superoxide dismu-
tase, CAT: Catalase, SE: Standard error. 
vValues are mean 1 SE. 
C - 0 
X - O - H ~ - :CI: 
5' 
Chlormadinone acetate (CV.A) 
lymphocytes with DNA migration in alkaline comet 
assay and frequency of SCEs per metaphase have 
been observed in the oral contraceptives user as 
compared with their age matched untreated controls24. 
Certain synthetic steroids have been reported to be 
mutagenic in Ames tester strains by generating active 
oxygen species in the system25. With a view to 
understand the mechanism and cause of the 
genotoxicity by CMA, one of the genotoxic doses (40 
\\.M of CMA) was given along with 10 and 20 Hg/ml 
of SOD. Since the teatment with SOD increases the 
CA and SCE frequency, we can say that possibly 
somehow CMA is generating reactive oxygen species, 
which on treatment with SOD changes into hydrogen 
peroxide (H2O2). H2O2 has been known to cause DNA 
damage in the form of single strand breaks and double 
strand breaks17, CAs26"27 and SCEs28. Superoxide 
dismutases (SODs) are a family of metaloenzymes 
that convert 02"to H2O2 according to the following 
29 
reaction : 
0 2 +02 
2H 
—> 
SOD 
H 2 0 2 + 0 2 
Further the treatment of 40 \iM of CMA with 10 
and 20 |j,g/ml of CAT separately and in combination 
of SOD results in the significant decrease in CAs and 
SCEs. This also proves the production of H202 
because CAT catalyses the decomposition of H2O2 to 
"9 ci 
Homolytic 
fission 
XOH 
CI 
OH" 
SOD 
CAT 
CI 
= Reactive nucleophlle within the cell 
= chlorine attached lo the carbon atom (C-6) of 
chlormadinone acetate 
= Enhancing the electrophilic nature of O moiety. 
= Hydroxyl radical unstable. 
= Superoxide dismutase 
= Catalase 
X - O l - O - H + 
XO + OH* 
OH + bH?59^H2o2 
2 H 2 0 2 C ^ i - 2 H 2 0 + 0 2 
CI 
Fig. 1—Possible mechanism of generating reactive oxygen species by chlormadinone acetate (CMA) 
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water and oxygen. CAT is a heame containing 
protein30. The mechanism of the action is: 
CAT 
2H202 -> 2H20 + 0 2 
CAT is found to reduce SCE levels resulting from 
the treatment with H20227. In the light of above 
results, it is suggested possible mechanism of 
generating reactive oxygen species by CMA, which is 
responsible for the genotoxicity (Fig. 1). As is 
obvious from Fig. 1, XOOH can also give rise to 
XOO* and *OOH radicals. The presence of alkoxyl 
(XOO)* radical appears to be a remote possibility in 
view of the highly polar nature of the living system 
because for that X has to be essentially an alkyl 
group25. 
Hence, it is suggested to minimum use of effective 
and acceptable doses of these drugs so as to minimize 
potential risk. 
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Abstract 
Ethinylestradiol, a steroidal estrogen, is widely used with various progestogens in oral contraceptives formulations. There are 
sufficient evidences for the carcinogenicity of ethinylestradiol in experimental animals. The reports on the genotoxic potential 
of ethinylestradiol are contradictory. Here in the present study we have tested the genotoxicity of ethinylestradiol in human 
lymphocytes using chromosomal aberrations (CAs), mitotic index (MI) and sister chromatid exchanges (SCEs) as a parameter. 
The study was carried out in the absence, as well as in the presence, of rat liver microsomal fraction, with and without NADP. 
Ethinylestradiol was studied at three different concentrations (1, 5 and 10 p.M) and was found non-genotoxic in the absence of 
metabolic activation (S9 mix) and in S9 mix without NADP. Ethinylestradiol was found to be genotoxic at 5 and 10|xM in the 
presence of S9 mix with NADP. To study the possible mechanism of the genotoxicity of ethinylestradiol, superoxide dismutase 
(SOD) and catalase (CAT) were used separately and in combination along with 10p.M of ethinylestradiol at different doses. 
SOD treatment increased CAs and SCEs and decreases MI as compared with treatment with 10p*M of ethinylestradiol alone 
in the presence of S9 mix with NADP at both of the tested doses. CAT treatment decreased the frequencies of CAs and SCEs 
and increased MI, as compared with treatment with 10p,M of ethinylestradiol alone in the presence of S9 mix with NADP. CAT 
treatment in combination with SOD also decreased the frequencies of CAs and SCEs and increased MI suggesting a possible 
role of reactive oxygen species for the genotoxic damage. 
© 2004 Elsevier Ireland Ltd. All rights reserved. 
Keywords: Ethinylestradiol; Human lymphocytes; Cytochrome P450; Estrogens; Reactive oxygen species 
1. Introduction 
Conjugated estrogens are listed in the Fourth-
Annual Report on Carcinogens (ROC), as known to 
be human carcinogens [1]. A number of individual 
steroidal estrogens, including estradiol-173, estrone, 
ethinylestradiol and mestranol, were listed in the ROC 
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as reasonably anticipated to be human carcinogens [ 1 ]. 
Steroidal estrogens are placed in Group 1 as carcino-
genic to humans, on the basis of sufficient evidence of 
carcinogenicity in humans [2,3]. Estrogens are used 
for treating many types of sexual disorders in oral 
contraceptives. Ethinylestradiol is used with various 
progestogens in combined oral contraceptive formu-
lations [4], Although there is sufficient evidence for 
the carcinogenicity of ethinylestradiol in experimental 
animals [23,5], gene mutation tests for it in bacterial 
and mammalian systems have been uniformly negative 
[6-8]. With few negative reports [9-12], ethinylestra-
diol induces sister chromatid exchanges (SCEs) and 
chromosomal aberrations (CAs) in both in vitro and 
in vivo test systems [6,7,13,14]. Several other workers 
have also reported unscheduled DNA synthesis (UDS) 
and adduct formation by ethinylestradiol in rat and hu-
man hepatocytes in vitro [15-17], whereas contradic-
tory results were reported by a group of other work-
ers [18,19]. Ethinylestradiol has also been reported to 
cause aneuploidy in Chinese Hamster DON cells in 
vitro [20], aneuploidy and polyploidy both, in V79 
cells in vitro [21]. Since the reports on the genotoxic 
potential of ethinylestradiol are contradictory, in the 
present study we studied the effect of ethinylestra-
diol at different doses on chromosomal aberrations 
(CAs), mitotic index (MI) and sister chromatid ex-
changes (SCEs) in the absence as well as in the pres-
ence of metabolic activation system (S9 mix) with 
and without NADP. Further, the effect of superoxide 
dismutase (SOD) and catalase (CAT) on ethinylestra-
diol genotoxic dose was also evaluated in the pres-
ence of a metabolic activation system (S9 mix) with 
NADP. 
2. Materials and methods 
2.1. Chemicals 
Ethinylestradiol (CAS: 57-63-6, Sigma); RPMI 
1640 (Gibco); fetal calf serum (Gibco); phyto-
haemagglutinin-M (Gibco); dimethylsulphoxide (E. 
Merck, India); colchicine (Microlab); Hoechst 33258 
stain (Sigma); 3% giemsa solution in phosphate buffer 
(pH 6.8, E. Merck, India); mitomycin C and cyclophos-
phamide (Sigma); superoxide dismutase and cata-
lase (Fluka); 5-bromo-2-deoxyuridine (SRL, India); 
antibiotic-antimycotic mixture (Gibco); sodium phe-
nobarbitone (Sigma). 
2.2. Human lymphocyte culture 
Duplicate peripheral blood cultures were treated ac-
cording to Carballo et al. [22]. Briefly 0.5 ml of hep-
arinized blood samples were obtained from a healthy 
female donor and were placed in a sterile flask con-
taining 7ml of RPMI 1640, supplemented with 1.5 ml 
of fetal calf serum and 0.1 ml of phytohaemagglutinin. 
These flasks were placed in an incubator at 37 °C for 
24 h. Untreated, negative and positive controls were 
also run simultaneously. 
2.3. Chromosomal aberrations (CAs) and mitotic 
index (MI) analysis 
After 24 h ethinylestradiol at 1, 5 and 10p,M dis-
solved in dimethylsulphoxide (DMSO) was added. The 
cells were cultured for another 48 h at 37 °C in an in-
cubator. For metabolic activation experiments, 0.5 ml 
of S9 mix (rat liver) was given along with each of 
the tested dose of ethinylestradiol. S9 mix was pre-
pared from the liver of healthy rats (Wistar strain) 
as per standard procedures of Maron and Ames [23]. 
The S9 fraction was enhanced by addition of 5 u.M 
of NADP and 10 |xM of glucose-6-phosphate just be-
fore use. The S9 mix without NADP was also given 
with each of the tested dose of ethinylestradiol. An 
amount of 0.2 ml of colchicine (0.2 p-g/ml) was added 
to the culture flask 1 h prior to harvesting. Cells were 
centrifuged at 1000rpm for lOmin. The supernatant 
was removed and 5 ml of prewarmed (37 °C) 0.075 M 
KC1 (hypotonic solution) was added. Cells were re-
suspended and incubated at 37 °C for 15 min. The su-
pernatant was removed by centrifugation, and 5 ml 
of chilled fixative (methanohglacial acetic acid, 3:1) 
was added. The fixative was removed by centrifuga-
tion and the procedure was repeated twice. To pre-
pare slides 3-5 drops of the fixed cell suspension 
were dropped on clean slides and air-dried. The slides 
were stained in 3% Giemsa solution in phosphate 
buffer (pH 6.8) for 15 min. Three hundred metaphases 
were examined for the occurrence of different types 
of abnormalities. Criteria to classify different types 
of aberrations were in accordance with the recom-
mendation of Environmental Health Committee 46 
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Table 1 
Chromosomal aberrations (CAs) in human lymphocytes treated with ethinylestradiol in the absence of S9 mixa 
Treatment 
Ethinylestradiol (p-M) 
1 
5 
10 
Untreated 
Negative control 
(DMSO 5 |xl/ml) 
Positive control 
(mitomycin C, 
0.3 p-g/ml) 
Cells 
scored 
300 
300 
300 
300 
300 
300 
Abnormal metaphases 
without gaps 
Number 
3 
4 
5 
2 
3 
30 
Mean%±S.E. 
1.0 ± 0.57 
1.33 ± 0.66 
1.67 ± 0.73 
0.66 ± 0.47 
1.0 ± 0.57 
10.0 ± 1.73b 
Total structural chromosomal 
aberrati 
Gaps 
2 
3 
3 
1 
2 
17 
ons 
CTB 
2 
3 
3 
2 
3 
20 
CSB 
1 
1 
2 
-
-
12 
CTE 
-
-
-
-
-
5 
DIC 
-
-
-
-
-
2 
Total breaks 
without gaps 
3(1.0) 
4(1.33) 
5(1.67) 
2 (0.66) 
3(1.0) 
46(15.33) 
(%) 
MI (%) 
2.7 
2.7 
2.6 
2.8 
2.7 
0.8 
CTB, chromatid break; CSB, chromosome break; CTE, chromatid exchange, DIC: dicentric; S.E., standard error. 
a
 Metaphase showing only gaps were not scored as abnormal. 
b
 Significant difference with respect to untreated (P<0.05). 
for Environmental Monitoring of Human Populations 
[24]. The mitotic index was scored as the number of 
metaphases among 1000 lymphocytes nuclei and ex-
pressed as a percentage. 
2.4. Sister chromatid exchanges (SCEs) analysis 
For SCE analysis, bromodeoxyuridine (BrdU, 
10|xg/ml) was added at the beginning of the cul-
ture. After 24 h ethinylestradiol at final concentra-
tions of 1, 5 and 10u,M, dissolved in DMSO was 
added and kept for another 48 h at 37 °C in an in-
cubator. For metabolic activation experiments 0.5 ml 
of S9 mix with and without NADP was given along 
with each of the tested dose. Mitotic arrest was done 
1 h prior to harvesting by adding 0.2 ml of colchicine 
(0,2 |xg/ml). Hypotonic treatment and fixation were 
done in the same way as described for chromosomal 
aberrations (CAs) analysis. The slides were processed 
according to Perry and Wolff [25]. The SCE induc-
tion was analysed from the 50 s division mitoses per 
dose. 
Table 2 
Chromosomal aberrations (CAs) in human lymphocytes treated with ethinylestradiol in the presence of S9 mix without NADPa 
Treatment 
Ethinylestradiol (p.M) 
1 
5 
10 
Untreated 
Negative control 
(DMSO 5 uj/ml) 
Positive control 
(cyclophosphamide, 
0.16u.g/ml) 
Cells 
scored 
300 
300 
300 
300 
300 
300 
Abnormal metaphases 
without gaps 
Number 
4 
6 
6 
2 
3 
29 
Mean%±S.E. 
1.35 ±0.66 
2.00 ±0.80 
2.00 ±0.80 
0.67 ±0.47 
1.00 ±0.57 
9.67±1.70h 
Total structural chromosomal 
aberrati 
Gaps 
3 
4 
4 
1 
2 
16 
ions 
CTB 
4 
5 
4 
2 
2 
17 
CSB 
-
1 
2 
-
-
11 
CTE 
-
-
-
-
-
4 
DIC 
-
-
-
-
-
2 
Total breaks 
without gaps 
4(1.33) 
6 (2.00) 
6 (2.00) 
2 (0.67) 
2 (0.57) 
40(13.33) 
(%) 
MI (%) 
2.7 
2.6 
2.6 
2.8 
2.8 
0.9 
CTB, chromatid break; CSB, chromosome break; CTE, chromatid exchange; DIC, dicentric; S.E., standard error. 
a
 Metaphase showing only gaps were not scored as abnormal. 
b
 Significant difference with respect to untreated (P<0.05). 
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Table 3 
Chromosomal aberrations (CAs) in human lymphocytes treated with ethinylestradiol in the presence of S9 mix with NADPa 
Treatment Cells Abnormal metaphases Total structural chromosomal Total breaks MI (%) 
scored without gaps aberrations without gaps (%) 
Ethinylestradiol (\xM) 
1 
5 
10 
Untreated 
Negative control 
(DMSO 5 |xl/ml) 
Positive control 
(cyclophosphamide, 
0.16|Ag/ml) 
300 
300 
300 
300 
300 
300 
Number 
5 
11 
20 
3 
3 
35 
Mean% ± S.E. 
1.67 ± 0.73 
3.67 ± 1.08b 
6.67 ± 1.44c 
1.00 ± 0.57 
1.00 ± 0.57 
11.67 d= 1.85c 
Gaps 
3 
8 
11 
2 
2 
19 
CTB 
3 
7 
13 
2 
2 
23 
CSB 
2 
4 
7 
1 
1 
14 
CTE 
-
-
-
-
-
6 
DIC 
-
-
-
-
-
3 
5(1.67) 
11 (3.67) 
20 (6.67) 
3(1.'00) 
3(1.00) 
55(18.3) 
2.6 
2.1 
1.8 
2.6 
2.7 
0.7 
CTB, chromatid break; CSB, chromosome break; CTE, chromatid exchange; DIC, dicentric; S.E., standard error. 
Metaphase showing only gaps were not scored as abnormal. 
Significant difference with respect to untreated (P<0.05). b 
c
 Significant difference with respect to untreated (P<0.01). 
Table 4 
Sister chromatid exchanges (SCEs) in cultured human lymphocytes exposed to ethinylestradiol 
Group SCEs/cell (mean ± S.E.) Range 
Without S9 mix 
Ethinylestradiol (|AM) 
1 2.33 ±0.21 0-5 
5 3.01 ± 0.32 1-5 
10 3.20 ± 0.36 1-5 
Untreated 1.56 ± 0.12 0-5 
Negative control (DMSO, 5 (d/ml) 1.43 ± 0.11 0-5 
Positive control (mitomycin C, 0.3 |xg/ml) 10.43 ± 0.81a 2-9 
With S9 mix without NADP 
Ethinylestradiol (JJLM) . 
1 2.56 ± 0.26 0-5 
5 3.04 ± 0.34 1-5 
10 3.31 ± 0.39 ' 1-5 
Untreated 1.58 ± 0.14 0-5 
Negative control (DMSO, 5 |xl/ml) 1.49 ± 0.13 0-5 
Positive control (cyclophosphamide, 0.16 u.g/ml) 10.89 ± 0.78a 2-9 
With S9 mix with NADP 
Ethinylestradiol (|j.M) 
1 2.93 ± 0.29 0-5 
5 6.31 ± 0.53a 2-5 
10 8.43 ± 0.67a 2-6 
Untreated 1.61 ± 0.16 0-5 
Negative control (DMSO, 5 ^ 1/ml) 1.52 ± 0.13 0-5 
Positive control (cyclophosphamide, 0.16u-g/ml) 11.23±0.82a 2-10 
DMSO, dimethylsulphoxide; S.E., standard error. 
a
 Significant difference with respect to untreated (P<0.05). 
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2.5. Induction ofCAs and SCEs in the presence of 
superoxide dismutase (SOD) and catalase (CAT) 
by ethinylestradiol 
An amount of 10 (xM of ethinylestradiol was treated 
with 10 and 20 fxg/ml of superoxide dismutase (SOD) 
and catalase (CAT) separately and in combination 
to see the effect on CAs, MI and SCEs induced by 
ethinylestradiol in the presence of S9 mix with NADP. 
Duplicate cultures for CAs, MI and SCEs analysis were 
set, similarly as described earlier in the text. 
2.6. Statistical analysis 
Student's Mest was used for the analysis of CAs 
and SCEs. The level of significance was tested 
from standard statistical tables of Fisher and Yates 
[26]. 
3. Results 
Ethinylestradiol neither induced CAs or SCEs nor 
affected MI at significant level in the absence of 
metabolic activation and also in S9 mix without NADP 
(Tables 1, 2 and 4). However, in the presence of S9 
mix with NADP, in CAs analysis, a significant in-
crease was observed at 5 and 10 \iM of ethinylestradiol 
(Table 3). When 10 uJVI of ethinylestradiol was treated 
with 10 and 20 u-g/ml of SOD the number of abnormal 
cells increases as compared with ethinylestradiol treat-
ment alone (Table 5). A significant decrease in abnor-
mal cells was observed when 10|xM of ethinylestra-
diol was treated with 10 and 20 fig/ml of CAT sepa-
rately and with combination of SOD as compared with 
ethinylestradiol treatment alone (Table 5). 
The MI showed a reduction in the percentage of mi-
tosis in all the dose assayed in the presence of S9 mix 
Table 5 
Effect of superoxide dismutase (SOD) and catalase (CAT) on chromosomal aberrations (CAs) induced by ethinylestradiol in the presence of S9 
mix with NADPa 
Treatment 
Ethinylestradio 
10 
Cells 
scored 
l(u.M) 
300 
Abnormal metaphases 
without 
Number 
22 
Ethinylestradiol (u,M) + SOD (u.g/ml) 
10+10 
10 + 20 
300 
300 
Ethinylestradiol (|xM) + CAT 
10 + 10 
10 + 20 
300 
300 
Ethinylestradiol (u,M) + SOD 
10+10+10 
10 + 20 + 20 
Untreated 
SOD ((ig/ml) 
10 
20 
CAT (jxg/ml) 
10 
20 
300 
300 
300 
300 
300 
300 
300 
25 
27 
(rxg/ml) 
13 
10 
(|xg/ml) + 
9 
8 
2 
3 
2 
3 
3 
gaps 
Mean%±S.E. 
7.33±1.5b 
8.33±1.59b 
9.00± 1.65b 
4.33 ± 1.17C 
3.33±1.03c 
CAT dxg/ml) 
3.00±0.98c 
2.67±0.93c 
0.66 ± 0.46 
1.00 ±0.57 
0.66 ±0.46 
1.00 ±0.57 
1.00 ±0.57 
Total structural chromosomal 
aberrations 
Gaps CTB 
13 
16 
19 
10 
8 
5 
4 
1 
1 
1 
2 
1 
15 
17 
18 
9 
7 
6 
5 
2 
3 
2 
2 
2 
CSB 
7 
8 
9 
4 
3 
3 
3 
-
-
-
I 
1 
CTE 
-
-
1 
-
-
-
-
-
-
-
-
-
Total breaks 
without gaps (%) 
DIC 
22 (7.33) 
25 (8.33) 
1 31 (10.33) 
13(4.33) 
10(3.33) 
9(3.00) 
8(2.67) 
2 (0.66) 
3(1.00) 
2 (0.66) 
3(1.00) 
3(1.00) 
MI (%) 
1.7 
1.6 
1.5 
2.5 
2.6 
2.6 
2.6 
2.8 
2.8 
2.7 
2.8 
2.8 
SOD, superoxide dismutase; CTB, chromatid break; CTE, chromatid exchange; DIC, dicentric; CSB, chromosome break; CAT, catalase. 
a
 Metaphase showing only gaps were not scored as abnormal. 
b
 Significant difference with respect to untreated (P<0.01). 
c
 Significant difference with respect to ethinylestradiol (P<0.01). 
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Table 6 
Effect of superoxide dismutase (SOD) ami catalase (CAT) on sis-
ter chromatid exchanges (SCEs) induced by ethinylestradiol in the 
presence of S9 mix with NADP 
Treatment SCEs/cell (mean ±S.E.) Range 
Ethinylestradiol (\x.M) 
10 8.75 ± 0.7 la 2-6 
Ethinylestradiol (u.M) + SOD (|Ag/mI) 
10+10 9.36 ±0.76" 2-8 
10 + 20 11.72 ±0.85" 2-10 
Ethinylestradiol (u.M) + CAT (p.g/ml) 
10+10 3.83±0.39b 1-5 
10 + 20 3.11±0.34b 1-5 
Ethinylestradiol (|xM) + SOD (u-g/ml) + CAT (u,g/ml) 
10+10+10 2.92 ± 0.28b 0-5 
10 + 20 + 20 2.53±0.24b 0-5 
Untreated 1.54 ±0.11 0-5 
SOD (M-g/ml) 
10 1.63 ± 0.17 0-5 
20 1.65 ± 0.18 0-5 
CAT (u-g/ml) 
10 1.36 ±0.12 0-5 
20 1.42 ±0.14 0-5 
SOD, superoxide dismutase; CAT, catalase; S.E., standard error. 
a
 Significant difference with respect to untreated (/><0.05). 
b
 Significant difference with respect to ethinylestradiol (P < 0.05). 
with NADP (Table 3). When 10 uM of ethinylestra-
diol was treated with 10 and 20jxg/ml of SOD sepa-
rately, in the presence of S9 mix with NADP, a reduc-
tion in the percentage of mitosis was observed. There 
was increase in the percentage of mitosis when 10 u,M 
of ethinyl-estradiol was treated with 10 and 20 |xg/ml 
of CAT separately and in combination of SOD, in the 
presence of S9 mix with NADP, as compared with 
ethinylestradiol treatment alone (Table 5). 
In SCEs analysis a clear dose dependent increase in 
SCEs/cell was observed when treated with ethinylestra-
diol alone in the presence of S9 mix with NADP 
(Table 4). SCEs/cell were significantly increased at 
5 and 10 (xM of ethinylestradiol. When 10 pM of 
ethinylestradiol was treated with 10 and 20|j,g/ml of 
SOD, SCEs/cell were further increased, but SCEs/cell 
were decreased significantly when treated with 10 
and 20|JLg/ml of CAT separately and in combina-
tion of SOD as compared with ethinylestradiol treat-
ment alone in the presence of S9 mix with NADP 
(Tables 5 and 6). 
4. Discussion 
The results of the present investigation reveal that 
ethinylestradiol is not potent enough to cause geno-
toxic damage in human lymphocytes in the absence of 
S9 mix as well as in the presence of S9 mix without 
NADP at the doses; which were found to be genotoxic 
in the presence of S9 mix with NADP. The experimen-
tal evidence suggests that the metabolic activation of 
ethinylestradiol and possible conversion of it to reac-
tive species is responsible for its genotoxicity. Simi-
lar observations on the DNA damaging properties of 
synthetic steroids as evident from chromosomal dam-
age, induction of SCEs [27-32] and formation of en-
dogenous DNA adducts and certain neoplastic changes 
have also been reported earlier [16,33]. Estrone 3,4-
quinone produces free radicals in human breast can-
cer cells (MCF) and these are responsible for chro-
mosomal damage [34]. Other catechol estrogens are 
reported to induce DNA damage by generating reac-
tive oxygen species or free radicals [35-39]. Certain 
synthetic steroids have been reported to be mutagenic 
in the Ames (ester strains by generating active oxygen 
species in the system [40]. With a view to understand 
the possible mechanism and cause of the genotoxic-
ity by ethinylestradiol, one of the genotoxic doses, i.e. 
10 pJVI of ethinylestradiol was given along with 10 and 
20 |xg/ml of SOD in the presence of S9 mix with NADP. 
Since the treatment with SOD increases the CAs and 
SCEs frequency, it is possible that ethinylestradiol gen-
erates reactive oxygen species, which on treatment with 
SOD converts into hydrogen peroxide (H2O2). H2O2 
has been known to cause DNA damage in the form of 
single strand breaks and double strand breaks [35], CAs 
[41,42] and SCEs [43]. Superoxide dismutases (SODs) 
are a family of metal enzymes that convert O2*- to 
H2O2 according to the following reaction [44]. 
02*~ + 02*~ - ^ 2Hb02 
SOD 
Further treatment of 10 jxM of ethinylestradiol with 10 
and 20 |xg/ml of catalase separately and in combina-
tion of superoxide dismutase, in the presence of S9 
mix with NADP, results in the significant decrease in 
CAs and SCEs. This also suggests the production of 
H2O2, in the presence of S9 mix with NADP, since 
catalase catalyses the decomposition of H2O2 to wa-
ter and oxygen. Catalase is a heme containing protein 
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Fig. 1. Possible metabolism of elhinylestradiol to catechols and quinones and generation of reactive oxygen species by redox cycling of 4-hydroxy 
equilenin. 
[45]. The mechanism of the action is: 
PAT 
2H202 ^ 2H20 + 0 2 
Catalase is found to reduce SCE levels resulting from 
the treatment with H 2 0 2 [43]. In light of the above 
results we have suggested a possible mechanism of 
generating reactive oxygen species by ethinylestra-
diol, which is responsible for the genotoxicity (Fig. 1). 
Since the ethinylestradiol is genotoxic only in the pres-
ence of S9 mix with NADP the first step may involve, 
the aromatic hydroxylation catalysed by cytochrome 
P450 as in the case of estrone and 17P-estradiol form-
ing catechol metabolites [46,47]. Cytochrome P450 in 
liver S9 fractions plays an important role in activat-
ing promutagens to proximate and/or ultimate muta-
gens. Rat and human liver P450 is involved in the 
activation of some chemical carcinogens having dif-
ferent isoforms [23,48], In the liver, 2-hydroxylation 
predominates over 4-hydroxylation by approximately 
9:1, however, in extra hepatic tissues the ratio drops 
to 1:1 [49]. Only 4-hydroxyestrone, 3,4-dihydroxy-
l,3,5(10)-oestratrien-17-one (4-OHE) was found to be 
carcinogenic in the male Syrian golden hamster kid-
ney tumor model whereas 2-OHE was without activity 
[50,51]. Once formed, the endogenous catechol estro-
gens can be oxidized by virtually any oxidative en-
zymes in the presence or absence of metal ion and can 
give rise to o-quinones [52,53]. The results of our study 
confirms the presence of ROS and the source of ROS 
has been suggested to be the result of redox cycling 
between the o-quinones and their semi-quinone rad-
icals generating superoxide, hydrogen peroxide, and 
ultimately reactive hydroxyl radicals which cause ox-
idative cleavage of the phosphate-sugar backbone as 
well as oxidation of the purine/pyrimidine residues of 
DNA [54]. 
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Abstract 
The genotoxicity of cyproterone acetate was studied in human lymphocytes using chromosomal aberrations (CAs), mitotic index 
(MI) and sister chromatid exchanges (SCEs) as a parameter. Cyproterone acetate was found to be genotoxic at 20 and 30 uM. To 
study the possible mechanism of the genotoxicity of cyproterone acetate, superoxide dismutase (SOD) and catalase (CAT) were used 
separately and in combination along with the 30 uM of cyproterone acetate at different doses. SOD treatment increases CAs, SCEs 
and decreases MI as compared to treatment with 30 uM CPA alone, at both of the tested doses. CAT treatment decreases the fre-
quencies of CAs and SCEs and increases MI in both, as compared to treatment with 30 uM CPA alone, separately and in combi* 
nation with SOD, suggesting a possible role of reactive oxygen species for the genotoxic damage. 
© 2004 Elsevier Ltd. All rights reserved. 
Keywords: Cyproterone acetate; Genotoxicity; Reactive oxygen species; Chromosomal aberrations; Sister chromatid exchanges 
1. Introduction 
Cyproterone acetate is a potent steroidal antiandro-
gen with progestational activity. It is used alone or in 
combination with ethinyl estradiol or estradiol valerate 
in the treatment of women suffering from disorders 
associated with androgenization, e.g. age or hisuitism. 
Cyproterone acetate competes with dihydrotestosterone 
for the androgen receptors and inhibits translocation of 
the hormone receptor complex into the cell nucleus (Sci-
arra et a l , 1990). 
Cyproterone acetate has been shown to induce DNA 
repair synthesis in rat and human hepatocytes (Topinka 
et al., 1995; Martelli et al., 1995; Kasper and Miiller, 
1996) and to form adducts in rat liver cells (Topinka 
et al., 1996). In female rats, D N A adducts have been 
Corresponding author. Tel.: +91 571 2703694; fax: +91 571 
2708088. 
E-mail address: yasir_hasansiddique@rediffmail.com (Y.H. 
Siddique). 
observed at low doses of cyproterone acetate, which 
are in the range of the therapeutic doses used in women 
(Werner et a l , 1995). Further findings shows that cypro-
terone acetate is a tumour initiating agent in the liver of 
female rats (Demi et al., 1993; Martelli et al., 1996). In 
the present study we studied the effect of cyproterone 
acetate at different doses on chromosomal aberrations 
(CAs), mitotic index (MI) and sister chromatid ex-
changes (SCEs) in human lymphocytes. Further the ef-
fect of superoxide dismutase (SOD) and catalase 
(CAT) on cyproterone acetate genotoxic dose was also 
worked out. 
2. Materials and methods 
2.1. Chemicals 
Cyproterone acetate (CAS: 427-51-0, Sigma); RPMI 
1640 (Gibco); Fetal calf serum (Gibco); Phytohae-
magglutinin-M (Gibco); Dimethylsulphoxide (E. Merck, 
0887-2333/$ - see front matter © 2004 Elsevier Ltd. All rights reserved. 
doi:10.1016/j.tiv.2004.06.008 
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India); Colchicine (Microlab); Hoechst 33258 stain 
(Sigma); 3% Giemsa solution in phosphate buffer (pH 
6.8, E. Merck, India); Mitomycin C (Sigma); Superox-
ide dismutase and Catalase (Fluka); 5-Bromo-2-deoxy-
uridine (Sigma); Antibiotic-antimycotic mixture 
(Gibco). 
2.2. Human lymphocyte culture 
Duplicate peripheral blood cultures were treated 
according to Carballo et al. (1993). Briefly 0.5 ml of hep-
arinized blood samples were obtained from two healthy 
female donors, and were placed in a sterile flask contain-
ing 7 ml of RPMI 1640 supplemented with 1.5 ml of 
fetal calf serum and 0.1 ml of phytohaemagglutinin. 
These flasks were placed in an incubator at 37 °C for 
24 h. Dimethyl sulphoxide (DMSO, 5 ul/ml) and Mito-
mycin C (0.3 ug/ml) were used as negative and positive 
control respectively. 
2.3. Chromosomal aberrations (CAs) and mitotic index 
(MI) analysis 
After 24 h cyproterone acetate at 5, 10, 20 and 30 uM 
dissolved in DMSO was added. The cells were cultured 
for another 48 h at 37 °C in the incubator. One hour 
prior to harvesting 0.2 ml of colchicine (0.2 ug/ml) was 
added to the culture flask. Cells were centrifuged at 
1000 rpm for 10 min. The supernatant was removed 
and 5 ml of prewarmed (37 °C) 0.075 M KC1 (hypotonic 
solution) was added. Cells were resuspended and incu-
bated at 37 °C for 15 min. The supernatant was removed 
by centrifugation, and 5 ml of chilled fixative (metha-
nokglacial acetic acid; 3:1) was added. The fixative was 
removed by centrifugation and the procedure was 
repeated twice. To prepare slides 3-5 drops of the fixed 
cell suspension were dropped on a clean slides and air-
dried. The slides were stained in 3% Giemsa solution 
in phosphate buffer (pH 6.8) for 15 min. Three hundred 
metaphases were examined for the occurrence of differ-
ent types of abnormality i.e. gaps, fragments and breaks. 
Criteria to classify the different types of aberrations were 
in accordance with the recommendation of EHC 46 for 
Environmental Monitoring of Human Populations 
(IPCS, 1985). The mitotic index (MI) was scored as 
the number of metaphases among 1000 lymphocytes 
nuclei and expressed as a percentage. 
2.4. Sister chromatid exchanges (SCEs) and mitotic 
index (MI) analysis 
For SCE analysis, Bromodeoxyuridine (BrdU, 10 ug/ 
ml) was added at the beginning of the culture. After 24 h 
cyproterone acetate at final concentration of 5, 10, 20 
and 30 uM dissolved in DMSO was added and kept 
for another 48 h at 37 °C in the incubatcr. Mitotic arrest 
was done 1 h prior to harvesting by adding 0.2 ml of col-
chicine (0.2 ug/ml). Hypotonic treatment and fixation 
were done in the same way as described for chromo-
somal aberrations (CAs) analysis. The slides were proc-
essed according to Perry and Wolff (1974). The SCE 
induction was analyzed in metaphase from the second 
cycle after treatment. The mitotic index (MI) was scored 
as the number of metaphases among 1000 lymphocytes 
nuclei and expressed as a percentage. 
2.5. Induction of CAs and SCEs in the presence of 
superoxide dismutase (SOD) and catalase (CAT) by 
cyproterone acetate 
Thirty uM of cyproterone acetate was treated with 10 
and 20 ug/ml of superoxide dismutase (SOD) and cat-
alase (CAT) separately and in combination to see the ef-
fect on CAs, SCEs and MI induced by cyproterone 
acetate. Duplicate cultures for CAs, MI and SCEs anal-
ysis were set, similarly as described earlier in the text. 
2.6. Statistical analysis 
Students "t" test was used for the analysis of CAs 
and SCEs. The level of significance was tested from 
standard statistical tables of Fisher and Yates (1963). 
3. Results 
In CAs analysis, treatment with cyproterone acetate 
alone resulted in a dose dependent increase of chromo-
somal aberrations. However a significant increase was 
observed at 20 and 30 uM of cyproterone acetate (Table 
1). When 30 uM of cyproterone acetate was treated with 
10 and 20 ug/ml of SOD the number of abnormal cells 
increases as compared to cyproterone acetate treatment 
alone (Table 2). A significant decrease in abnormal cells 
were observed when 30 uM of cyproterone acetate was 
treated with 10 and 20 ug/ml of CAT separately and 
with combination of SOD as compared to cyproterone 
acetate treatment alone (Table 2). 
In SCEs analysis a clear dose dependent increase in 
SCEs/cell was observed when treated with cyproterone 
acetate alone (Table 3). SCEs/cell were significantly in-
creased at 20 and 30 uM of cyproterone acetate. When 
30 uM of cyproterone acetate was treated with 10 and 
20 ug/ml of SOD, SCEs/cell were further increased, 
but SCEs/cell were decreased significantly when treated 
with 10 and 20 ug/ml of CAT separately and in combi-
nation of SOD as compared to cyproterone treatment 
alone (Table 4). 
The MI showed a reduction in the percentage of 
mitosis in all the dose assayed (Tables 1 and 3). When 
30 uM of cyproterone acetate was treated with 10 and 
20 ug/ml of SOD separately, a reduction in the percent-
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Table 1 
Chromosomal aberrations (CAs) in human lymphocytes treated with cyproterone acetate 
Treatment 
CPA (uM) 
5 
10 
20 
30 
Untreated 
Negative control (DMSO, 5 ul/ 
Positive control (Mitomycin C, 
ml) 
0.3 ug/ml) 
Abnormal metaphases 
without gaps 
Number Mean 
% ± SE 
4 
5 
9 
17 
3 
2 
28 
1.34 + 0.66 
1.67 + 0.73 
3.00 + 0.98a 
5.67±1.33b 
1.00 ±0.57 
0.67 ± 0.47 
9.34+ 1.68 
Chromosome aberrations 
Gaps 
Number 
2 
4 
5 
9 
1 
2 
13 
% 
0.67 
1.34 
1.67 
3.00 
0.34 
0.67 
4.34 
Fragments 
Number 
-
-
2 
5 
-
-
10 
% 
-
-
0.67 
1.67 
-
-
3.33 
CTB 
Number 
3 
5 
7 
12 
2 
3 
18 
% 
1.00 
1.67 
2.33 
4.00 
0.67 
1.00 
6.00 
CSB 
Number 
2 
3 
4 
6 
1 
1 
10 
% 
0.67 
1.00 
1.33 
2.00 
0.33 
0.33 
3.33 
MI% 
2.5 
2.3 
2.1 
'1.9 
2.7 
2.6 
0.9 
CPA: cyproterone acetate; DMSO: dimethylsulphoxide; CTB: chromatid break; CSB: chromosome break. 
a
 Significant difference with respect to untreated (P < 0.05). 
Table 2 
Effect of superoxide dismutase (SOD) and catalase (CAT) on chromosomal aberrations in human lymphocytes treated with cyproterone acetate 
Treatment 
CPA (uM) 
30 
CPA (iiM) + 
30+ 10 
30 + 20 
Abnormal metaphases 
without gaps 
Number Mean 
% ± SE 
19 
SOD (uglml) 
22 
24 
CPA (fiM) + CAT (uglml) 
30+10 10 
30 + 20 
CPA (fiM) + 
30+10+10 
30 + 20 + 20 
Untreated 
SOD (uglml) 
10 
20 
CAT (uglml) 
10 
20 
8 
6.34 ± 1.40a 
7.34 ± 1.50a 
8.00 ± 1.56a 
3.34±1.03b 
2.67+0.93* 
SOD (uglml) + CAT (uglml) 
7 2.34 ± 0.87b 
6 
2 
2 
3 
2 
2 
2.00 + 0.80b 
0.67 ± 0.47 
0.67 ± 0.47 
1.00 ±0.57 
0.67 ± 0.47 
0.67 ± 0.47 
Chromosome aberrations 
Gaps 
Number 
9 
11 
14 
7 
4 
4 
3 
1 
2 
1 
1 
1 
% 
3.00 
3.67 
4.67 
2.34 
1.34 
1.34 
1.00 
0.34 
0.67 
0.34 
0.34 
0.34 
Fragments 
Number 
6 
6 
7 
-
-
-
-
-
% 
2.00 
2.00 
2.33 
-
-
-
-
-
CTB 
Number 
14 
16 
16 
7 
6 
6 
5 
2 
3 
3 
2 
2 
% 
4.67 
5.33 
5.33 
2.33 
2.00 
2.00 
1.67 
0.67 
1.00 
1.00 
0.67 
0.67 
CSB 
Number 
5 
6 
7 
2 
1 
1 
-
1 
-
-
% 
1.67 
2.00 
2.33 
0.67 
0.33 
0.33 
-
0.33 
-
-
MI% 
1.8 
1.7 
1.5 
2.4 
2.4 
2.5 
2.6 
2.8 
2.7 
2.7 
2.6 
2.7 
CPA: cyproterone acetate; SOD: superoxide dismutase. CTB: chromatid break, CSB: chromosome break. 
a
 Significant difference with respect to untreated (P < 0.01). 
b
 Significant difference from the CPA (P<0.01), CAT: catalase. 
age of mitosis was observed as compared to cyproterone 
acetate treatment alone. There was increase in the per-
centage of mitosis when 30 uM of cyproterone acetate 
was treated with 10 and 20 ug/ml of CAT separately 
and in combination of SOD as compared to cyproterone 
acetate treatment alone (Tables 2 and 4). 
4. Discussion 
The results of the present investigation reveals that 
cyproterone acetate increases CAs and SCEs frequencies 
significantly at two doses of the four tested doses. Sim-
ilar observations on the DNA damaging properties of 
steroids as evident from chromosomal damage, induc-
tion of SCEs (Singh et al , 1994; Dhillon et al., 1994; 
Ahmed et al., 2001; Siddique and Afzal, 2003; Siddique 
and Afzal, in press; Siddique and Afzal, 2004) and for-
mation of endogenous DNA adducts and certain neo-
plastic changes have also been reported earlier 
(Martelli et al., 2003; Brambilla and Martelli, 2002). Es-
trone 3,4-quinone produces free radicals in human 
breast cancer cells (MCF) and these are responsible 
for chromosomal damage (Nutter et al., 1994). Other 
catecholestrogens are reported to induce DNA damage 
by generating reactive oxygen species or free radicals 
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Table 3 
Sister chromatid exchanges (SCEs) in cultured human lymphocytes exposed to cyproterone acetate 
Treatment 
CPA (nM) 
5 
10 
20 
30 
Untreated 
Negative control (DMSO, 5 ul/ml) 
Positive control (mitomycin C, 0.3 ug/ml) 
Cells scored 
50 
50 
50 
50 
50 
50 
50 
SCEs/cell (i 
2.31 ±0.14 
3.79 + 0.22 
5.89 ± 0.36= 
7.60 ± 0.42s 
1.30 ±0.08 
1.70 + 0.10 
9.33 ± 0.56' 
Range MI% 
1-5 
1-5 
2-6 
2-7 
0-5 
0-5 
2-11 
2.5 
2.4 
2.2 
1.8 
2.8 
2.6 
0.8 
CPA: cyproterone acetate; DMSO: dimethylsulphoxide. 
a
 Significant difference with respect to untreated (P < 0.05). 
Table 4 
Effect of superoxide dismutase (SOD) and catalas;e (CAT) on sister chromatid exchanges (SCEs) induced by cyproterone acetate 
Treatment Cells scored SCEs/cell (mean + SE) Range MI% 
CPA (fiM) 
30 
CPA (p.M) + SOD 
30 + 10 
30 + 20 
(iiglml) 
CPA (ftM) +CAT (uglml) 
30 + 10 
30 + 20 
50 
50 
50 
50 
50 
CPA (nM) + SOD (uglml) +CAT (uglml) 
30+10+ 10 
30 + 20 + 20 
Untreated 
SOD (iiglml) 
10 
20 
CAT (uglml) 
10 
20 
50 
50 
50 
50 
50 
50 
50 
7.96 + 0.51" 
8.32 + 0.56" 
9.01 ±0.61a 
3.93 ± 0.27b 
3.02 +0.16b 
2.61 + 0.14b 
2.23 ± 0.1 lb 
1.30 ±0.08 
1.53 ±0.10 
1.68 ±0.13 
1.43 + 0.11 
1.57 ±0.12 
2-8 
2-8 
2-9 
1-6 
1-6 
1-5 
1-5 
0-5 
0-5 
0-5 
0-5 
0-5 
1.7 
1.6 
1.6 
2.5 
2.5 
2.6 
2.7 
2.8 
2.7 
2.7 
2.7 
2.8 
CPA: Cyproterone acetate; SOD: superoxide dismutase; CAT: catalase. 
a
 Significant difference with respect to untreated (P < 0.05). 
b
 Significant difference with respect to CPA (P < 0.05). 
(Thi-bodeau and Paquette, 1999; Chen et al , 1998; Han 
and Liehr, 1995; Li et al., 1994; Roy et al., 1991). Induc-
tion of DNA repair was reported in primary rat hepato-
cytes exposed to synthetic progestins (Martelli ct al., 
2003; Martelli, 1997). Synthetic progestins like meges-
trol acetate and chlormadinone acetate also shows the 
formation of DNA adducts in primary cultures of hu-
man hepatocytes (Werner et al., 1997). A significant in-
crease in the number of lymphocytes with DNA 
migration in alkaline comet assay and frequency of 
SCEs per metaphase were observed in the oral contra-
ceptive user as compared with their age matched un-
treated controls (Biri et al., 2002). 
Certain synthetic steroids have been reported to be 
mutagenic in the Ames tester strains by generating ac-
tive oxygen species in the system (Islam et al., 1991). 
With a view to understand the mechanism and cause 
of the genotoxicity by cyproterone acetate, one of the 
genotoxic dose i.e. 30 uM of cyproterone acetate was 
given along with 10 and 20 ug/ml of SOD. Since the 
treatment with SOD increases the CAs and SCEs fre-
quency so we can say that possibly somehow cyproter-
one acetate is generating reactive oxygen species, 
which on treatment with SOD changes into Hydrogen 
peroxide (H202). H 2 0 2 has been known to cause DNA 
damage in the form of single strand breaks and double 
strand breaks (Thi-bodeau and Paquette, 1999), CAs 
(Sofni and Ishidate, 1984; MacRac and Stich, 1979) 
and SCEs (Tsuda, 1981). Superoxide dismutases (SODs) 
are a family of metal enzymes that convert 02"~ to H 2 0 2 
according to the following reaction (Culotta, 2000) 
o r + o2" ™ 2H2o2 + o2 
1 l
 SOD 
Further the treatment of 30 uM of cyproterone ace-
tate with 10 and 20 ug/ml of CAT separately and in 
combination of SOD results in the significant decrease 
in CAs and SCEs. This also proves the production of 
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H2C( 
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Cyproterone acetate (CPA) 
Homolytio 
» fission 
x ~ * 
nr" CI 
X - 0 4 - O - H + 
XO + OH CI 
OH + 
2H202 
OH 
CAT. 
SOD H202 
2H20+02 
XOH - Reactive nucleophite within the cell 
CI = chlorine attached to the carbon atom (C-6) of cyproterone acetate 
— r = Enhancing the electrophtlic nature of 0 moiety. 
OH" = Hydroxyl radical unstable. 
SOD = Superoxide dismutase 
CAT = Catalase 
Fig. 1. Possible mechanism of generating reactive oxygen species by cyproterone acetate (CPA). 
H 20 2 because CAT catalyses the decomposition of 
H 2 0 2 to water and oxygen. CAT is a heame containing 
protein (Reid et al., 1981). The mechanism of the action 
is: 
2H202CAT2H20 + 0 2 
CAT is found to reduce SCE levels resulting from the 
treatment with H 2 0 2 (MacRac and Stich, 1979). In the 
light of above results we have suggested a possible mech-
anism of generating reactive oxygen species by cyproter-
one acetate, which is responsible for the genotoxicity 
(Fig. 1). As is obvious from Fig. 1, XOOH can also give 
rise to XOO" and "OOH radicals. The presence of alk-
oxyl (XOO) radical appears to be a very remote possibil-
ity in view of the highly polar nature of the living system 
because for that the X has to be essentially an alkyl 
group (Islam et al., 1991). 
Hence it is therefore advisable to be careful of the 
potential hazards of these drugs as they may become 
capable of attacking the genetic material. 
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Antigenotoxic effects of ascorbic acid against 
megestrol acetate-induced genotoxicity in 
mice 
Yasir Hasan Siddique*, Tanveer Beg and Mohammad Afzal 
Section of Genetics, Department of Zoology, Faculty of Life Sciences, Aligarh Muslim University, 
Aligarh, India 
The genotoxicity of megestrol acetate was studied in 
mouse bone marrow cells using sister chromatid ex-
changes (SCEs) and chromosomal aberrations (CAs) as 
parameters. Megestrol acetate (8.12, 16.25 and 32.50 mg/ 
kg of body weight) was injected intraperitoneally sepa-
rately in different groups of animals. Both CAs and SCEs 
were statistically increased at 16.25 and 32.50 mg/kg of 
body weight. Our earlier in vitro studies show the 
generation of free oxygen radicals, by synthetic proges-
tins responsible for the genotoxic damage. As the geno-
toxic effects of steroids can be reduced by natural 
products having antioxidant properties, and ascorbic 
acid possesses antioxidant activity, ascorbic acid (20, 40 
or 60 mg/kg of body weight) administered together with 
Int roduct ion 
Synthetic progestins are widely used as oral 
contraceptives in addition to their use in the 
treatment of various menstrual disorders, some 
types of cancers and in hormonal replacement 
therapy. For contraception, they are either used 
alone or in combination with oestrogens. Proges-
tins, like oestrogen, diffuse easily across the cell 
membranes and bind to highly specific, soluble 
receptor proteins in the cytoplasm. The steroid 
receptor complex modifies the expression of 
specific genes by binding to control elements in 
DNA.1 
The carcinogenicity of megestrol acetate was 
tested by oral administration in mice, rats, dogs 
and monkeys. It produced nodular hyperplasia, 
and benign and malignant mammary tumours in 
dogs.2 Megestrol acetate plus ethinyl estradiol was 
tested for carcinogenicity by oral administration 
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megestrol acetate (32.50 mg/kg of body weight) signifi-
cantly decreased CAs and SCEs, suggesting an antigeno-
toxic role of ascorbic acid against megestrol acetate-
induced genotoxic damage in mice bone marrow cells. 
The antigenotoxic effect was clearly dose dependent. The 
highest protective effect was observed at 60 mg/kg body 
weight of ascorbic acid treated with 32.50 mg/kg body 
weight of megestrol acetate. Human &• Experimental 
Toxicology (2005) 24, 121-127 
Key words: antioxidants; ascorbic acid; chromosomal aberra-
tions; free radicals; genotoxicity; megestrol acetate; mice bone 
marrow cells; sister chromatid exchanges 
in mice and rats. In mice, an increased incidence 
of malignant mammary tumours was observed in 
both sexes but no increase in tumour incidence 
was seen in rats.3 A significant increase in the 
number of lymphocytes with DNA migration in 
alkaline comet assay and frequency of sister 
chromatid exchanges (SCEs,) was observed in 
oral contraceptives users as'compared with their 
age-matched untreated controls.4 In our earlier 
study, chromadinone acetate (CMA) and cyproter-
one acetate (CPA) were shown to be genotoxic in 
human lymphocytes in vitro by generating free 
radicals via a nucleophilic reaction.5,6 The geno-
toxic effects of steroids can be reduced by the use 
of various antioxidants7 and natural products 
having antioxidant potential.8 Ascorbic acid is a 
powerful antioxidant, which plays an important 
role in intracellular oxidation/reduction systems, 
and in binding of free radicals produced endo-
genously.9 In the present study, we examined the 
effect of megestrol acetate on the frequencies 
of SCEs and CAs in mouse bone marrow 
cells. Furthermore, the possible protective effect 
of a co-treatment with ascorbic acid was also 
studied. 
© 2005 Edward Arno ld (Publishers) Ltd 10.1191/0960327104ht508oa 
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Materials and methods 
Chemicals 
Megestrol acetate (CAS No: 595-33-5), colchicine 
(6.0mg/kg body weight), Hoechst 33258 stain 
(0.05% w/v), N-methyl-N'-nitro-N-nitrosoguanidine 
(1.2 x 104 ng/kg body weight) and 5-bromo-2-deox-
yuridine (1.6 g/kg body weight) were purchased 
from Sigma (Woodland, Texas, USA). Three per 
cent and 7% Giemsa solution in phosphate buffer 
(pH 6.8) and dimethyl sulphoxide (0.1 mL/animal) 
were purchased from E. Merck, India, and L-ascor-
bic acid (CAS No: 50-81-7) was purchased from 
Central Drug House, India. 
Animals 
Swiss albino female mice [Mus musculus L.) 
25-30 g, 10-12 weeks old were procured from 
Lucknow (U.P.), India and grouped in different 
polypropylene cages (five animals/group) at a 
mean temperature of 25°C. Permission was granted 
for experimentation by the departmental ethical 
committee. 
Sister chromatid exchanges analysis 
The fluorescent plus Giemsa Technique was followed 
with slight modification for SCEs analysis.10 5-
Bromo-2-deoxyuridine in tablet form (BrdU; 1.6 g/ 
kg body weight) was implanted subcutaneously in the 
neck region of each mouse under mild anaesthesia, 
and 30 min later megestrol acetate at 8.12, 16.25 and 
32.5 mg/kg body weight was injected intraperitone-
ally (i.p.). As the LD50 of megestrol acetate was 
determined by the method of Lorke to be 130 mg/kg 
body weight,11 the highest tested corresponded to 1/4 
of the LD50 value. Dimethyl sulphoxide (DMSO) 
(0.1 mL) was used as a negative control and N-
methyl-N'-nitro-N-nitrosoguanidine (MNNG) (1.2 x 
104 ng/kg body weight) was used as a. positive control. 
Both were injected i.p. After 21 hours the animals 
received an i.p. injection of colchicine (6.0 mg/kg 
body weight), and 3 hours later the bone marrow of 
both femurs was collected in KC1 0.075 M at 37°C 
in which the cells were kept for 30 min. The super-
natant was removed by centrifugation and 5 mL of 
fixative (methanohglacial acetic acid; 3:1) was added. 
The fixative was removed and the procedure was 
repeated twice. The microscopic slides were pre-
pared by air drying and were stained for 20 min in a 
0.05% (w/v) Hoechst 33258 solution, rinsed with tap 
water and placed under a UV lamp for 90 min, 
covered with Srensen's buffer, pH 6.8, and stained 
with 3% Giemsa solution in phosphate buffer (pH 6.8) 
for 15 min. The SCE average was obtained from 
the analysis of metaphases in the second cycle of 
divisions. At least 60 second division metaphases 
per mouse were scored to determine the frequency of 
SCEs. The slides were scored blindly by one scorer. 
Chromosomal aberrations analysis 
For the analysis of CAs the tested and control doses 
were the same as described for the SCE analysis. 
Twenty-one hours after the treatment, the animals 
were injected i.p. with colchicine (6.0 mg/kg body 
weight), 2 hours before sacrifice. Bone marrow pre-
parations for the analysis of CAs in metaphases cells 
were obtained by the technique of Yosida and 
Amano.12 The slides were stained with 7% Giemsa 
stain in phosphate buffer (pH 6.8). Five animals were 
included in each treatment group, and 100 well 
spread metaphases were analysed per animal for 
CAs. The slides were scored blindly by one scorer. 
Treatment of megestrol acetate along with ascorbic 
acid 
Megestrol acetate (32.50 mg/kg body weight) was 
given along with 20, 40 or 60 mg/kg body weight of 
ascorbic acid i.p. The doses of ascorbic acid fall 
within the dose range used in humans.13 Ascorbic 
acid treatments alone were also given to different 
groups of animals. Analysis of CAs and SCEs were 
done similarly as described earlier in the text. 
Statistical analysis 
Student's two-tailed f-test was used for the analysis 
of CAs and SCEs. The level of significance was 
obtained from the standard statistical table of Fisher 
and Yates.14 
Results 
In the SCEs analysis, a clear dose-dependent in-
crease in SCEs/cell was observed when megestrol 
acetate alone was administered (Table 1). SCEs/cell 
were statistically significantly increased at 16.25 
and 32.50 mg/kg of body weight. When 32.50 mg/kg 
body weight of megestrol acetate was given along 
with different doses of ascorbic acid, a clear sig-
nificant dose-dependent decrease in SCEs/cell was 
observed at all of the doses tested (Table 2). 
In the CAs analysis, a dose-dependent increase 
was observed in the number of abnormal cells. A 
statistically significant increase was observed at 
16.25 and 32.50 mg/kg body weight of megestrol 
acetate (Table 3). Treatment with 32.50 mg/kg body 
weight of megestrol acetate along with 20, 40 or 
60 mg/kg body weight of ascorbic acid resulted in a 
significant decrease in the number of abnormal cells 
(Table 4). Robertsonian translocations were comple-
tely eliminated when 32.50 mg/kg body weight of 
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Table 1 Frequency of SCEs induced by megestrol acetate in mice bone marrow 
Treatment No. of metaphases analysed Mean SCEs/metaphase±SE Range 
Megestrol acetate (mg/kg body weight) 
8.12 
16.25 
32.50 
Untreated 
Positive control (MNNG, 1.2 x 104 ug/kg body weight) 
Negative control (DMSO, 0.1 mL/animal) 
BrdU (1.6 g/kg body weight) 
300 
300 
300 
300 
300 
300 
300 
3.87 + 0.31 
9.43a + 0.67 
10.04a + 0.70 
2.13 + 0.16 
12.53a + 0.77 
2.47 + 0.21 
2.93 + 0.29 
1-6 
2-8 
2 -9 
0-5 
3-10 
0-5 
0-5 
"P <0.01 with respect to untreated (Student's (-test) (five animals per group). 
SE, standard error. 
Table 2 Frequency of SCEs induced by megestrol acetate and ascorbic acid treatment 
Treatment No. of metaphases analysed Mean SCEs/metaphase +SE Range 
Megestrol acetate (mg/kg body weight) 
32.50 300 
Megestrol acetate (mg/kg body weight) + ascorbic acid (mg/kg body weight) 
32.50+20 300 
32.50 + 40 300 
32.50 + 60 300 
Ascorbic acid (mg/kg body weight) 
20 300 
40 300 
60 300 
Untreated 300 
11.02a + 0.74 
8.13b + 0.64 
7.42b + 0.61 
6.73b + 0.54 
2.30 + 0.20 
2.73 + 0.23 
2.90 + 0.28 
2.10 + 0.18 
2-9 
2-7 
2-7 
2-6 
0-5 
0-5 
0-5 
0-5 
"P <0.01 with respect to untreated (student's (-test) (five animals per group); SE, standard error. 
bP <0.05 with respect to megestrol acetate (student's (-test). 
megestrol acetate was given along with 60 mg/kg 
body weight of ascorbic acid. 
Discussion 
In the present investigation megestrol acetate was 
observed to increase CAs and SCEs frequencies at 
two of three tested doses. There have been similar 
observations on the DNA-damaging properties of 
steroids, as evident from chromosomal damage and 
induction of SCEs.15-21 Catechol oestrogens have 
been reported to induce DNA damage by generating 
reactive oxygen species or free radicals.22-27 Certain 
synthetic steroids were mutagenic in Ames Salmo-
nella tester strains probably by generating active 
oxygen species in the system.28 
Table 3 Mean percentage of CAs in mouse bone marrow cells after megestrol acetate 
Treatment 
Megestrol acetate 
(mg/kg body weight) 
8.12 
16.25 
32.50 
Untreated 
Positive control MNNG 
(1.2 x 104 ug/kg body weight) 
Negative control DMSO 
(0.1 mL/animal) 
Abnormal metaphases 
without gaps 
Number 
12 
43 
70 
9 
122 
8 
Mean %±SE 
2.4 + 0.6 
8.6a + 1.2 
14.0a + 1.5 
1.8 + 0.6 
24.4a + 1.9 
1.6 + 0.5 
i 
Gaps 
Number 
7 
21 
27 
7 
30 
5 
% 
1.4 
4.2 
5.4 
1.4 
6.0 
1.0 
Chromosome 
aberrations 
Fragments 
andlor breaks 
Number 
10 
32 
50 
6 
85 
7 
% 
2.0 
6.4 
10.0 
1.2 
17.0 
1.4 
Robertsonian 
translocations 
Number 
4 
9 
20 
% 
0.8 
1.8 
4.0 
Polyploidy 
Number % 
2 0.4 
7 1.4 
11 2.2 
3 0.6 
17 3.4 
1 0.2 
One hundred cells were analysed per animal, for a total of 500 cells/treatment (five animals per group). 
aP < 0.01 with respect to untreated (student's f-test). 
SE, standard error. I 
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Table 4 Mean percentage of CAs in mouse bone marrow cells after megestrol acetate and ascorbic acid treatment 
Treatment Abnormal metaphases 
without gaps 
Number Mean%+SE 
Chromosome aberrations 
Gaps Fragments and/ Robertsonian 
or breaks translocations 
Number % Number % Number % 
Polyploidy 
Number 
Megestrol acetate (mg/kg body weight) 
32.50 73 14.6a±1.5 28 5.6 51 1Q.2 12 2.4 10 
Megestrol acetate (mg/kg body weight) + ascorbic acid (mg/kg body weight) 
One hundred cells were analysed per animal, for a total of 500 cells/treatment (five animals per group). 
°P <0.01 with respect to untreated (student's t-test). 
hP <0.05 with respect to megestrol acetate (student's r-test). 
SE, standard error. 
2.0 
32.50 + 20 
32.50 + 40 
32.50 + 60 
Ascorbic acid (mg/kg body weight) 
20 
40 
60 
Untreated 
41 
37 
25 
10 
11 
12 
7 
8.2b±1.2 
7 .4 b ±l . l 
5.0b±0.9 
2.0±0.6 
2.2 ±0.6 
2.4 + 0.6 
1.4 + 0.5 
15 
12 
11 
6 
7 
7 
5 
3.0 
2.4 
2.2 
1.2 
1.4 
1.4 
1.0 
31 
30 
21 
8 
9 
9 
6 
6.2 
6.0 
4.2 
1.6 
1.8 
1.8 
1.2 
3 
2 
-
-
-
-
-
0.6 
0.4 
-
-
-
-
-
7 
5 
4 
2 
2 
3 
1 
1.4 
1.0 
0.8 
0.4 
0.4 
0.6 
0.2 
Vitamins act as antioxidants and free radical 
scavengers, thereby acting as anticarcinogenic, an-
ticlastogenic and antimutagenic agents. Of these, 
ascorbic acid and a-tocopherol are among the best 
known antioxidants used in in vivo animal mod-
els.29 Ascorbic acid possesses a substantial nucleo-
philic character and it has been suggested that 
ascorbate might protect against electrophilic attack 
on cellular DNA by intercepting reactive agents, or 
that ascorbyl anion radical, with a high extent of 
unpaired electron derealization, is responsible for 
the scavenging of jxee radicals.31,32 However, ascor-
bic acid has been shown to be cytotoxic at higher 
concentrations, but the selected doses lie within the 
range of humans.33 As the treatment with ascorbic 
acid results in a decrease of the genotoxic damage 
Megestrol acetate (MGA) 
Homolytic 
— i 
fission vr1 CH, CHS 
OH + O H ^ D ^ H 2 0 2 
Fe2++ H202^2!5ireac,i°n ,3+ *. Fe
J
 + OH+OhT 
XOH 
CH3 
i 
OH* 
SOD 
Fe2* 
= Reactive nucleophile within the cell. 
= Methyl group attached to the carbon atom (C-6) of megestrol acetate. 
= Enhancing the electrophilic nature of O moiety. 
= Hydroxyl radical unstable. 
= Superoxide dismutase. 
= Ferrous ion present within the cell. 
Figure 1 Possible mechanism of generating free radicals by megestrol acetate (MGA). 
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HC/.
 r V + 
Ascorbic acid Ascorbate OH 
HO H 
^ ^ ° \ G—CH2OH 
0—C 
HO H 
^ ° \ .C-CH2OH +H20 
Ascorbate 
OH* = Hydroxyl radical unstable 
H+ = Hydrogen ion present within the cell 
Figure 2 Possible mechanism of ascorbic acid in scavenging free radicals generated by megestrol acetate. 
induced by megestrol acetate, it is possible that it 
generates free radicals or reactive oxygen species, 
which are responsible for the genotoxic damage. In 
the light of the results obtained in our study, we 
suggest a possible mechanism of free radical gen-
eration for megestrol acetate (Figure 1) with a 
scavenging role of ascorbic acid (Figure 2). As is 
obvious from Figure 1, XOOH can also give rise to 
XOO' (alkoxyl) and 'OOH (peroxyl) radicals. The 
presence of alkoxyl (XOO") radical appears to be a 
very remote possibility in view of the highly polar 
nature of the living system, because X would have to 
be essentially an alkyl group.28 Hydroxyl radical 
(*0H) is converted into hydrogen peroxide by 
superoxide dismutases.34 Hydrogen peroxide is 
known to cause DNA damage in the form of single 
and double strand breaks, CAs35'36 and SCEs.37 The 
reactive oxygen species that interacts with DNA is 
considered to be the hydroxyl radical (*0H) gener-
ated from hydrogen peroxide by the Fenton reac-
tion.38 Ascorbic acid scavenges the hydroxyl radical 
(*0H) and prevents genotoxic damage (Figure 2). 
Certain steroids have been reported to induce 
DNA repair synthesis39,40 and DNA adducts in rat 
liver cells.41 Megestrol acetate induces DNA repair 
synthesis42 and DNA adducts in cultured human 
hepatocytes.43 No significant difference in the fre-
quency of abnormal karyotypes was seen in a study 
of spontaneous abortuses of women who had taken 
oral contraceptives having megestrol acetate.44 Our 
study shows induction of SCEs and CAs by meges-
trol acetate. Most CAs observed in cells are lethal, 
but corresponding aberrations that are viable cause 
genetic effects% either somatic or inherited. Ascorbic 
acid treatment results in the reduction of genotoxic 
damage induced by megestrol acetate, suggesting a 
protective role of ascorbic acid against genotoxic 
damage. 
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Protective role of allicin and L-ascorbic acid against the genotoxic damage 
induced by chlormadinone acetate in cultured human lymphocytes 
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In our present study, different doses of allicin and L-ascorbic acid were tested against the genotoxic damage induced by 
chlormadinone acetate (CMA; 40 \iM) using chromosomal aberrations (CAs) and sister chromatid exchanges (SCEs) as the 
parameters. Treatment with allicin and L-ascorbic acid resulted in reduction of CAs and SCEs. The results suggested a 
protective role of allicin and L-ascorbic acid against CMA induced genotoxic damage. 
Keywords: Allicin, Antioxidants, L-Ascorbic acid, Chlormadinone acetate, Chromosomal aberrations, Sister chromatid 
exchanges 
Synthetic progestins are widely used as oral 
contraceptives and to treat hormonal imbalances. 
Prolonged use of oral contraceptives have been shown 
to develop different types of cancer.1 The genotoxic 
effects of steroids can be reduced by the use of 
various antioxidants2 and natural plant products." In 
our earlier study, chlormadinone acetate (CMA) has 
been shown to cause chromosomal aberrations (CAs) 
and sister chromatid exchanges (SCEs) in mice bone 
marrow cells.4 In in vitro study it is reported to be 
genotoxic by generating reactive oxygen species 
(ROS).5 Allicin (diallyl thiosulphinate) and L-ascorbic 
acid are well known antioxidants. Allicin, one of the 
sulphur • compounds of garlic (Allium sativum), 
possess antioxidant,6 antigenotoxic7"8 and free radical 
scavenging property.9 In our present study, we have 
tested the effect of allicin and L-ascorbic acid against 
the genotoxic damage induced by CMA in human 
lymphocytes. 
Materials and Methods 
Chemicals—RPMI 1640 (Gibco), fetal calf serum 
(Gibco), phytohaemagglutinin-M (Gibco), Hoechst 
33258 stain (0.05% w/v; Sigma), dimethylsulphoxide 
(5 ul/ml; E. Merck, India), colchicine 0.20 ug/ml 
(Microlab), allicin, chlormadinone acetate (CAS No: 
302-22-7; 17-(acetyloxy)-6-chloropreg-4,6-diene-3,20-
diene (Wyeth lab), 5-bromo-2-deoxyuridine (Sigma), 
antibiotic antimycotic mixture (Gibco), 3% Giemsa 
•"Correspondent author 
email: yasir_hasansiddique@rediffmail.com 
solution in phosphate buffer (pH 6.8; E. Merck, India), 
mitomycin C (Sigma), L-ascorbic acid (CAS No. 50-
81-7, SRL). 
Human lymphocyte culture—duplicate peripheral 
blood cultures were prepared according to Carballo et 
al.i0 Heparinized blood samples (0.5 ml) were obtained 
from a healthy female donor, and were placed in a 
sterile flask containing 7 ml of RPMI 1640 
supplemented with fetal calf serum (1.5 ml) and of 
phytohaemagglutinin (0.1 ml). They were placed in the 
incubator at 37°C for 24 hr. Untreated, negative and 
positive controls were also run simultaneously. 
Chromosomal aberrations (CAs) analysis—After 24 
hr of incubation of human lymphocyte culture, 
chlormadinone acetate (40 uAf) was supplemented 
alone, and along with 5 and 10 \xM of allicin and 40 
and 80 \xM of L-ascorbic acid and kept for 48 hr at 
37°C in the incubator. Doses .of allicin (5, 10 \xM) and 
L-ascorbic acid (40, 80 \xM) were also given 
separately. Prior to 1 hr of harvesting 0.2 ml of 
colchicine (0.2 ug/ml) was added to the culture flasks. 
Cells were centrifuged at 1000 rpm for 10 min. The 
supernatant was removed and 5 ml of prewarmed 
(37°C) KC1 hypotonic solution (0.075 M) was added. 
Cells were resuspended and incubated at 37°C for 15 
min. The supernatant was removed by centrifugation at 
1000 rpm for 10 min, and 5 ml of chilled fixative 
(methanohglacial acetic acid; 3:1) was added. The 
fixative was removed by centrifugation and the 
procedure was repeated twice. The slides were stained 
in 3% of Giemsa solution in phosphate buffer (pH 6.8) 
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for 15 min. At least 300 metaphases were examined for 
the occurrence of different types of abnormality i.e. 
gaps, fragments, breaks and exchanges. Criteria to 
classify the different types of aberrations were in 
accordance with the recommendation of EHC 46 for 
Environmental Monitoring of Human Population". 
Sister chromatid exchanges (SCEs) analysis—For 
SCE analysis, bromodeoxyuridine (BrdU, 10 fxg/ml) 
was added at the beginning of the culture. After 24 hr 
of culture, 40 \iM of CMA alone and along with 5 and 
10 u.M of allicin and 40 and 80 \iM of L-ascorbic acid 
was treated and kept for 48 hr at 37°C in the 
incubator. Mitotic arrest was done 1 hr prior to 
harvesting by adding 0,2 ml of colchicine (0.2 \iglm\). 
Hypotonic treatment and fixation were performed in 
the same way as described for CAs analysis. The 
sides were processed according to Perry and Wolff.12 
SCE average was taken from an analysis of 50 sec 
division metaphases. 
Statistical analysis—Student's t test was used for 
the analysis of CAs and SCEs. The level of 
significance was tested from standard statistical tables 
of Fisher and Yates13. 
Results 
In CAs analysis, reduction in the number of 
abnormal cells was observed when treated with 5 and 
10 \iM of allicin. Similarly, 40 and 80 \iM of L-
ascorbic acid treatment with 40 \iM of CMA results in 
the reduction of abnormal cells (Table 1). • 
In SCEs analysis a clear dose depended decrease 
was observed when 40 \iM of CMA was treated with 
5 and 10 \iM of allicin. Similar trend was observed 
when 40 \y.M of CMA was treated with 40 and 80 \xM 
of L-ascorbic acid (Table 2). 
Discussion 
The results of our investigation revealed that allicin 
and L-ascorbic acid treatment results in the reduction 
of the genotoxic damage induced by CMA. Allicin 
possesses antioxidant6 and thioldisulphide exchange 
activity . Allicin might have diffused through cell 
membrane and probably prevents free radicals from 
reacting the critical target sites (Fig. 1) and results in 
the reduction of the genotoxic damage induced by 
CMA '. L-ascorbic acid is a powerful antioxidant, 
which plays an important role in intracellular 
Table 1—Effect of allicin and L-ascrobic acid against chromosomal aberrations (CAs) induced by chlormadinone 
Treatment 
CMA (uA/) 
40 
CMA (uAf) + Allicin {\xM) 
40 + 5 
40+10 
CMA (|iM) + L-ascorbic acid {\i.M) 
40 + 40 
40 + 80 
Allicin (\xM) 
5 
10 
L-ascorbic acid (|i,M) 
40 
80 
Untreated 
Negative control 
DMSO (5u.l/ml) 
Positive control 
(Mitomycin C 0.3 (xg/ml) 
Abnormal metaphases 
without gaps Chromosomal aberrations 
Number 
18 
9 
7 
10 
6 
2 
3 
3 
4 
2 
3 
27 
Percentage H* 
6.00±1.37a 
3.00±0.98b 
2.33+0.87" 
3.33±1.03b 
2.00±0.80b 
0.67±0.47 
1.00+0.57 
1.00±0.57 
1.33±0.66 
0.67±0.47 
1.00±0.57 
9.00±1.65 
"Significant with respect to untreated (P<0.01) 
"Significant with respect to CMA (P<0.01) 
CMA: Chlormadinone acetate; DMSO: Dimethylsulphoxide. 
*F Values are mean ± SE. 
Gaps 
8 
5 
4 
4 
3 
14 
CTB 
11 
7 
5 
7 
4 
2 
2 
2 
2 
2 
2 
20 
CSB 
7 
2 
2 
3 
2 
CTE DIC 
10 
acetate 
Total breaks 
without gaps 
(%) 
18 (6.00) 
9 (3.00) 
7 (2.33) 
10(3.33) 
6 (2.00) 
2 (0.67) 
3(1.00) 
3(1.00) 
4(1.33) 
2 (0.67) 
3(1.00) 
42 (14.00) 
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Table 2—Effect of allicin and L-ascorbic acid against sister 
chromatid exchanges (SCEs) induced by chlormadinone acetate 
Cells scored SCEs/Cell ¥ Treatment 
CMA(y.M) 
40 50 
CMA (jiM) + Allicin (uM) 
40 + 5 50 
40+10 50 
CMA (uM) + L-ascorbic acid (uM) 
40 + 40 
40 + 80 
Untreated 
Allicin (\iM) 
5 
10 
L-ascorbic acid (uA/) 
40 
80 
Untreated 
Negative control 
DMSO (5 fxl/ml) 
Positive control 
50 
50 
50 
50 
50 
50 
50 
50 
50 
50 
6.89±0.88a 
3.2910.68" 
2.79±0.64b 
3.54±0.71b 
2.33+0.51" 
1.76+0.29 
5.31+0.83" 
6.23±0.86a 
2.31+0.48 
3.01+0.55 
1.87+0.32 
2.01±0.38 
9.34±1.24a 
Range 
2 - 8 
1-6 
1 - 5 
1-6 
1 - 5 
0 - 5 
2 - 6 
2 - 7 
0 - 5 
1-5 
0 - 5 
0 - 5 
2 - 1 2 
(Mitomycin C, 0.3 fig/ml) 
"Significant with respect to untreated (f<0.05); "respect to CMA 
(P<0.05) 
CMA: Chlormadinone acetate DMSO: Dimethylsulphoxide 
4* Values are mean ± SE. 
oxidation/reduction system, and in binding of free 
radicals produced endogenously15. L-ascorbic acid 
reduced the clastogenic effects of generated by certain 
chemical agents in the in vivo and in vitro assays16"18. 
According to Edgar19 L-ascorbic acid possesses 
substantial nucleophilic property and ascorbate might 
protect against electrophilic attack on cellular DNA 
by intercepting reactive agents or ascorbyl anion 
radical (Fig. 2) with a high extent of unpaired electron 
derealization is responsible for the scavenging of 
free radicals20"21. However, L-ascorbic acid has been 
shown to be cytotoxic at higher concentration22 but 
the selected doses in the present study lies within the 
range of human use23. The treatment with L-ascorbic 
acid results in the reduction of genotoxic damage 
induced by CMA. This also confirmed the production 
of reactive oxygen species by CMA. Our study 
confirmed, that the free radical scavenging property 
of allicin and L-ascorbic acid is responsible for the 
reduction of the genotoxic damage. 
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Abstract 
Nordihydroguaiaretic acid (NDGA) is a phenolic lignan and possesses antioxidant and number of properties potentially useful to 
man. The effect of NDGA was studied against norgestrel induced genotoxic damage, using sister chromatid exchanges (SCEs), chro-
mosomal aberrations (CAs), mitotic index (MI) and replication index (RI) as parameters. Amounts of 5, 10 and 20 uM of norgestrel 
was tested for its genotoxic effect in the absence as well as presence of S9 mix, and was found to be genotoxic at 10 and 20 uM in the 
presence of S9 mix. Again, 10 uM of norgestrel was treated with 0.5 and 1 uM of NDGA, separately, in the presence of S9 mix. 
Similar treatment was given with 20 uM of norgestrel. Treatments given with NDGA result in the reduction of SCE, CA and 
increase of MI as well as RI, suggesting its protective action on human lymphocytes in vitro against the norgestrel induced genotoxic 
damage. 
© 2005 Elsevier Ltd. All rights reserved. 
Keywords: Nordihydroguaiaretic acid; Norgestrel; Human lymphocytes; Antioxidants; Genotoxicity 
1. Introduction 
Synthetic progestins are used in oral contraceptives, 
treatment of various menstrual disorders, different types 
of cancer and hormonal replacement therapy (Rubin, 
1990). Norgestrel was reported to be genotoxic in 
human peripheral blood lymphocytes in vitro (Ahmed 
et al., 2001). Chromosomal abnormalities and sister 
chromatid exchanges have been reported in peripheral 
blood lymphocytes of women taking oral contraceptives 
(Carr, 1967; Goh, 1967; Murthy and Prema, 1979). A 
significant increase in the number of lymphocytes with 
DNA migration in alkaline comet assay and frequency 
of sister chromatid exchanges (SCEs) per metaphase 
was observed in oral contraceptive users as compared 
* Corresponding author. Tel.: +91 5712703694; fax: +91 
5712708088. 
E-mail address: yasir_hasansiddique@rediffmail.com (Y.H. Siddi-
que). 
with their age-matched untreated controls (Biri et al., 
2002). Synthetic progestins have DNA damaging prop-
erty as evident from chromosomal damage, induction 
of SCEs (Singh et al., 1994; Dhillon et a l , 1994; Siddi-
que and Afzal, 2004b,c,d,e,f; Siddique and Afzal, 
2005), formation of endogenous D N A adducts and cer-
tain neoplastic changes (Martelli et al., 2003; Brambilla 
and Martelli, 2002). Certain synthetic steroids and estro-
gens are reported to generate reactive oxygen species 
or free radicals responsible for the genotoxic damage 
(Islam et a l , 1991; Nutter et al., 1994; Thibodeau and 
Paquette, 1999). 
Nordihydroguaiaretic acid (NDGA) is a phenolic lig-
nan, present in the evergreen shrubs Larrea divaricata 
and Guaiacum officinale (Agarwal et al., 1991). N D G A 
possesses a number of interesting biological properties, 
which are of potential use for humans such as an enzyme 
inhibitor (Capdevilla et al., 1988), having antimicrobial 
properties (Hurtado et al., 1979), a protector from 
neurotoxicity and bladder toxicity (Frasier and Kehrer, 
0887-2333/$ - see front matter © 2005 Elsevier Ltd. All rights reserved. 
doi:10.1016/j.tiv.2005.06.027 
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1993; Rothman et al., 1993), stimulator of corpus lut-
eum for the secretion of progesterone (Carlson et al., 
1995), potential vaso and branchiodilator (Nagano 
et al., 1996) and antimutagenic action (Wang et al., 
1991). 
The use of synthetic progestins cannot be completely 
eliminated as oral contraceptives, but the genotoxic 
damage caused by steroids can be reduced by the use 
of antioxidants (Ahmad et al , 2002; Siddique et al., 
2005b) and natural plant products (Ahmad et al., 
2002; Siddique and Afzal, 2004a) and, so in this context 
natural plant products, having antioxidant or free radi-
cal scavenging property can form a good base. NDGA 
has been reported to possess both genotoxic (Madri-
gal-Bujaidar et al., 1998a) and antigenotoxic potential 
(Madrigal-Bujaidar et al., 1998b) both in vivo and 
in vitro. In the present, we studied the antigenotoxic ef-
fect of NDGA against norgestrel induced genotoxic 
damage in human lymphocytes in vitro. 
2. Material and methods 
2.1. Chemicals 
Norgestrel (CAS No. 797-63-7), Mitomycin C and 
cyclophosphamide were purchased from Sigma Chemi-
cals. RPMI 1640, Phytohaemagglutinin-M, Antibiotic-
Antimycotic mixture, fetal calf serum, were purchased 
from Gibco. Dimethylsulphoxide, Giemsa solution from 
Merck, India. 5-Bromo-2-deoxyuridine was purchased 
from SRL, India. Nordihydroguaiaretic acid (CAS 
No. 500-38-9) and Hoechst 33258 stain were procured 
from Fluka. 
2.2. Human lymphocyte culture 
Duplicate peripheral blood cultures were treated 
according to Carballo et al. (1993). Briefly 0.5 ml of hep-
arinized blood samples were obtained form a healthy fe-
male donor, and were placed in a sterile flask containing 
7 ml of RPMI 1640 medium, supplemented with 1.5 ml 
of fetal calf serum and 0.1 ml of phytohaemagglutinin 
and kept in an incubator at 37 °C for 72 h. 
2.3. Sister chromatid exchange analysis 
For sister chromatid exchange analysis, bromodeoxy-
uridine (BrdU, 10 ug/ml) was added at the beginning of 
the culture. After 24 h of initiation of the culture, norge-
strel dissolved in dimethylsulphoxide at 5, 10 and 20 uM 
was added. For metabolic activation experiments, the 
tested doses were given along with 0.5 ml of rat liver 
microsomal fraction (S9 mix). Rat liver S9 mix was pre-
pared from Swiss albino healthy rats (Wistar strain) as 
per standard procedures of Maron and Ames (1983). 
The S9 fraction was enhanced by addition of 5 uM 
NADP and 10 uM glucose-6-phosphate just before 
use. Dimethylsulphoxide (5 ul/ml) was taken as negative 
control. Mitomycin C (0.3 ug/ml) and cyclophospha-
mide (0.16 ug/ml) were taken as positive control for 
metabolic and without activation experiments, respec-
tively. One hour prior to harvesting, 0.2 ml of colchicine 
(0.2 ug/ml) was added to the culture flask. Cells were 
centrifuged at 1000 rpm for 10 min. Five millilitres of 
prewarmed (37 °C) 0.075 M KC1 (hypotonic solution) 
was added. Cells were resuspended and incubated at 
37 °C for 15 min. The supernatant was removed by cen-
trifugation and 5 ml of fixative (methanohglacial acetic 
acid; 3:1) was added. The fixative was removed by cen-
trifugation and the procedure was repeated twice. The 
slides were processed according to Perry and Wolff 
(1974). Slides were stained for 20 min in a 0.05% (w/ 
v), Hoechst 33258 solution rinsed with tap water and 
placed under a UV lamp for 90 min, covered with Soren-
sen's buffer (pH 6.8) and stained with 3% Giemsa solu-
tion in phosphate buffer (pH 6.8) for 15 min. The 
sister chromatid exchange average was taken from an 
analysis of the metaphases during the second cycle of 
divisions. 
2.4. Chromosomal aberration analysis 
For analysis of structural chromosomal aberrations 
parallel culture were carried out without BrdU for 
72 h. Treatments were similar as described in sister chro-
matid exchanges analysis. After 24 h of initiation of the 
culture, norgestrel at 5, 10 and 20 uM dissolved in 
DMSO was added. For metabolic activation experi-
ments, the tested doses of norgestrel dissolved in DMSO 
were given along with 0.5 ml of S9 mix. The cells were 
cultured for another 48 h at 37 °C in an incubator. 
One hour prior to harvesting 0.2 ml of colchicine 
(0.2 ug/ml) was added to the culture flask. Hypotonic 
treatment and fixation were performed in the same 
way as in sister chromatid exchange analysis. To prepare 
slides, 3-5 drops of the fixed cell suspension were 
dropped on a clean slide and air-dried. The slides were 
stained in 3% Giemsa solution in phosphate buffer 
(pH 6.8) for 15 min. Three hundred metaphases were 
examined for the occurrence of different types of abnor-
mality. Criteria to classify the different types of aberra-
tions were in accordance with the recommendation of 
EHC 46 for Environmental Monitoring of Human pop-
ulations (IPCS, 1985). The mitotic index (MI) was 
scored as the number of metaphases among 1000 lym-
phocytes nuclei and expressed as a percentage. 
2.5. Cell cycle kinetics 
Cells undergoing, first (Mi), second (M2) and third 
(M3) metaphase divisions were detected with BrdU-
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Harlequin technique for differential staining of meta-
phase chromosomes (Tice et al., 1976; Crossen and 
Morgan, 1977) both in the presence and absence of met-
abolic activation (S9 mix). Treatments were similar as 
described earlier in the text. The replication index 
(RI), an indirect measure of studying cell cycle progres-
sion was calculated by applying the following formula 
(Ivett and Tice, 1982): 
Mi + 2M2 + 3M3 RI = : 100 
2.6. Induction ofSCEs, CAs and analysis of cell cycle 
kinetics in the presence of nordihydroguaiaretic acid 
(NDGA) by norgestrel 
Ten uM of norgestrel was treated with 0.5 and 1 nM 
of NDGA to see the effect on SCEs, CAs, MI, and cell 
cycle kinetics induced by norgestrel in the presence of 
0.5 ml of S9 mix. Similar treatment was given along with 
20 uM of norgestrel. Duplicate cultures for SCEs, CAs, 
MI and cell cycle kinetics analysis were set, similarly, in 
the presence of 0.5 ml of S9 mix, as described earlier in 
the text. 
Table 1 
Effect of norgestrel on sister chromatid exchanges (SCEs) in the 
absence of S9 mix 
Treatment 
Norgestrel (uM) 
5 
10 
20 
Untreated 
Negative control 
(DMSO, 5 ul/ml) 
Positive control 
(Mitomycin C, 0.3 ug/ml) 
Metaphase 
scanned 
50 
50 
50 
50 
50 
50 
SCEs/cell ± SE 
3.21 ±0.32 
4.13 ±0.38 
4.67 ± 0.41 
1.79 ±0.27 
2.32 ±0.30 
13.46 ±0.71* 
Range 
0-5 
0-5 
0-5 
0-5 
0-5 
2-9 
DMSO: dimethylsulphoxide; SE: standard error. 
Significant with respect to untreated (P<0.01). 
2.7. Statistical analysis 
Student's two-tailed Y test was used for the analysis 
of SCEs and CAs, whereas chi-square test (%2) was used 
to analyse the cell cycle kinetics. The level of significance 
was tested from standard statistical tables of Fisher and 
Yates (1963). 
3. Results 
Norgestrel induced neither SCEs nor CA, nor af-
fected MI and RI at significant level in the absence of 
metabolic activation (Tables 1, 2 and 5). In SCEs anal-
ysis, a clear dose dependent increase in SCEs/cell was 
observed when treated with norgestrel alone in the pres-
ence of metabolic activation (Table 3). SCEs/cell were 
significantly increased at 10 and 20 uM of norgestrel. 
When 10|iM of norgestrel was treated with 0.5 and 
1 uM of NDGA, SCEs/cell got decreased significantly 
as compared to norgestrel treated alone. Similar trend 
was observed when 20 uM of norgestrel was treated with 
0.5 and 1 uM of NDGA (Table 3). 
In CAs analysis, treatment with norgestrel alone re-
sulted in a dose dependent increase of chromosomal 
aberrations in the presence of metabolic activation. 
However a significant increase was observed at 10 and 
20 uM of norgestrel (Table 4). When 10 uM of norge-
strel was treated with 0.5 and 1 uM of NDGA, a signif-
icant decrease in abnormal cells was observed as 
compared to norgestrel treated alone. Similar trend 
was observed when 20 \iM of norgestrel was treated with 
0.5 and 1 uM of NDGA (Table 4). 
The MI showed a reduction in the percentage of 
mitosis in all the dose assayed in the presence of meta-
bolic activation (Table 4). There was increase in the per-
centage of mitosis when 10 \xM of norgestrel was treated 
with 0.5 and 1 uM of NDGA as compared to norgestrel 
treated alone. Similar trend was observed when 20 uM 
Table 2 
Chromosomal aberrations (CAs) in human lymphocytes treated with norgestrel without S9 mix3 
Treatment Abnormal metaphases Chromosome aberrations 
without gaps 
Number Mean ± SE Gaps CTB CSB CTE DIC 
MI% 
Norgestrel (uM) 
5 
10 
•20 
Untreated 
Negative control (DMSO, 5 ul/ml) 
Positive control (Mitomycin C, 0.3 ug/ml) 
7 
10 
11 
3 
2 
70 
2.3 ±0.8 
3.3 ±1.0 
3.6 ±1.0 
1.0 ±0.3 
0.6 ±0.2 
13.3 ± 2.4* 
5 
7 
8 
1 
1 
36 
5 
7 
8 
2 
2 
47 
2 
3 
3 
1 
-
25 
2.5 
2.4 
2.4 
2.8 
2.7 
0.7 
CTE: chromatid exchange; DIC: dicentric; DMSO: dimethylsulphoxide; SE: standard error; CTB: chromatid break; CSB: chromosome break. 
* Significant with respect to untreated (P < 0.01). 
a
 Metaphases showing only gaps were not scored as abnormal. 
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Table 3 
Effect of nordihydroguaiaretic acid on sister chromatid exchanges (SCEs) induced by norgestrei in the presence of S9 mix 
Treatment Metaphase scanned SCEs/cell ± SE Range 
Norgestrei (uM) 
5 
10 
20 
NDGA (uM) + Norgestrei (uM) 
0.5 + 10 
0.5 + 20 
1.0+10 
1.0 + 20 
Untreated 
Negative control (DMSO, 5 ul/ml) 
Positive control (Cyclophosphamide, 0.16 ug/ml) 
NDGA (uM) 
0.5 
1.0 
50 
50 
50 
50 
50 
50 
50 
50 
50 
50 
50 
50 
3.61 ± 0.34 
9.32 + 0.61* 
11.47 + 0.69* 
5.01 ± 0.46" 
7.31 + 0.53" 
4.23 + 0.41** 
6.01 ± 0.48** 
1.83 + 0.25 
2.01+0.29 
13.46 + 0.71* 
2.97 ± 0.30 
3.41 ± 0.31 
0-5 
1-7 
2-8 
0-5 
0-6 
0-5 
0-6 
0-5 
0-5 
2-9 
0-5 
0-5 
NDGA: nordihydroguaiaretic acid; DMSO: dimethylsulphoxide; SE: standard error, 
Significant with respect to untreated (P < 0.01). 
Significant with respect to norgestrei (P < 0.05). 
Table 4 
Effect of nordihydroguaiaretic acid on chromosomal aberrations (CAs) induced by norgestrei in the presence of S9 mix" 
Treatment Abnormal metaphases 
without gaps 
Chromosome aberrations 
Number Mean ± SE Gaps CTB CSB CTE DIC 
MI% 
Norgestrei (uM) 
5 
10 
20 
NDGA (uM) + Norgestrei (uM) 
0.5+10 
0.5 + 20 
1.0 + 10 
1.0 + 20 
Untreated 
Negative control (DMSO, 5 ul/ml) 
Positive control (Cyclophosphamide, 0.16 ug/ml) 
NDGA (uM) 
0.5 
1.0 
10 
18 
24 
9 
13 
7 
10 
2 
3 
65 
4 
6 
3.3 + 1.0 
6.0+1.3* 
8.0+1.5* 
3.0 + 0.9" 
4 .3+ l . f* 
2.3 + 0.8" 
3.3 + 1.0** 
0.6 ± 0.4 
1.0 + 0.5 
!1.7 ±2.3* 
1.3 + 0.6 
2.0 ± 0.8 
6 
10 
16 
6 
8 
5 
7 
1 
2 
31 
3 
5 
6 
11 
14 
7 
9 
5 
7 
2 
2 
42 
3 
4 
4 
7 
9 
2 
4 
2 
3 
-
1 
20 
1 
2 
2.1 
1.9 
1.8 
2.0 
1.9 
2.0 
2.1 
2.8 
2.7 
0.8 
2.5 
2.5 
CTE: chromatid exchange; DIC: dicentric; NDGA: nordihydroguaiaretic acid; DMSO: dimethylsulphoxide; SE: standard error; CTB: chromatid 
break; CSB: chromosome break. 
Significant with respect to untreated (P < 0.01). 
Significant with respect to norgestrei (P < 0.05), 
a
 Metaphases showing only gaps were not scored as abnormal. 
Table 5 
Effect of norgestrei on cell growth kinetics in the absence of S9 mix 
Treatment 
Norgestrei (uM) 
5 
10 
20 
Untreated 
Negative control (DMSO, 5 ui/mi) 
Positive control (Mitomycin C, C >.3 ug/ml) 
Cells scored 
200 
200 
200 
200 
200 
200 
Percent cells 
M, 
42 
44 
46 
35 
33 
64 
in 
M2 
42 
40 
39 
46 
52 
33 
M3 
16 
16 
15 
19 
15 
3 
Replication index 
1.74 
1.72 
1.69 
1.84 
1.82 
1.39* 
DMSO: dimethylsulphoxide. 
Significant with respect to untreated (P < 0.05). 
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Table 6 
Effect of nordihydroguaiaretic acid and norgestrel on cell growth kinetics in the presence of S9 mix 
Treatment 
Norgestrel (uM) 
5 
10 
20 
NDGA (uM)+Norgestrel (uM) 
0.5+10 
0.5 + 20 
1.0+10 
1.0 + 20 
Untreated 
Negative control {DMSO, 5 ul/ml) 
Positive control (Cyclophosphamide, 0.16 ng/ml) 
NDGA (uM) 
0.5 
1.0 
Cells scored 
200 
200 
200 
200 
200 
200 
200 
200 
200 
200 
200 
200 
Percent cells 
M, 
47 
56 
62 
49 
42 
46 
38 
37 
39 
68 
33 
36 
in 
M2 
42 
37 
34 
41 
50 
41 
47 
45 
46 
31 
51 
50 
M3 
11 
7 
4 
10 
8 
13 
15 
18 
' 15 
1 
16 
14 
Replication index 
1.64 
1.51* 
1.42* 
1.61" 
1.66" 
1.67" 
1.77" 
1.81 
1.76 
1.33" 
1.83 
1.78 
NDGA: nordihydroguaiaretic acid; DMSO: dimethylsulphoxide 
* Significant with respect to untreated (P < 0.05). 
" Significant with respect to norgestrel (P < 0.05). 
of norgestrel was treated with 0.5 and 1 uM of NDGA 
as compared to norgestrel treatment alone (Table 4). 
In cell cycle kinetics, treatment with norgestrel alone 
resulted in a dose dependent decrease in replication indi-
ces in the presence of metabolic activation. However, a 
significant decrease was observed at 10 and 20 u.M of 
norgestrel (Table 6). When 10 uM of norgestrel was 
treated with 0.5 and 1 uM of NDGA a significant in-
crease in replication indices was observed as compared 
to norgestrel treatment alone. Similar trend was ob-
served when 20 uM of norgestrel was treated with 0.5 
and 1 uM of NDGA (Table 6). 
4. Discussion 
The results of the present investigation reveal that nor-
gestrel was not genotoxic in the absence of S9 mix, but in-
creases SCEs and CAs frequencies significantly at two of 
the three tested doses in the presence of S9 mix. This is 
contrary to the observation by Ahmed et al. (2001), in 
which norgestrel was reported genotoxic in the absence 
as well as presence of metabolic activation (S9 mix), 
which might have been due to the high doses (> 25 \igl 
ml) of norgestrel used by them. The exact cause for the 
genotoxicity of norgestrel is not yet known. The meta-
bolic activation of norgestrel and possible conversion of 
it to a reactive species may be responsible for its genotox-
icity. Metabolic activation of estrogens such as estradiol-
170 and ethinyl estradiol results in the production of 
reactive oxygen species via redox cycling between qui-
nones and semi-quinone radicals (Bolton, 2002; Siddique 
et al., 2005a). Antioxidants and natural plant products 
are reported to reduce the genotoxic potential of steroids 
(Ahmad et al., 2002, 2004; Siddique and Afzal, 2004a). 
NDGA possess antioxidant (Olivetto, 1972) and free rad-
ical scavenging property (Nakadate, 1989; Marthy et al., 
1990), which may be use&il in reducing the genotoxic po-
tential of synthetic progestins. Cytochrome P450 in liver 
S9 fraction plays an important role in activating promu-
tagens to proximate and/or ultimate mutagens. Rat and 
human liver P450 is involved in the activation of some 
chemical carcinogens having different isoforms (Maron 
and Ames, 1983; Guengerich and Shimada, 1991). 
NDGA is also a potent inhibitor of cytochrome P450 
(Capdevilla et al., 1988). Since the NDGA treatment, in 
the presence of S9 mix reduced the genotoxic damage 
by norgestrel, the reduction may be due to the inhibition 
of cytochrome P450, which prevents the metabolic acti-
vation of norgestrel. The doses of NDGA were selected 
on the basis of study performed by Madrigal-Bujaidar 
et al. (1998b). In our present study NDGA reduces the 
genotoxic potential of norgestrel. The identification of 
specific mechanisms are under investigation. The modu-
latory property of NDGA may be responsible for the 
reduction of the genotoxic damage. 
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